DERIVADOS BICÍCLICOS DE IMIDAZO

Bicyclic imidazo derivatives with specific structural features address the challenge of controlling phytopathogenic fungi, particularly oomycetes, by offering effective fungicidal activity in agrochemical compositions for plant protection.

BR112025021764A2Pending Publication Date: 2026-11-10SYNGENTA CROP PROTECITON AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
BR112025021764
Authority / Receiving Office
BR · BR
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-04-13
Filing Date
2024-04-11
Publication Date
2026-11-10

AI Technical Summary

Technical Problem

Existing agricultural and horticultural methods lack effective compounds to combat phytopathogenic fungi, particularly oomycetes, which cause significant infestation and damage to plants and harvested crops.

Method used

Development of bicyclic imidazo derivatives with specific structural features, including various substituents and optionally forming heterocycles, which exhibit microbiocidal activity, particularly fungicidal activity against oomycetes, and are used in agrochemical compositions to control phytopathogenic fungi.

Benefits of technology

The bicyclic imidazo derivatives effectively reduce phytopathogenic fungi infestation to an improvement level, providing control and prevention of fungal attacks on plants and plant-derived products.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The current invention relates to compounds of the formula (I) wherein the substituents are as defined in claim 1, to processes and methods for preparing compounds of formula (I), to agrochemical compositions comprising compounds of formula (I) as defined in claim 1, to preparation of these compositions and to the use of the compounds or compositions in agriculture or horticulture for combating, preventing or controlling infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, in particular fungi.
Need to check novelty before this filing date? Find Prior Art

Description

[0001] The present invention relates to microbiocidal bicyclic imidazo derivatives, e.g., as active ingredients, which have microbiocidal activity, in particular fungicidal activity, more particularly activity against oomycetes. The invention also relates to the preparation of these bicyclic imidazo derivatives, to intermediates useful in the preparation of these bicyclic imidazo derivatives, to the preparation of these intermediates, to agrochemical compositions comprising at least one of the bicyclic imidazo derivatives, to the preparation of these compositions and to the use of the bicyclic imidazo derivatives or compositions in agriculture or horticulture for combating, controlling or preventing infestation of plants, harvested food crops, seeds or non-living materials by phytopathogenic microorganisms, in particular fungi, more particularly oomycetes.

[0002] Surprisingly, it has now been discovered that certain new bicyclic imidazo derivatives have favorable fungicidal properties, particularly against oomycetes.

[0003] Consequently, in a first aspect, the present invention provides compounds of formula (I) Petition 870260106348, dated 10 / 15 / 2026, p. 7 / 266 2 / 245 where Z is O or S and preferably Z is O; each A1 is N or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1s are independently selected from hydrogen, hydroxyl, halogen, CN, C1-alkyl, C3-6-cycloalkyl, C16-alkoxy-C1-6alkyl, C3-6-cycloalkyl-C1-4alkyl, C16-alkylsulfanyl, C1-6-alkylsulfinyl, C1-6-alkylsulfonyl, C1-6-alkoxy, amino and -NHC(O)C1-6alkyl; A2 are independently CR2 or N, provided that no more than three A2 are N, preferably no more than two A2 are N, preferably no more than one A2 is N, and most preferably all four A2 are CR2; R2s are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C2-6-alkenyl, C2-6-alkynyl, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-6alkyl, C16-alkylsulfanyl, C1-6-alkylsulfinyl, C1-6-alkylsulfonyl, C1-6-alkoxycarbonyl, C1-6-alkylaminocarbonyl, diC16-alkylaminocarbonyl and C1-6-alkylcarbonyl, wherein each of the groups C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C16-alkoxy-C1-6alkoxy, C2-6-alkenyl, C2-6-alkynyl, C36-cycloalkyl, C3-6cycloalkyl-C1-6alkyl,C16alkylsulfanyl,C1-6alkylsulfinyl,C1-6alkylsulfonyl,C1-6alkoxycarbonyl,C1-6alkylaminocarbonyl,diC16alkylaminocarbonyl and C1-6alkylcarbonyl is optionally replaced by one to three substituents independently selected from halogen, hydroxyl and CN; A3é CR3ou N; R3 is selected from hydrogen, halogen, CN, C16 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1 Petition 870260106348, dated 15 / 10 / 2026, page 8 / 266 3 / 245 ealkoxy, C2-ealkenyl, C2-6-alkynyl, C3-cycloalkyl, C3-6-cycloalkyl-C1-6-alkyl, C1-6-alkylsulfanyl, C1-alkylsulfinyl, C1-alkylsulfonyl, amino, C1-6-alkylamino, diC1-6-alkylamino and C3-6-cycloalkylamino, wherein each of the C1-alkyl, C1-ealkoxy, C1-6-alkoxy-C1-6-alkyl, C1-6-alkoxy-C1-6-alkoxy, C2-ealkenyl, C2-ealkynyl, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-6-alkyl, C1-6-alkylsulfanyl, C1-6-alkylsulfinyl, C1-6-alkylsulfonyl, amino, C1-6-alkylamino, diC1-6-alkylamino and C3-cycloalkylamino groups is optionally substituted by one to three substituents independently selected from halogen and CN; A4 is CH or N; R4 is selected from Ci-alkyl, Ci-alkoxy-Ci-alkyl, C36cycloalkyl, C3-6cycloalkyl-Ci-4alkyl, C2-6alkenyl, C2alkynyl, Ci-alkoxy, Ci-alkylsulfanyl-Ci-alkyl, Cyaalkylsulfinyl-Ci-alkyl, C1-alkylsulfonyl-C1-alkyl, C1-alkoxycarbonyl-C1-alkyl, C1-alkylaminocarbonyl-C1-alkyl, diC1-alkylaminocarbonyl-C1-alkyl and CN, wherein each of the groups C1-alkyl, C1-alkoxy-C1-alkyl, C3-cycloalkyl, C3-ecycloalkyl-Ci-4alkyl, C2-ealkenyl, C2ealkynyl, Ci-ealkoxy, C1-e-alkylsulfanyl-C1-e-alkyl, C1-e-alkylsulfinyl-C1-e-alkyl, C1-e-alkylsulfonyl-C1-e-alkyl, C1-e-alkoxycarbonyl-C1-e-alkyl, C1-e-alkylaminocarbonyl-C1-e-alkyl and diC1-e-alkylaminocarbonyl-C1-e-alkyl is optionally replaced by one to three substituents independently selected from halogen and CN; wherein A3 and R4, considered together, optionally form a ring, preferably a heterocycle with 5 to 8 Petition 870260106348, dated 10 / 15 / 2026, page 9 / 266 4 / 245 members and more preferably a heterocycle with 6 members; and R5 is selected from C1-g alkyl, C1-galkoxy, C3-g cycloalkyl, C3-6-cycloalkyl-C1-6-alkyl, C1-galkoxyC1-g alkyl, C1-g alkylamino, diC1-g alkylamino, C1-galkoxyamino and C1-6-alkylC1-6 alkoxyamino, wherein each of the C1-g alkyl, C1-galkoxy, C3-g cycloalkyl, C3-g cycloalkyl-C1-g alkyl, C1-galkoxyC1-g alkyl, C1-g alkylamino, diC1-galkoxyamino, C1-galkoxyamino and C1-g alkylC1-galkoxyamino groups is optionally replaced by one to three substituents independently selected from halogen and CN; or a salt or N-oxide thereof.

[0004] In a second aspect, the present invention provides an agrochemical composition comprising a compound of formula (I) and, more particularly, an agrochemical composition comprising a fungicidal effective amount of a compound of formula (I). Said composition may further comprise at least one compound selected from an additional active ingredient, an appropriate formulation inert, a carrier, an adjuvant and any mixtures thereof.

[0005] The compounds of formula (I) can be used to control phytopathogenic microorganisms. Thus, to control a phytopathogen, a compound of formula (I) or a composition comprising a compound of formula (I), according to the invention, can be applied directly to the phytopathogen, to the locus of a phytopathogen, in particular to a plant susceptible to attack by phytopathogens or to plant propagation material. Petition 870260106348, dated 10 / 15 / 2026, page 10 / 266 5 / 245

[0006] Thus, in a third aspect, the present invention provides the use of a compound of formula (I), or a composition comprising a compound of formula (I), as described herein, to combat, prevent or control a phytopathogen.

[0007] In a fourth aspect, the present invention provides a method for combating, preventing or controlling phytopathogens, comprising applying a compound of formula (I), or a composition comprising a compound of formula (I), as described herein, to said phytopathogen, at the locus of said phytopathogen, in particular to a plant susceptible to attack by a phytopathogen or to plant propagation material. According to this fourth aspect of the invention, the method may exclude methods for treating the human or animal body by surgery or therapeutics.

[0008] The compounds of formula (I) are particularly effective in combating, preventing or controlling phytopathogenic fungi, in particular oomycetes. Thus, in a fifth aspect, the present invention provides the use of a compound of formula (I), or a composition comprising a compound of formula (I), as described herein, to control phytopathogenic fungi, in particular oomycetes.

[0009] In a sixth aspect, the present invention provides a method of combating, preventing or controlling phytopathogenic diseases, such as phytopathogenic fungi, comprising applying a compound of formula (I), or a composition comprising a compound of formula (I), as described herein, to said phytopathogenic fungi, or to the locus of said phytopathogenic fungi, in particular to a plant susceptible to attack by phytopathogenic fungi, in Petition 870260106348, dated 10 / 15 / 2026, page 11 / 266 6 / 245 particular oomycetes, or in a plant propagation material. According to this sixth aspect of the invention, the method may exclude methods for treating the human or animal body by surgery or therapeutics.

[0010] When a group is indicated as being substituted, e.g., alkyl, this includes groups that are part of others, e.g., alkyl in alkylthio. Definitions: The term halogen or halo refers to fluorine (F), chlorine (Cl), bromine (Br), or iodine (I), preferably fluorine, chlorine, or bromine. The term amino refers to an -NH2 group. The term alkyl, as used herein—alone or as part of a chemical group—represents linear or branched chain hydrocarbons, preferably with 1 to 6 carbon atoms, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl, t-butyl, pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 1,2-dimethylpropyl, 1,1-dimethylpropyl, 2,2-dimethylpropyl, 1-ethylpropyl, hexyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,2-dimethylpropyl, 1,3-dimethylbutyl, 1,4-dimethylbutyl, 2,3-dimethylbutyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl. 3,3-dimethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethylbutyl and 2-ethylbutyl. Alkyl groups with 1 to 4 carbon atoms are preferred, for example, methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, s-butyl or t-butyl. The term alkenyl – used alone or as part of a chemical group – represents linear or branched chain hydrocarbons, preferably with 2 to 6 carbon atoms. Petition 870260106348, dated 10 / 15 / 2026, p. 12 / 266 7 / 245 and at least one double bond, for example, vinyl, 2-propenyl, 2-butenyl, 3-butenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-2-propenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 3-methyl-3-pentenyl, 4methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-2butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-2-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-2-butenyl, 2,3dimethyl-3-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2propenyl, 1-ethyl-1-methyl-2-propenyl and 1-ethyl-2-methyl-2propenyl.Alkenyl groups with 2 to 4 carbon atoms are preferred, for example, 2-propenyl, 2-butenyl, or 1-methyl-2-propenyl. The term alkynyl – alone or as part of a chemical group – represents linear or branched chain hydrocarbons, preferably with 2 to 6 carbon atoms and at least one triple bond, for example, 2-propynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 2-pentynyl, 3-pentinyl, 4-pentinyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 1-methyl-2-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 2-hexinyl, 3-hexinyl, 4-hexinyl, 5-hexinyl, 1-methyl-2-pentinyl, 1-methyl-3-pentinyl, 1-methyl-4-pentinyl, 2-methyl-3-pentinyl, 2-methyl-4 Petition 870260106348, dated 10 / 15 / 2026, page 13 / 266 8 / 245 pentinyl, 3-methyl-4-pentinyl, 4-methyl-2-pentinyl, 1,1-dimethyl-3-butinyl, 1,2-dimethyl-3-butinyl, 2,2-dimethyl-3-butinyl, 1-ethyl-3-butinyl, 2-ethyl-3-butinyl, 1-ethyl-1-methyl-2-propinyl and 2,5-hexadi-inyl. Alkynyl groups with 2 to 4 carbon atoms are preferred, for example, ethinyl, 2-propinyl or 2-butynyl-2-propenyl. The term haloalkyl refers to an alkyl radical, as generally defined above, substituted by one or more of the same or different halogen atoms, for example, fluoromethyl, fluoroethyl, difluoromethyl, trifluoromethyl or 2,2,2-trifluoroethyl. The term cyanoalkyl refers to an alkyl radical, as generally defined above, substituted by one or more cyano groups. - The term cycloalkyl - alone or as part of a chemical group - represents saturated or partially unsaturated mono-, bi- or tricyclic hydrocarbons, preferably with 3 to 10 carbon atoms, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl or adamantyl. Cycloalkyls with 3, 4, 5, 6 or 7 carbon atoms are preferred, for example, cyclopropyl or cyclobutyl. The term halocycloalkyl refers to a cycloalkyl ring, as defined above, substituted with one or more of the same or different halogen atoms. The term cyanocycloalkyl refers to a cycloalkyl radical, as generally defined above, substituted by one or more cyano groups. Petition 870260106348, dated 10 / 15 / 2026, p. 14 / 266 9 / 245 The term alkoxy refers to a radical of the formula -ORa, where Ra is an alkyl radical, as generally defined above. Examples of alkoxy include, but are not limited to, methoxy, ethoxy, propoxy, isopropoxy, and tert-butoxy. The term alkoxyalkyl refers to an alkyl radical (as mentioned above) substituted by said alkoxy group. Examples are methoxymethyl, methoxyethyl, ethoxymethyl, and propoxymethyl. The term alkylsulfanyl refers to a radical of the formula -SRa, where Ra is an alkyl radical as generally defined above. The term alkylsulfinyl refers to a radical of the formula -S(O)Ra, where Ra is an alkyl radical as generally defined above. The term alkylsulfonyl refers to a radical of the formula -S(O)2Ra, where Ra is an alkyl radical as generally defined above. The term alkylcarbonyl refers to a radical of the formula RaC(O)-, where Ra is an alkyl radical as generally defined above. The term alkoxycarbonyl refers to a radical of the formula RaOC(O)-, where Ra is an alkyl radical as generally defined above. The term alkylamino refers to a radical of the formula RaNH-, where Ra is an alkyl radical as generally defined above. The term cycloalkylamino refers to a radical of the formula Ra-NH-, where Ra is a cycloalkyl radical as generally defined above. Petition 870260106348, dated 10 / 15 / 2026, p. 15 / 266 10 / 245 The term alkoxyamino refers to a radical of the formula RaNH-, where Ra is an alkoxy radical as generally defined above. The term alkylaminocarbonyl refers to a radical of the formula RaNHC(O)-, where Ra is an alkyl radical as generally defined above. - Hydroxyl or hydroxyl symbolizes an -OH group.

[0011] The term combat, prevention or control, as well as its inflections, within the context of the present invention, means reduction of any undesirable effect, such as pathogenic and, more particularly, phytopathogenic, especially fungi, such as oomycetes, infestation or attack of, and pathogenic damage to a plant or a plant-derived product to such a level that an improvement is demonstrated.

[0012] As used herein, the term effective quantity refers to the amount of the compound, of a salt or N-oxide thereof, which, after single or multiple applications, provides the desired effect.

[0013] An effective amount is readily determined by a person skilled in the art, using known techniques and observing results obtained under analogous circumstances. In determining the effective amount, numerous factors are considered, including, but not limited to: the type of plant or derived product to be applied; the pathogen to be controlled and its life cycle; the particular compound applied; the type of application; and other relevant circumstances.

[0014] Compounds of formula (I) that have at least one basic center can form, for example, acid addition salts, for example, with strong inorganic acids, such as Petition 870260106348, dated 10 / 15 / 2026, page 16 / 266 11 / 245 mineral acids, for example, perchloric acid, sulfuric acid, nitric acid, nitrous acid, a phosphoric acid or a hydrohalic acid, with strong organic carboxylic acids, such as C1-C4 alkanecarboxylic acids, which are unsubstituted or substituted, for example, by a halogen, for example, acetic acid, such as saturated or unsaturated dicarboxylic acids, for example, oxalic acid, malonic acid, succinic acid, maleic acid, fumaric acid or phthalic acid, such as hydroxycarboxylic acids, for example, ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or such as benzoic acid, or with organic sulfonic acids, such as C1-C4 alkanesulfonic or arylsulfonic acids which are unsubstituted or substituted, for example, by a halogen, for example, methanesulfonic acid or ptoluenesulfonic acid.Compounds of formula (I) having at least one acid group can form, for example, salts with bases, for example, mineral salts, such as salts of alkali metals or alkaline earth metals, for example, sodium, potassium or magnesium salts, or salts with ammonia or an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower-alkylamine, for example, ethyl-, diethyl-, triethyl- or dimethylpropylamine, or a mono-, di- or tri-hydroxy-lower-alkylamine, for example, mono-, di- or triethanolamine.

[0015] In each case, the compounds of formula (I), according to the invention, are in free form, in oxidized form as an N-oxide, in a covalently hydrated form or in salt form, e.g., in an agronomically usable or agrochemically acceptable salt form. N-oxides are forms Petition 870260106348, dated 10 / 15 / 2026, page 17 / 266 12 / 245 oxidized tertiary amines or heteroaromatic compounds containing nitrogen. These are described, for example, in the book “Heterocyclic N-oxides” by A. Albini and S. Pietra, CRC Press, Boca Raton 1991. The compounds of formula (I) according to the invention also include hydrates that may be formed during the formation of the salts.

[0016] The compounds of formula (I) according to the invention also include hydrates that may be formed during the formation of salts.

[0017] In another embodiment, a compound of formula (I) is provided according to the present invention, wherein R1 are independently selected from hydrogen, C16 alkyl, C3-6 cycloalkyl, C1-6 alkoxy-C1-6 alkyl, C36 cycloalkyl-C1-4 alkyl and C1-6 alkoxy and, more preferably, R1 are independently selected from hydrogen and C1-6 alkyl.

[0018] In another embodiment, a compound of formula (I) is provided according to the present invention, wherein R2 are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C16 alkyl, C1-6 alkoxy-C1-6 alkoxy, C1-6 alkoxycarbonyl, C16 alkyl amino carbonyl, diC1-6 alkyl amino carbonyl and C16 alkyl carbonyl, wherein each of the C1-6 alkyl, C16 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkoxy, C16 alkoxy carbonyl, C1-6 alkyl amino carbonyl, diC16 alkyl amino carbonyl and C1-6 alkyl carbonyl groups is optionally substituted by one to three substituents independently selected from halogen, hydroxyl and CN; preferably R2 are independently selected Petition 870260106348, dated 10 / 15 / 2026, p. 18 / 266 13 / 245 among hydrogen, halogen, CN, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy carbonyl and C1-6 alkoxy-C1-6 alkoxy, wherein each of the C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy carbonyl and C1-6 alkoxy-C1-6 alkoxy groups is optionally substituted by one to three substituents independently selected from halogen, hydroxy and CN; and more preferably R2 are independently selected from hydrogen, halogen, CN, C1-6 alkyl, C1-6 alkoxy and C1-6 alkoxy-C1-6 alkyl.

[0019] In another embodiment, a compound of formula (I) is provided according to the present invention, wherein R3 is selected from hydroxy, halogen, CN, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkoxy, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-6 alkyl, amino, C1-6 alkylamino, diC1-6 alkylamino and C3-6 cycloalkylamino, wherein each of the C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkoxy, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-6 alkyl, amino, C1-6 alkylamino, diC1-6 alkylamino and C3-6 cycloalkylamino groups is optionally substituted by one to three substituents selected independently from halogen, hydroxy and CN; and preferably R3 is hydrogen.

[0020] In another embodiment, a compound of formula (I) is provided according to the present invention, wherein four A2s are CR2s and A3s are Ns.

[0021] In another embodiment, a compound of formula (I) is provided according to the present invention, wherein Petition 870260106348, dated 10 / 15 / 2026, p. 19 / 266 14 / 245 Ah?A“Aé and preferably all three A2s are CR2 and A3 is CR3.

[0022] In another embodiment, a compound of formula (I) is provided according to the present invention, wherein Ah, the A A is and preferably the three A2s are CR2 and A3s are CR3.

[0023] In another embodiment, a compound of formula (I) is provided according to the present invention, in which four A2 is CR2 and A3 is CR3 and preferably

[0024] In this particular modality Ah? AA is in which Ah, the A“ A is R2 is defined in the present invention; Preferably, R2 groups are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C3-6-cycloalkyl, C36-cycloalkyl-C1-6alkyl, C1-6-alkoxycarbonyl, C16-alkylaminocarbonyl, diC1-6-alkylaminocarbonyl and C16-alkylcarbonyl, wherein each of the C1-alkyl, C16-alkoxy, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C36-cycloalkyl, C3-6-cycloalkyl-C1-6alkyl, C16-alkoxycarbonyl, C1-6-alkylaminocarbonyl, diC16-alkylaminocarbonyl and C1-6-alkylcarbonyl groups is optionally substituted by one to three substituents independently selected from halogen, hydroxyl and CN; more Petition 870260106348, dated 10 / 15 / 2026, page 20 / 266 15 / 245 preferably R2 is independently selected from hydrogen, halogen, CN, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxycarbonyl and C1-6alkoxy-C1-6alkoxy, wherein each of the C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxycarbonyl and C1-6alkoxy-C1-6alkoxy groups is optionally substituted by one to three substituents independently selected from halogen, hydroxy and CN; and even more preferably R2 is independently selected from hydrogen, halogen, CN, C1-6alkyl, C1-6alkoxy and C1-6alkoxy-C1-6alkyl.

[0025] In another embodiment, a compound of formula (I) is provided according to the present invention, wherein R4 is selected from C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C1-4alkyl, C2-6alkenyl, C2-6alkynyl and C1-6alkoxy groups, wherein each of the C1-6alkyl, C1-6alkoxy-C1-6alkyl, C3-6cycloalkyl, C3-6cycloalkyl-C14alkyl, C2-6alkenyl, C2-6alkynyl and C1-6alkoxy groups is optionally replaced by one to three substituents independently selected from halogen and CN; and preferably R4 is selected from C1-6 alkyl, C16 alkoxy-C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C14 alkyl and C1-6 alkoxy, wherein each of the C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C14 alkyl and C1-6 alkoxy groups is optionally substituted by one to three substituents independently selected from halogen and CN; and

[0026] wherein A3 and R4, considered together, optionally form a ring, preferably a heterocycle with 5 to 8 members and more preferably a heterocycle with 6 members. Petition 870260106348, dated 10 / 15 / 2026, p. 21 / 266 16 / 245

[0027] In another embodiment, a compound of formula (I) is provided according to the present invention, wherein A3 is CR3e wherein R3e R4, considered together, form a ring, preferably a 5- to 8-membered heterocycle, preferably a 6-membered heterocycle, and more preferably one of the W1, W2, or W3 rings as described in the compounds of formula (I) below: (I-W1) (I-W2) (I-W3)

[0028] The carbon and / or nitrogen atoms forming said ring (W1, W2 or W3) may be substituted, especially by an R3' group, wherein R3' is selected from hydrogen, C1-g-alkyl and C3-6-cycloalkyl, wherein each of the C1-g-alkyl and C3-6-cycloalkyl groups is optionally substituted by one to three substituents independently selected from halogen and CN. For example, compounds of formula (I-W3) may be as follows: (I-W3)

[0029] In a preferred embodiment, the compounds of formula (I-W1), (I-W2) and (I-W3) may be as described below: Petition 870260106348, dated 10 / 15 / 2026, p. 22 / 266 17 / 245 (I-W2) (I-W3)

[0030] The carbon and / or nitrogen atoms forming said ring (W1, W2 or W3) may be substituted, especially by an R3' group, wherein R3' is selected from hydrogen, C1-6 alkyl and C3-6 cycloalkyl, wherein each of the C1-6 alkyl and C3-6 cycloalkyl groups is optionally substituted by one to three substituents independently selected from halogen and CN. For example, compounds of formula (I-W3) may be as follows: A compound of formula (I) is provided according to the present invention, wherein R5 is selected from C1-6 alkyl, C1-6 alkoxy, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-6 alkyl and C1-6 alkoxy-C1-6 alkyl, wherein each of said groups is optionally replaced by one to three substituents independently selected from halogen and CN.

[0032] In one particular embodiment, a compound of formula (I) is provided according to the present invention, wherein Z is O; Petition 870260106348, dated 10 / 15 / 2026, page 23 / 266 18 / 245 one A1 is N and one A1 is CR1; R1s are independently selected from hydrogen, C16 alkyl, C3-6 cycloalkyl, C1-6 alkoxy-C1-6 alkyl, C36 cycloalkyl-C1-4 alkyl and C1-6 alkoxy and, more preferably, R1s are independently selected from hydrogen and C1-6 alkyl; all four A2s are CR2; with R2 being independently selected from hydrogen, hydroxyl, halogen, CN, C16alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxy-C16alkoxy, C2-6alkenyl, C2-6alkynyl, C3-6cycloalkyl, C36cycloalkyl-C1-6alkyl, C1-6alkylsulfanyl, C16alkylsulfinyl and C1-6alkylsulfonyl, wherein each of the C1-6alkyl, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C16alkoxy-C1-6alkoxy, C2-6alkenyl, C2-6alkynyl, C36cycloalkyl, C3-6cycloalkyl-C1-6alkyl, C16alkylsulfanyl, C1-6alkylsulfinyl and C1-6alkylsulfonyl groups is optionally replaced by one to three substituents independently selected from halogen, hydroxyl and CN;preferably R2 being independently selected from hydrogen, halogen, CN, C1-6-alkyl, C1-6-alkoxy, C16-alkoxy-C1-6-alkyl and C1-6-alkoxy-C1-6-alkoxy, wherein each of the C1-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6-alkyl and C1-6-alkoxy-C1-6alkoxy groups is optionally replaced by one to three substituents independently selected from halogen, hydroxy and CN; and more preferably R2 being independently selected from hydrogen, halogen, CN, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C16 alkoxy carbonyl and C1-6 alkoxy-C1-6 alkoxy, wherein each of the C1-alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C16 alkoxy carbonyl and C1-6 alkoxy-C1-6 alkoxy groups is optionally; Petition 870260106348, dated 10 / 15 / 2026, page 24 / 266 19 / 245 replaced by one to three substituents independently selected from halogen, hydroxyl and CN; A3 is CR3, with R3 being independently selected from hydrogen, hydroxyl, halogen, CN, C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C2-6-alkenyl, C2-6-alkynyl, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-6alkyl, C1-6-alkylsulfanyl, C1-6-alkylsulfinyl, C1-6-alkylsulfonyl, amino, C1-6-alkylamino, diC1-6-alkylamino and C3-6-cycloalkylamino, wherein each of the groups C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C2-6-alkynyl, C2-6-alkynyl, C3-6-cycloalkyl, C3-6cycloalkyl, C1-6alkylsulfanyl, C1-6alkylsulfinyl, C1-6alkylsulfonyl, amino, C1-6alkylamino, diC1-6-alkylamino and C3-6cycloalkylamino is optionally replaced by one to three substituents independently selected from halogen, hydroxyl and CN; and preferably R3 being hydrogen; A4 is CH or N, preferably N; R4 is selected from C1-alkyl, C1-6-alkoxy-C1-6-alkyl, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-4-alkyl and C1-6-alkoxy groups, wherein each of the C1-6-alkyl, C1-6-alkoxy-C1-6-alkyl, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-4-alkyl and C1-6-alkoxy groups is optionally substituted by one to three substituents selected independently from halogen and CN; and where A3 and R4, considered together, optionally form a ring, preferably a 5- to 8-membered heterocycle and more preferably a 6-membered heterocycle; and R5 is selected from C1-alkyl, C1-6-alkoxy, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-6alkyl, C1-6-alkoxyC1-6alkyl, C1-6-alkylamino, diC1-6alkylamino and C1-6-alkylC1 Petition 870260106348, dated 10 / 15 / 2026, p. 25 / 266 20 / 245 * , in invention; 6alkoxyamino, wherein each of said groups is optionally substituted by one to three substituents independently selected from halogen and CN, and preferably R5 is selected from C1-alkyl, C1-6alkoxy, C3-6cycloalkyl, C3-6cycloalkyl-C1-6alkyl and C1-6alkoxyC1-6alkyl, wherein each of said groups is optionally substituted by one to three substituents independently selected from halogen and CN. νψγ / I 3 AA I2 H2 A .2A

[0033] In a preferred embodiment, R2 is as defined herein, preferably R2 are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-6alkyl, C16-alkoxycarbonyl, C1-6-alkylaminocarbonyl, diC16-alkylaminocarbonyl and C1-6-alkylcarbonyl, wherein each of the groups C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C16-alkoxy-C1-6alkoxy, C3-6-cycloalkyl, C3-6-cycloalkyl-C16alkyl, C1-6 alkoxycarbonyl, C1-6 alkylaminocarbonyl, diC16 alkylaminocarbonyl and C1-6 alkylcarbonyl is optionally replaced by one to three substituents independently selected from halogen, hydroxyl and CN;More preferably, R2s are independently selected from hydrogen, halogen, CN, C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C1-6alkoxycarbonyl and C1-6alkoxy-C1-6alkoxy, wherein each of the C1-6alkoxy, C1-6alkoxy-C1-6alkyl, C16alkoxycarbonyl and C1-6alkoxy-C1-6alkoxy groups is optionally substituted by one to three substituents independently; Petition 870260106348, dated 10 / 15 / 2026, page 26 / 266 21 / 245 selected from halogen, hydroxyl and CN; and even more preferably R2 are independently selected from hydrogen, halogen, CN, C1-6 alkyl and C1-6 alkoxy.

[0034] In another embodiment, the compound according to the present invention is selected from: N-[5-[6-[(4-fluoro-3-methylphenyl)-methylcarbamoyl]-8-methylimidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]methyl carbamate; Methyl N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8methyl-imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate; N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]-8-methylimidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate de methyl; N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methyl-carbamoyl]-8methyl-imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate demethyl; N-[5 - [6-(6-fluoro-3,4-di-hidro-2H-quinoline-1carbonyl)imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate de methyl; N-[5-[6-[(4-fluorophenyl)-methyl-carbamoyl]imidazo[1,2b]pyridazin-3-yl]-2-pyridyl]carbamate de methyl; N-[5-[6-[(4-fluoro-3-methyl-phenyl)-methylcarbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate de methyl; N-[5-[6-[(4-fluoro-3-methoxy-phenyl)-methylcarbamoyl]imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]carbamate de methyl; 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2a]pyrimidino-6-carboxamida; And Petition 870260106348, 15 / 10 / 2026, pág. 27 / 266 22 / 245 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2b]pyridazine-6-carboxamide.

[0035] The method of the present invention has advantageous properties for or against pathogenic infestation, protecting plants against attack such as phytopathogenic, especially fungi such as oomycetes, which results in disease and damage to the plant; particularly in the case of plants, the present invention can control, limit or prevent pathogenic damage to the plant, plant parts, plant propagation material and / or cultivated plant.

[0036] The compounds in Lists 1.1 to 1.100 and in Lists 2.1 to 2.50 below illustrate specific compounds of the invention.

[0037] List 1.1 provides compounds E1.1 to E1.952 of R4, A2a, A2bsão

[0038] More specifically, Table 1 also includes compounds where R3 and R4, considered together, form a ring. In this case, said ring is depicted in columns R3 and R4 (Table 1) merged together, along the amide atom bonded to the bicyclic nucleus of formula (Ia). For example, see columns R3 and R4 of compound E1. 103. Petition 870260106348, dated 10 / 15 / 2026, p. 28 / 266 23 / 245 Table 1: Definitions of substituents for R1a, R3, R4, A2ae A2b: Compostos R3 R4 A2a A2b R1a E1.1 H CH3 N CH H E1.2 H CH3 CH CH H E1.3 H CH3 CH NH E1.4 H CH3 CF CH H E1.5 H CH3 CF NH E1.6 H CH3 CCl CH H E1.7 H CH3 CCl NH E1.8 H CH3 CBr CH H E1.9 H CH3 CBr NH E1.10 H CH3 CCH3 CH H E1.11 H CH3 CCH3 NH E1.12 H CH3 CCH2CH3 CH H E1.13 H CH3 CCH2CH3 NH E1.14 H CH3 CCN CH H E1.15 H CH3 CCN NH E1.16 H CH3 COCH3 CH H E1.17 H CH3 COCH3 NH E1.18 H CH2CH3 N CH H E1.19 H CH2CH3 CH CH H E1.20 H CH2CH3 CH NH E1.21 H CH2CH3 CF CH H E1.22 H CH2CH3 CF NH E1.23 H CH2CH3 CCl CH H E1.24 H CH2CH3 CCl NH E1.25 H CH2CH3 CBr CH H E1.26 H CH2CH3 CBr NH Petition 870260106348, of 15 / 10 / 2026, pág. 29 / 266 24 / 245 Compostos R3 R4 A2a A2b R1a E1.27 H CH2CH3 CCH3 CH H E1.28 H CH2CH3 CCH3 NH E1.29 H CH2CH3 CCH2CH3 CH H E1.30 H CH2CH3 CCH2CH3 NH E1.31 H CH2CH3 CCN CH H E1.32 H CH2CH3 CCN NH E1.33 H CH2CH3 COCH3 CH H E1.34 H CH2CH3 COCH3 NH E1.35 H CH2OCH3 N CH H E1.36 H CH2OCH3 CH CH H E1.37 H CH2OCH3 CH NH E1.38 H CH2OCH3 CF CH H E1.39 H CH2OCH3 CF NH E1.40 H CH2OCH3 CCl CH H E1.41 H CH2OCH3 CCl NH E1.42 H CH2OCH3 CBr CH H E1.43 H CH2OCH3 CBr NH E1.44 H CH2OCH3 CCH3 CH H E1.45 H CH2OCH3 CCH3 NH E1.46 H CH2OCH3 CCH2CH3 CH H E1.47 H CH2OCH3 CCH2CH3 NH E1.48 H CH2OCH3 CCN CH H E1.49 H CH2OCH3 CCN NH E1.50 H CH2OCH3 COCH3 CH H E1.51 H CH2OCH3 COCH3 NH E1.52 H CH2CH2OCH3 N CH H E1.53 H CH2CH2OCH3 CH CH H E1.54 H CH2CH2OCH3 CH NH Petition 870260106348, of 15 / 10 / 2026, pág. 30 / 266 25 / 245 Compostos R3 R4 A2a A2b R1a E1.55 H CH2CH2OCH3 CF CH H E1.56 H CH2CH2OCH3 CF NH E1.57 H CH2CH2OCH3 CCl CH H E1.58 H CH2CH2OCH3 CCl NH E1.59 H CH2CH2OCH3 CBr CH H E1.60 H CH2CH2OCH3 CBr NH E1.61 H CH2CH2OCH3 CCH3 CH H E1.62 H CH2CH2OCH3 CCH3 NH E1.63 H CH2CH2OCH3 CCH2CH3 CH H E1.64 H CH2CH2OCH3 CCH2CH3 NH E1.65 H CH2CH2OCH3 CCN CH H E1.66 H CH2CH2OCH3 CCN NH E1.67 H CH2CH2OCH3 COCH3 CH H E1.68 H CH2CH2OCH3 COCH3 NH E1.69 H CH2CN N CH H E1.70 H CH2CN CH CH H E1.71 H CH2CN CH NH E1.72 H CH2CN CF CH H E1.73 H CH2CN CF NH E1.74 H CH2CN CCl CH H E1.75 H CH2CN CCl NH E1.76 H CH2CN CBr CH H E1.77 H CH2CN CBr NH E1.78 H CH2CN CCH3 CH H E1.79 H CH2CN CCH3 NH E1.80 H CH2CN CCH2CH3 CH H E1.81 H CH2CN CCH2CH3 NH E1.82 H CH2CN CCN CH H Petition 870260106348, of 15 / 10 / 2026, pág. 31 / 266 26 / 245 Compostos R3 R4 A2a A2b R1a E1.83 H CH2CN CCN N H E1.84 H CH2CN COCH3 CH H E1.85 H CH2CN COCH3 N H E1.86 H CH2CH2CN N CH H E1.87 H CH2CH2CN CH CH H E1.88 H CH2CH2CN CH N H E1.89 H CH2CH2CN CF CH H E1.90 H CH2CH2CN CF N H E1.91 H CH2CH2CN CCl CH H E1.92 H CH2CH2CN CCl N H E1.93 H CH2CH2CN CBr CH H E1.94 H CH2CH2CN CBr N H E1.95 H CH2CH2CN CCH3 CH H E1.96 H CH2CH2CN CCH3 N H E1.97 H CH2CH2CN CCH2CH3 CH H E1.98 H CH2CH2CN CCH2CH3 N H E1.99 H CH2CH2CN CCN CH H E1.100 H CH2CH2CN CCN N H E1.101 H CH2CH2CN COCH3 CH H E1.102 H CH2CH2CN COCH3 N H E1.103 Y» [[ J N CH H E1.104 Y> Y j CH CH H E1.105 CH N H E1.106 Y» (L J CF CH H Petição 870260106348, de 15 / 10 / 2026, pág. 32 / 266 27 / 245 Compounds R3 R4 A2a A2b R1a E1.107 '-Αχ / / ..A. CF NH E1.108 A2” (LJA <A2bXX CCl CH H E1.109 a2® lL J CCl N H E1.110 θΧ / Χ^1 A2 (L J Ά1’'-X CBr CH H E1.111 x.^'.. ..A. !L J Axx CBr N H E1.112 θχ^ X / \ / X a2 !L J Ά1’'X CCH3 CH H E1.113 a2 iL J ^a’1'X CCH3 N H E1.114 RXZXA, A2® (L J x^x CCH2CH3 CH H E1.115 RXvX^X / NX a2 (1Γ J A<Ab\- / CCH2CH3 N H E1.116 χί !L J CCN CH H E1.117 θχχ^ RXvX^X / NX a2 íL J A-<A'b\^ CCN N H E1.118 [L J COCH3 CH H E1.119 a2® AL J A~vbXX COCH3 N H E1.120 X Ο—Z\ Z. N CH H Petition 870260106348, of 15 / 10 / 2026, p. 33 / 266 28 / 245 Compounds R3 R4 A2a A2b R1a E1.121 co—z^ ^Z— CH CH H E1.122 co—z^ ^z — CH NH E1.123 zr Υ J 1 ch3 CF CH H E1.124 ζΤ [Γ J ^A2b^N^ ch N^ N^ 15 °—15 ° H CCl CH H E1.126 ζΓ ίΓ J Α^α2^νΑ 1 ch3 CCl NH E1.127 ti Ο—Z^ ^Z — CBr CH H E1.128 O—Z^ / Z— CBr NH E1.129 c O—Z\ ^íf. CCH3 CH H E1.130 co—z^ ^z— CCH3 NH E1.131 o—z^ ^z— CCH2CH3 CH H Petition 870260106348, of 15 / 10 / 2026, p. 34 / 266 29 / 245 Compostos R3 R4 A2a A2b R1a E1.132 co—z^ ^Z— CCH2CH3 NH E1.133 c O—Z^ ^Z — CCN CH H E1.134 a? YJA^A2b^N^ 1 ch3 CCN NH E1.135 zr [Γ J ^A2b^N^ 1 ch3 COCH3 CH H E1.136 \—o ° y COCH3 NH E1.137 H CH3 N CH CH3 E1.138 H CH3 CH CH CH3 E1.139 H CH3 CH N CH3 E1.140 H CH3 CF CH CH3 E1.141 H CH3 CF N CH3 E1.142 H CH3 CCl CH CH3 E1.143 H CH3 CCl N CH3 E1.144 H CH3 CBr CH CH3 E1.145 H CH3 CBr N CH3 E1.146 H CH3 CCH3 CH CH3 E1.147 H CH3 CCH3 N CH3 E1.148 H CH3 CCH2CH3 CH CH3 E1.149 H CH3 CCH2CH3 N CH3 E1.150 H CH3 CCN CH CH3 E1.151 H CH3 CCN N CH3 E1.152 H CH3 COCH3 CH CH3 Petition 870260106348, of 15 / 10 / 2026, pág. 35 / 266 30 / 245 Compostos R3 R4 A2a A2b R1a E1.153 H CH3 COCH3 N CH3 E1.154 H CH2CH3 N CH CH3 E1.155 H CH2CH3 CH CH CH3 E1.156 H CH2CH3 CH N CH3 E1.157 H CH2CH3 CF CH CH3 E1.158 H CH2CH3 CF N CH3 E1.159 H CH2CH3 CCl CH CH3 E1.160 H CH2CH3 CCl N CH3 E1.161 H CH2CH3 CBr CH CH3 E1.162 H CH2CH3 CBr N CH3 E1.163 H CH2CH3 CCH3 CH CH3 E1.164 H CH2CH3 CCH3 N CH3 E1.165 H CH2CH3 CCH2CH3 CH CH3 E1.166 H CH2CH3 CCH2CH3 N CH3 E1.167 H CH2CH3 CCN CH CH3 E1.168 H CH2CH3 CCN N CH3 E1.169 H CH2CH3 COCH3 CH CH3 E1.170 H CH2CH3 COCH3 N CH3 E1.171 H CH2OCH3 N CH CH3 E1.172 H CH2OCH3 CH CH CH3 E1.173 H CH2OCH3 CH N CH3 E1.174 H CH2OCH3 CF CH CH3 E1.175 H CH2OCH3 CF N CH3 E1.176 H CH2OCH3 CCl CH CH3 E1.177 H CH2OCH3 CCl N CH3 E1.178 H CH2OCH3 CBr CH CH3 E1.179 H CH2OCH3 CBr N CH3 E1.180 H CH2OCH3 CCH3 CH CH3 Petition 870260106348, of 15 / 10 / 2026, pág. 36 / 266 31 / 245 Compostos R3 R4 A2a A2b R1a E1.181 H CH2OCH3 CCH3 N CH3 E1.182 H CH2OCH3 CCH2CH3 CH CH3 E1.183 H CH2OCH3 CCH2CH3 N CH3 E1.184 H CH2OCH3 CCN CH CH3 E1.185 H CH2OCH3 CCN N CH3 E1.186 H CH2OCH3 COCH3 CH CH3 E1.187 H CH2OCH3 COCH3 N CH3 E1.188 H CH2CH2OCH3 N CH CH3 E1.189 H CH2CH2OCH3 CH CH CH3 E1.190 H CH2CH2OCH3 CH N CH3 E1.191 H CH2CH2OCH3 CF CH CH3 E1.192 H CH2CH2OCH3 CF N CH3 E1.193 H CH2CH2OCH3 CCl CH CH3 E1.194 H CH2CH2OCH3 CCl N CH3 E1.195 H CH2CH2OCH3 CBr CH CH3 E1.196 H CH2CH2OCH3 CBr N CH3 E1.197 H CH2CH2OCH3 CCH3 CH CH3 E1.198 H CH2CH2OCH3 CCH3 N CH3 E1.199 H CH2CH2OCH3 CCH2CH3 CH CH3 E1.200 H CH2CH2OCH3 CCH2CH3 N CH3 E1.201 H CH2CH2OCH3 CCN CH CH3 E1.202 H CH2CH2OCH3 CCN N CH3 E1.203 H CH2CH2OCH3 COCH3 CH CH3 E1.204 H CH2CH2OCH3 COCH3 N CH3 E1.205 H CH2CN N CH CH3 E1.206 H CH2CN CH CH CH3 E1.207 H CH2CN CH N CH3 E1.208 H CH2CN CF CH CH3 Petition 870260106348, of 15 / 10 / 2026, pág. 37 / 266 32 / 245 Compostos R3 R4 A2a A2b R1a E1.209 H CH2CN CF N CH3 E1.210 H CH2CN CCl CH CH3 E1.211 H CH2CN CCl N CH3 E1.212 H CH2CN CBr CH CH3 E1.213 H CH2CN CBr N CH3 E1.214 H CH2CN CCH3 CH CH3 E1.215 H CH2CN CCH3 N CH3 E1.216 H CH2CN CCH2CH3 CH CH3 E1.217 H ​​CH2CN CCH2CH3 N CH3 E1.218 H CH2CN CCN CH CH3 E1.219 H CH2CN CCN N CH3 E1.220 H CH2CN COCH3 CH CH3 E1.221 H CH2CN COCH3 N CH3 E1.222 H CH2CH2CN N CH CH3 E1.223 H CH2CH2CN CH CH CH3 E1.224 H CH2CH2CN CH N CH3 E1.225 H CH2CH2CN CF CH CH3 E1.226 H CH2CH2CN CF N CH3 E1.227 H CH2CH2CN CCl CH CH3 E1.228 H CH2CH2CN CCl N CH3 E1.229 H CH2CH2CN CBr CH CH3 E1.230 H CH2CH2CN CBr N CH3 E1.231 H CH2CH2CN CCH3 CH CH3 E1.232 H CH2CH2CN CCH3 N CH3 E1.233 H CH2CH2CN CCH2CH3 CH CH3 E1.234 H CH2CH2CN CCH2CH3 N CH3 E1.235 H CH2CH2CN CCN CH CH3 E1.236 H CH2CH2CN CCN CH3 Petition 870260106348, of 15 / 10 / 2026, pág. 38 / 266 33 / 245 Compostos R3 R4 A2a A2b R1a E1.237 H CH2CH2CN COCH3 CH CH3 E1.238 H CH2CH2CN COCH3 N CH3 E1.239 N CH CH3 E1.240 J?» DL J CH CH CH3 E1.241 ,N,, Y> Y^ j CH N CH3 E1.242 Y· Y j CF CH CH3 E1.243 CF N CH3 E1.244 CCl CH CH3 E1.245 Jz» YJ CCl N CH3 E1.246 a< CBr CH CH3 E1.247 CBr N CH3 E1.248 Y> DL J CCH3 CH CH3 E1.249 CCH3 N CH3 E1.250 Y> DL J CCH2CH3 CH CH3 E1.251 Y· Y j A- <A2h\ / CCH2CH3 N CH3 Petition 870260106348, 15 / 10 / 2026, p. 39 / 266 34 / 245 Compostos R3 R4 A2a A2b R1a E1.252 ο..χ x_^\xx XXX CCN CH CH3 E1.253 xxx CCN N CH3 E1.254 X COCH3 CH CH3 E1.255 X COCH3 N CH3 E1.256 χ N CH CH3 E1.257 Χ / χ,Νχ Λ® XJ X2x^ 1 ch3 CH CH CH3 E1.258 zr ίΓ JA^A2b^N^ 1 ch3 CH N CH3 E1.259 XO—Z^ Z. “X. CF CH CH3 E1.260 °Xx'''XX» y J x^x 1 ch3 CF N CH3 E1.261 o—Z\ ^z — CCl CH CH3 E1.262 X o—z^ ^z— CCl N CH3 E1.263 X o —z^ ^z CBr CH CH3 Petition 870260106348, 15 / 10 / 2026, p. 40 / 266 35 / 245 Compostos R3 R4 A2a A2b R1a E1.264 co—z^ ^Z— CBr N CH3 E1.265 c O—Z^ ^Z — CCH3 CH CH3 E1.266 a? YJ 1 ch3 CCH3 N CH3 E1.267 zr [Γ J ^A2b^N^ 1 ch3 CCH2CH3 CH CH3 E1.268 \—o ° y CCH2CH3 N CH3 E1.269 ζΓ ίΓ J 1 ch3 CCN CH CH3 E1.270 c O—Z^ ^Z — CCN N CH3 E1.271 c O—Z^ / Z— COCH3 CH CH3 E1.272 c O—Z\ ^z —íf. COCH3 N CH3 E1.273 H CH3 N CH CH2CH3 E1.274 H CH3 CH CH CH2CH3 E1.275 H CH3 CH N CH2CH3 E1.276 H CH3 CF CH CH2CH3 E1.277 H CH3 CF N CH2CH3 E1.278 H CH3 CCl CH CH2CH3 Petição 870260106348, de 15 / 10 / 2026, pág. 41 / 266 36 / 245 Compostos R3 R4 A2a A2b R1a E1.279 H CH3 CCl N CH2CH3 E1.280 H CH3 CBr CH CH2CH3 E1.281 H CH3 CBr N CH2CH3 E1.282 H CH3 CCH3 CH CH2CH3 E1.283 H CH3 CCH3 N CH2CH3 E1.284 H CH3 CCH2CH3 CH CH2CH3 E1.285 H CH3 CCH2CH3 N CH2CH3 E1.286 H CH3 CCN CH CH2CH3 E1.287 H CH3 CCN N CH2CH3 E1.288 H CH3 COCH3 CH CH2CH3 E1.289 H CH3 COCH3 N CH2CH3 E1.290 H CH2CH3 N CH CH2CH3 E1.291 H CH2CH3 CH CH CH2CH3 E1.292 H CH2CH3 CH N CH2CH3 E1.293 H CH2CH3 CF CH CH2CH3 E1.294 H CH2CH3 CF N CH2CH3 E1.295 H CH2CH3 CCl CH CH2CH3 E1.296 H CH2CH3 CCl N CH2CH3 E1.297 H CH2CH3 CBr CH CH2CH3 E1.298 H CH2CH3 CBr N CH2CH3 E1.299 H CH2CH3 CCH3 CH CH2CH3 E1.300 H CH2CH3 CCH3 N CH2CH3 E1.301 H CH2CH3 CCH2CH3 CH CH2CH3 E1.302 H CH2CH3 CCH2CH3 N CH2CH3 E1.303 H CH2CH3 CCN CH CH2CH3 E1.304 H CH2CH3 CCN N CH2CH3 E1.305 H CH2CH3 COCH3 CH CH2CH3 E1.306 H CH2CH3 COCH3 N CH2CH3 Petition 870260106348, of 15 / 10 / 2026, pág. 42 / 266 37 / 245 Compostos R3 R4 A2a A2b R1a E1.307 H CH2OCH3 N CH CH2CH3 E1.308 H CH2OCH3 CH CH CH2CH3 E1.309 H CH2OCH3 CH N CH2CH3 E1.310 H CH2OCH3 CF CH CH2CH3 E1.311 H CH2OCH3 CF N CH2CH3 E1.312 H CH2OCH3 CCl CH CH2CH3 E1.313 H CH2OCH3 CCl N CH2CH3 E1.314 H CH2OCH3 CBr CH CH2CH3 E1.315 H CH2OCH3 CBr N CH2CH3 E1.316 H CH2OCH3 CCH3 CH CH2CH3 E1.317 H CH2OCH3 CCH3 N CH2CH3 E1.318 H CH2OCH3 CCH2CH3 CH CH2CH3 E1.319 H CH2OCH3 CCH2CH3 N CH2CH3 E1.320 H CH2OCH3 CCN CH CH2CH3 E1.321 H CH2OCH3 CCN N CH2CH3 E1.322 H CH2OCH3 COCH3 CH CH2CH3 E1.323 H CH2OCH3 COCH3 N CH2CH3 E1.324 H CH2CH2OCH3 N CH CH2CH3 E1.325 H CH2CH2OCH3 CH CH CH2CH3 E1.326 H CH2CH2OCH3 CH N CH2CH3 E1.327 H CH2CH2OCH3 CF CH CH2CH3 E1.328 H CH2CH2OCH3 CF N CH2CH3 E1.329 H CH2CH2OCH3 CCl CH CH2CH3 E1.330 H CH2CH2OCH3 CCl N CH2CH3 E1.331 H CH2CH2OCH3 CBr CH CH2CH3 E1.332 H CH2CH2OCH3 CBr N CH2CH3 E1.333 H CH2CH2OCH3 CCH3 CH CH2CH3 E1.334 H CH2CH2OCH3 CCH3 N CH2CH3 Petição 870260106348, de 15 / 10 / 2026, pág. 43 / 266 38 / 245 Compostos R3 R4 A2a A2b R1a E1.335 H CH2CH2OCH3 CCH2CH3 CH CH2CH3 E1.336 H CH2CH2OCH3 CCH2CH3 N CH2CH3 E1.337 H CH2CH2OCH3 CCN CH CH2CH3 E1.338 H CH2CH2OCH3 CCN N CH2CH3 E1.339 H CH2CH2OCH3 COCH3 CH CH2CH3 E1.340 H CH2CH2OCH3 COCH3 N CH2CH3 E1.341 H CH2CN N CH CH2CH3 E1.342 H CH2CN CH CH CH2CH3 E1.343 H CH2CN CH N CH2CH3 E1.344 H CH2CN CF CH CH2CH3 E1.345 H CH2CN CF N CH2CH3 E1.346 H CH2CN CCl CH CH2CH3 E1.347 H CH2CN CCl N CH2CH3 E1.348 H CH2CN CBr CH CH2CH3 E1.349 H CH2CN CBr N CH2CH3 E1.350 H CH2CN CCH3 CH CH2CH3 E1.351 H CH2CN CCH3 N CH2CH3 E1.352 H CH2CN CCH2CH3 CH CH2CH3 E1.353 H CH2CN CCH2CH3 N CH2CH3 E1.354 H CH2CN CCN CH CH2CH3 E1.355 H CH2CN CCN N CH2CH3 E1.356 H CH2CN COCH3 CH CH2CH3 E1.357 H CH2CN COCH3 N CH2CH3 E1.358 H CH2CH2CN N CH CH2CH3 E1.359 H CH2CH2CN CH CH CH2CH3 E1.360 H CH2CH2CN CH N CH2CH3 E1.361 H CH2CH2CN CF CH CH2CH3 E1.362 H CH2CH2CN CF N CH2CH3 Petição 870260106348, de 15 / 10 / 2026, pág. 44 / 266 39 / 245 Compostos R3 R4 A2a A2b R1a E1.363 H CH2CH2CN CCl CH CH2CH3 E1.364 H CH2CH2CN CCl N CH2CH3 E1.365 H CH2CH2CN CBr CH CH2CH3 E1.366 H CH2CH2CN CBr N CH2CH3 E1.367 H CH2CH2CN CCH3 CH CH2CH3 E1.368 H CH2CH2CN CCH3 N CH2CH3 E1.369 H CH2CH2CN CCH2CH3 CH CH2CH3 E1.370 H CH2CH2CN CCH2CH3 N CH2CH3 E1.371 H CH2CH2CN CCN CH CH2CH3 E1.372 H CH2CH2CN CCN N CH2CH3 E1.373 H CH2CH2CN COCH3 CH CH2CH3 E1.374 H CH2CH2CN COCH3 N CH2CH3 E1.375 Y> J N CH CH2CH3 E1.376 Y J CH CH CH2CH3 E1.377 Y> (L J CH N CH2CH3 E1.378 Y J CF CH CH2CH3 E1.379 Y» Y^ J CF N CH2CH3 E1.380 / V Y J CCl CH CH2CH3 E1.381 Y» Y j A<A2b^\ / CCl N CH2CH3 E1.382 Y» (L J vv2 CBr CH CH2CH3 Petição 870260106348, de 15 / 10 / 2026, pág. 45 / 266 40 / 245 Compounds R3 R4 A2a A2b R1a E1.383 AcA2b'\ / CBr N CH2CH3 E1.384 O;3⁄4γ^' A2” 1 J CCH3 CH CH2CH3 E1.385 X CCH3 N CH2CH3» X1 CH E X !CH2CH3 CCH2CH3 N CH2CH3 E1.388 X» uT j CCN CH CH2CH3 E1.389 X CCN N CH2CH3 E1.390 X» (LJ xx COCH3 CH CH2CH3 E1.391 X COCH3 N CH2CH3 E1.392 CH2— X Z—z 'Χ— Z^ \Ξ—O ° tí- CH CH CH2CH3 E1.394 XO—Z^ / Z— CH N CH2CH3 E1.395 X o—z^ ^z — CF CH CH2CH3 Petition 870260106348, dated 10 / 15 / 2026, p. 46 / 266 41 / 245 Compounds R3 R4 A2a A2b R1a E1.396 co—z^ ^Z— CF N CH2CH3 E1.397 co—z^ ^z — CCl CH CH2CH3 E1.398 a? YJ 1 ch3 CCl N CH2CH3 E1.399 zr [Γ J ^A2b^N^ 1 ch3 CBr CH CH2CH3 E1.400 \—o ° y CBr N CH2CH3 E1.401 cζΓ OίΓ J 1 ch—3 CCH23 CH1 CCH3 N CH2CH3 E1.403 O—Z^ / Z— CCH2CH3 CH CH2CH3 E1.404 c O—Z\ ^z —íf. CCH2CH3 N CH2CH3 E1.405 co—z^ ^z— CCN CH CH2CH3 E1.406 co—z^ ^z— CCN N CH2CH3 Petition 870260106348, dated 10 / 15 / 2026, p. 47 / 266 42 / 245 Compostos R3 R4 A2a A2b R1a E1.407 co—z^ ^Z— COCH3 CH CH2CH3 E1.408 co—z^ ^z — COCH3 N CH2CH3 E1.409 H CH3 N CH CH2OCH3 E1.410 H CH3 CH CH CH2OCH3 E1.411 H CH3 CH N CH2OCH3 E1.412 H CH3 CF CH CH2OCH3 E1.413 H CH3 CF N CH2OCH3 E1.414 H CH3 CCl CH CH2OCH3 E1.415 H CH3 CCl N CH2OCH3 E1.416 H CH3 CBr CH CH2OCH3 E1.417 H CH3 CBr N CH2OCH3 E1.418 H CH3 CCH3 CH CH2OCH3 E1.419 H CH3 CCH3 N CH2OCH3 E1.420 H CH3 CCH2CH3 CH CH2OCH3 E1.421 H CH3 CCH2CH3 N CH2OCH3 E1.422 H CH3 CCN CH CH2OCH3 E1.423 H CH3 CCN N CH2OCH3 E1.424 H CH3 COCH3 CH CH2OCH3 E1.425 H CH3 COCH3 N CH2OCH3 E1.426 H CH2CH3 N CH CH2OCH3 E1.427 H CH2CH3 CH CH CH2OCH3 E1.428 H CH2CH3 CH N CH2OCH3 E1.429 H CH2CH3 CF CH CH2OCH3 E1.430 H CH2CH3 CF N CH2OCH3 E1.431 H CH2CH3 CCl CH CH2OCH3 Petition 870260106348, of 15 / 10 / 2026, pág. 48 / 266 43 / 245 Compostos R3 R4 A2a A2b R1a E1.432 H CH2CH3 CCl N CH2OCH3 E1.433 H CH2CH3 CBr CH CH2OCH3 E1.434 H CH2CH3 CBr N CH2OCH3 E1.435 H CH2CH3 CCH3 CH CH2OCH3 E1.436 H CH2CH3 CCH3 N CH2OCH3 E1.437 H CH2CH3 CCH2CH3 CH CH2OCH3 E1.438 H CH2CH3 CCH2CH3 N CH2OCH3 E1.439 H CH2CH3 CCN CH CH2OCH3 E1.440 H CH2CH3 CCN N CH2OCH3 E1.441 H CH2CH3 COCH3 CH CH2OCH3 E1.442 H CH2CH3 COCH3 N CH2OCH3 E1.443 H CH2OCH3 N CH CH2OCH3 E1.444 H CH2OCH3 CH CH CH2OCH3 E1.445 H CH2OCH3 CH N CH2OCH3 E1.446 H CH2OCH3 CF CH CH2OCH3 E1.447 H CH2OCH3 CF N CH2OCH3 E1.448 H CH2OCH3 CCl CH CH2OCH3 E1.449 H CH2OCH3 CCl N CH2OCH3 E1.450 H CH2OCH3 CBr CH CH2OCH3 E1.451 H CH2OCH3 CBr N CH2OCH3 E1.452 H CH2OCH3 CCH3 CH CH2OCH3 E1.453 H CH2OCH3 CCH3 N CH2OCH3 E1.454 H CH2OCH3 CCH2CH3 CH CH2OCH3 E1.455 H CH2OCH3 CCH2CH3 N CH2OCH3 E1.456 H CH2OCH3 CCN CH CH2OCH3 E1.457 H CH2OCH3 CCN N CH2OCH3 E1.458 H CH2OCH3 COCH3 CH CH2OCH3 E1.459 H CH2OCH3 COCH3 N CH2OCH3 Petition 870260106348, of 15 / 10 / 2026, pág. 49 / 266 44 / 245 Compostos R3 R4 A2a A2b R1a E1.460 H CH2CH2OCH3 N CH CH2OCH3 E1.461 H CH2CH2OCH3 CH CH CH2OCH3 E1.462 H CH2CH2OCH3 CH N CH2OCH3 E1.463 H CH2CH2OCH3 CF CH CH2OCH3 E1.464 H CH2CH2OCH3 CF N CH2OCH3 E1.465 H CH2CH2OCH3 CCl CH CH2OCH3 E1.466 H CH2CH2OCH3 CCl N CH2OCH3 E1.467 H CH2CH2OCH3 CBr CH CH2OCH3 E1.468 H CH2CH2OCH3 CBr N CH2OCH3 E1.469 H CH2CH2OCH3 CCH3 CH CH2OCH3 E1.470 H CH2CH2OCH3 CCH3 N CH2OCH3 E1.471 H CH2CH2OCH3 CCH2CH3 CH CH2OCH3 E1.472 H CH2CH2OCH3 CCH2CH3 N CH2OCH3 E1.473 H CH2CH2OCH3 CCN CH CH2OCH3 E1.474 H CH2CH2OCH3 CCN N CH2OCH3 E1.475 H CH2CH2OCH3 COCH3 CH CH2OCH3 E1.476 H CH2CH2OCH3 COCH3 N CH2OCH3 E1.477 H CH2CN N CH CH2OCH3 E1.478 H CH2CN CH CH CH2OCH3 E1.479 H CH2CN CH N CH2OCH3 E1.480 H CH2CN CF CH CH2OCH3 E1.481 H CH2CN CF N CH2OCH3 E1.482 H CH2CN CCl CH CH2OCH3 E1.483 H CH2CN CCl N CH2OCH3 E1.484 H CH2CN CBr CH CH2OCH3 E1.485 H CH2CN CBr N CH2OCH3 E1.486 H CH2CN CCH3 CH CH2OCH3 E1.487 H CH2CN CCH3 N CH2OCH3 Petition 870260106348, of 15 / 10 / 2026, pág. 50 / 266 45 / 245 Compostos R3 R4 A2a A2b R1a E1.488 H CH2CN CCH2CH3 CH CH2OCH3 E1.489 H CH2CN CCH2CH3 N CH2OCH3 E1.490 H CH2CN CCN CH CH2OCH3 E1.491 H CH2CN CCN N CH2OCH3 E1.492 H CH2CN COCH3 CH CH2OCH3 E1.493 H CH2CN COCH3 N CH2OCH3 E1.494 H CH2CH2CN N CH CH2OCH3 E1.495 H CH2CH2CN CH CH CH2OCH3 E1.496 H CH2CH2CN CH N CH2OCH3 E1.497 H CH2CH2CN CF CH CH2OCH3 E1.498 H CH2CH2CN CF N CH2OCH3 E1.499 H CH2CH2CN CCl CH CH2OCH3 E1.500 H CH2CH2CN CCl N CH2OCH3 E1.501 H CH2CH2CN CBr CH CH2OCH3 E1.502 H CH2CH2CN CBr N CH2OCH3 E1.503 H CH2CH2CN CCH3 CH CH2OCH3 E1.504 H CH2CH2CN CCH3 N CH2OCH3 E1.505 H CH2CH2CN CCH2CH3 CH CH2OCH3 E1.506 H CH2CH2CN CCH2CH3 N CH2OCH3 E1.507 H CH2CH2CN CCN CH CH2OCH3 E1.508 H CH2CH2CN CCN N CH2OCH3 E1.509 H CH2CH2CN COCH3 CH CH2OCH3 E1.510 H CH2CH2CN COCH3 N CH2OCH3 E1.511 R2 n 2a LL j -V1' N CH CH2OCH3 E1.512 R2 2“ 1 J -A1' CH CH CH2OCH3 Petition 870260106348, of 15 / 10 / 2026, pág. 51 / 266 46 / 245 Compounds R3 R4 A2a A2b R1a E1.513 X> flT j Χ'ΛΑ CH N CH2OCH3 E1.514 X j A'XV CF CH CH2OCH3 E1.515 X CF N CH2OCH3 E1.516 X CCl CH 12OCH3 E1.516 X CCl CH 12OCH3, etc. CCl N CH2OCH3 E1.518 uT j CBr CH CH2OCH3 E1.519 o^X\ Rx / \>N< XJ A-2a'3\A CBr N CH2OCH3 E1.520 o...XX> flT J CCH3 CH CH2OCH3 E1.52 CCH / CCH3 Av X3 X2OCH3 E1.522 X> XJ CCH2CH3 CH CH2OCH3 E1.523 X· X j a-2a''A\.A CCH2CH3 N CH2OCH3 E1.524 (LJ CCN CH CH2OCH3 E1.525 X· flL J CCN N CH2OCH3 E1.525 X· Χ·Χϧ“. COCH3 CH2OCH3 Petition 870260106348, of 15 / 10 / 2026, p. 52 / 266 47 / 245 Compounds R3 R4 A2a A2b R1a E1.527 ^'k^ COCH3 N CH2OCH3 E1.528 k N CH CH2OCH3 E1.529 zr [Γ J 1 ch3 CH CH CH2OCH3 E1.530 ko—z^ “X^ CH3 N 1231 T ch3 CF CH CH2OCH3 E1.532 k O—Z\ ^z CF N CH2OCH3 E1.533 k O—Z\ ^z CCl CH CH2OCH3 E1.534 k O—Z^ ^z— CCl N CH2OCH3 E1.535 k O—Z\ ^r ^ CH23 k ECH. O—Z^ ^z— CBr N CH2OCH3 E1.537 k O—Z\ ^Z ~ CCH3 CH2OCH3 Petition 870260106348, of 15 / 10 / 2026, p. 53 / 266 48 / 245 Compounds R3 R4 A2a A2b R1a E1.538 co—z^ ^Z— CCH3 N CH2OCH3 E1.539 co—z^ ^z — CCH2CH3 CH CH2OCH3 E1.540 zr Υ JA^A2b^N^ 1 ch3 CCH2CH3 N CH2OCH3 E1. J ^A2b^N^ 1 ch3 CCN CH CH2OCH3 E1.542 \—o ° y CCN N CH2OCH3 E1.543 zr ίΓ JA^A2b^N^ 1 ch3 COCH3 CH CH2OCH3 E1.544 O—Z^ ^Z — COCH3 CH2OCH3 125 H. cyclopropyl E1.546 H CH3 CH CH cyclopropyl E1.547 H CH3 CH N cyclopropyl E1.548 H CH3 CF CH cyclopropyl E1.549 H CH3 CF N cyclopropyl E1.550 H CH3 CCl CH1 CH N cyclopropyl E1.552 H CH3 CBr CH cyclopropyl E1.553 H CH3 CBr N cyclopropyl E1.554 H CH3 CCH3 CH cyclopropyl E1.555 H CH3 CCH3 N cyclopropyl E1.555 H CH3 CCH3 N cyclopropyl Petition 870260106348, of 15 / 10 / 2026, p. 54 / 266 49 / 245 Compounds R3 R4 A2a A2b R1a E1.556 H CH3 CCH2CH3 CH cyclopropyl E1.557 H CH3 CCH2CH3 N cyclopropyl E1.558 H CH3 CCN CH cyclopropyl E1.559 H CH3 CCN N cyclopropyl E1.559 H CH3 CCN N cyclopropyl E1. cyclopropyl E1.561 H CH3 COCH3 N cyclopropyl E1.562 H CH2CH3 N CH cyclopropyl E1.563 H CH2CH3 CH CH cyclopropyl E1.564 H CH2CH3 CH N cyclopropyl E1.565 H CH3 CH3 CH 615 cyclopropyl. H CH2CH3 CF N cyclopropyl E1.567 H CH2CH3 CCl CH cyclopropyl E1.568 H CH2CH3 CCl N cyclopropyl E1.569 H CH2CH3 CBr CH cyclopropyl E1.570 H CH2CH3 CBr N cyclopropyl E1.571 H CH2CH3 CBr CH CCH3 CH cyclopropyl E1.572 H CH2CH3 CCH3 N cyclopropyl E1.573 H CH2CH3 CCH2CH3 CH cyclopropyl E1.574 H CH2CH3 CCH2CH3 N cyclopropyl E1.575 H CH2CH3 CCN CH cyclopropyl E1. N cyclopropyl E1.577 H CH2CH3 COCH3 CH cyclopropyl E1.578 H CH2CH3 COCH3 N cyclopropyl E1.579 H CH2OCH3 N CH cyclopropyl E1.580 H CH2OCH3 CH CH cyclopropyl E1.581 H CH2OCH3 H CH. cyclopropyl E1.582 H CH2OCH3 CF CH cyclopropyl E1.583 H CH2OCH3 CF N cyclopropyl. Petition 870260106348, dated 10 / 15 / 2026, p. 55 / 266 50 / 245 Compounds R3 R4 A2a A2b R1a E1.584 H CH2OCH3 CCl CH cyclopropyl E1.585 H CH2OCH3 CCl N cyclopropyl E1.586 H CH2OCH3 CBr CH cyclopropyl E1.586 H CH2OCH3 CBr CH cyclopropyl E1.587 H CH2OCH83 CBr H158 cyclopropyl. CH2OCH3 CCH3 CH cyclopropyl E1.589 H CH2OCH3 CCH3 N cyclopropyl E1.590 H CH2OCH3 CCH2CH3 CH cyclopropyl E1.591 H CH2OCH3 CCH2CH3 N cyclopropyl E1.592 H CH2OCH3 H C E1.593 H CH2OCH3 CCN N cyclopropyl E1.594 H CH2OCH3 COCH3 CH cyclopropyl E1.595 H CH2OCH3 COCH3 N cyclopropyl E1.596 H CH2CH2OCH3 N CH cyclopropyl E1.5CH27 CH2CHO CH E1.598 H CH2CH2OCH3 CH N cyclopropyl E1.599 H CH2CH2OCH3 CF CH cyclopropyl E1.600 H CH2CH2OCH3 CF N cyclopropyl E1.601 H CH2CH2OCH3 CCl CH cyclopropyl E1. cyclopropyl E1.603 H CH2CH2OCH3 CBr CH cyclopropyl E1.604 H CH2CH2OCH3 CBr N cyclopropyl E1.605 H CH2CH2OCH3 CCH3 CH cyclopropyl E1.606 H CH2CH2OCH CCH3 cyclopropyl E1.607 H1. CH2CH2OCH3 CCH2CH3 CH cyclopropyl E1.608 H CH2CH2OCH3 CCH2CH3 N cyclopropyl E1.609 H CH2CH2OCH3 CCN CH cyclopropyl E1.610 H CH2CH2OCH3 CCN N cyclopropyl E1.611 H CH2CH2OCH3 COCH3 CH cyclopropyl. Petition 870260106348, dated 10 / 15 / 2026, p. 56 / 266 51 / 245 Compounds R3 R4 A2a A2b R1a E1.612 H CH2CH2OCH3 COCH3 N cyclopropyl E1.613 H CH2CN N CH cyclopropyl E1.614 H CH2CN CH CH cyclopropyl E1.615 H CH2CN CH N cyclopropyl E1.616 H CH2CN CF CH cyclopropyl E1.617 H CH2CN CF N cyclopropyl E1.618 H CH2CN CCl CH cyclopropyl E1.619 H CH2CN CCl N cyclopropyl E1.620 H CH2CN CBr CH cyclopropyl E1.621 H CH2CN CBr N cyclopropyl E1.622 H CH2CN CCH3 CH cyclopropyl E1.623 H CH2CN CCH3 N cyclopropyl E1.624 H CH2CN CCH2CH3 CH cyclopropyl E1.625 H CH2CN CCH2CH3 N cyclopropyl E1.626 H CH2CN CCN CH cyclopropyl E1.627 H CH2CN CCN N cyclopropyl E1.628 H CH2CN COCH3 CH cyclopropyl E1.629 H CH2CN COCH3 N cyclopropyl E1.630 H CH2CH2CN N CH cyclopropyl E1.631 H CH2CH2CN CH CH cyclopropyl E1.632 H CH2CH2CN CH N cyclopropyl E1.633 H CH2CH2CN CF CH cyclopropyl E1.634 H CH2CH2CN CF N cyclopropyl E1.635 H CH2CH2CN CCl CH cyclopropyl E1.636 H CH2CH2CN CCl N cyclopropyl E1.637 H CH2CH2CN CBr CH cyclopropyl E1.638 H CH2CH2CN CBr N cyclopropyl E1.639 H CH2CH2CN CCH3 CH cyclopropyl. Petition 870260106348, of 15 / 10 / 2026, p. 57 / 266 52 / 245 Compounds R3 R4 A2a A2b R1a E1.640 H CH2CH2CN CCH3 N cyclopropyl E1.641 H CH2CH2CN CCH2CH3 CH cyclopropyl E1.642 H CH2CH2CN CCH2CH3 N cyclopropyl E1.643 H CH2CH2 CCH E1.644 H CH2CH2CN CCN N cyclopropyl E1.645 H CH2CH2CN COCH3 CH cyclopropyl E1.646 H CH2CH2CN COCH3 N cyclopropyl E1.647 Y» JN CH cyclopropyl E1.648 Y» JN CH cyclopropyl E1.648 Y CH propyla E1. cyclopropyl E1.650 Y» (LJA <A2b'^ / CF CH ciclopropila E1.651 Y CF N ciclopropila E1.652 Y» J CCl CH ciclopropila E1.653 Y CCl N ciclopropila E1.654 Y CBr CH ciclopropila E1.655 Y» (L J CBr N ciclopropila E1.656 o^Y Y» Y j CCH3 CH ciclopropila Petition 870260106348, of 15 / 10 / 2026, p. 58 / 266 53 / 245 Compounds R3 R4 A2a A2b R1a E1.657 'aA CCH3 N cyclopropyl E1.658 flT j Xb\ / CCH2CH3 CH cyclopropyl E1.659 I® lL J Av CCH2CH3 N cyclopropyl E1.660 θΧ / Χ / Χ' / 1\L\'Av\" CCN CH cyclopropyl E1.661 !LJA <A2b^ / CCN N ciclopropila E1.662 a2® flT j COCH3 CH ciclopropila E1.663 a2” iL J COCH3 N ciclopropila E1.664 A? (L J 1 ch3 N CH ciclopropila E1.665 θΧγ^ r2\^\xn\ !L J '2A2b'^N^ 1 ch3 CH CH ciclopropila E1.666 ΟΧγ^Χ r2x^^^^nx A? [L J ^A2b^N^ 1 ch3 CH N ciclopropila E1.667 zT Y J 1 ch3 CF CH ciclopropila E1.668 θΧγ^1 LL J A~X2b^N^ 1 ch3 CF N ciclopropila Petition 870260106348, of 15 / 10 / 2026, p. 59 / 266 54 / 245 Compounds R3 R4 A2a A2b R1a E1.669 zr ΰΓ JA^A2bA^ 1 ch3 CCl CH cyclopropyl E1.670 1 ch3 CCl N cyclopropyl E1.671 a? YJA^A2b^N^ 1 ch3 CBr CH cyclopropyl E1.672 A2 [Γ J ^α2^ν^ 1 ch3 CBr N cyclopropyl E1.673 A2! ÍL J 1 ch3 CCH3 CH cyclopropyl E1.674 zr íT JA^A2b^N^ 1 ch3 CCH3 N cyclopropyl E1.675 θ^τ^'Χ A^ X j ^Α^Ν^ 1 ch3 CCH2CH3 CH cyclopropyl E1.676 A? if J ^A2b^N^ 1 ch3 CCH2CH3 N cyclopropyl E1.677 °^^ / X A2 YJ ^A2b^N^ 1 ch3 CCN CH cyclopropyl E1.678 θ^γ^Χ A?” !LJ 1 ch3 CCN N cyclopropyl E1.679 Ο^ϊγ^Χ rX^^^^^xa?” (LJ 1 ch3 COCH3 CH cyclopropyl Petition 870260106348, of 15 / 10 / 2026, p. 60 / 266 55 / 245 Compostos R3 R4 A2a A2b R1a E1.680 co—z^ ^Z— COCH3 N ciclopropila E1.681 H CH3 N CH NHAc E1.682 H CH3 CH CH NHAc E1.683 H CH3 CH N NHAc E1.684 H CH3 CF CH NHAc E1.685 H CH3 CF N NHAc E1.686 H CH3 CCl CH NHAc E1.687 H CH3 CCl N NHAc E1.688 H CH3 CBr CH NHAc E1.689 H CH3 CBr N NHAc E1.690 H CH3 CCH3 CH NHAc E1.691 H CH3 CCH3 N NHAc E1.692 H CH3 CCH2CH3 CH NHAc E1.693 H CH3 CCH2CH3 N NHAc E1.694 H CH3 CCN CH NHAc E1.695 H CH3 CCN N NHAc E1.696 H CH3 COCH3 CH NHAc E1.697 H CH3 COCH3 N NHAc E1.698 H CH2CH3 N CH NHAc E1.699 H CH2CH3 CH CH NHAc E1.700 H CH2CH3 CH N NHAc E1.701 H CH2CH3 CF CH NHAc E1.702 H CH2CH3 CF N NHAc E1.703 H CH2CH3 CCl CH NHAc E1.704 H CH2CH3 CCl N NHAc E1.705 H CH2CH3 CBr CH NHAc E1.706 H CH2CH3 CBr N NHAc Petition 870260106348, of 15 / 10 / 2026, pág. 61 / 266 56 / 245 Compostos R3 R4 A2a A2b R1a E1.707 H CH2CH3 CCH3 CH NHAc E1.708 H CH2CH3 CCH3 N NHAc E1.709 H CH2CH3 CCH2CH3 CH NHAc E1.710 H CH2CH3 CCH2CH3 N NHAc E1.711 H CH2CH3 CCN CH NHAc E1.712 H CH2CH3 CCN N NHAc E1.713 H CH2CH3 COCH3 CH NHAc E1.714 H CH2CH3 COCH3 N NHAc E1.715 H CH2OCH3 N CH NHAc E1.716 H CH2OCH3 CH CH NHAc E1.717 H CH2OCH3 CH N NHAc E1.718 H CH2OCH3 CF CH NHAc E1.719 H CH2OCH3 CF N NHAc E1.720 H CH2OCH3 CCl CH NHAc E1.721 H CH2OCH3 CCl N NHAc E1.722 H CH2OCH3 CBr CH NHAc E1.723 H CH2OCH3 CBr N NHAc E1.724 H CH2OCH3 CCH3 CH NHAc E1.725 H CH2OCH3 CCH3 N NHAc E1.726 H CH2OCH3 CCH2CH3 CH NHAc E1.727 H CH2OCH3 CCH2CH3 N NHAc E1.728 H CH2OCH3 CCN CH NHAc E1.729 H CH2OCH3 CCN N NHAc E1.730 H CH2OCH3 COCH3 CH NHAc E1.731 H CH2OCH3 COCH3 N NHAc E1.732 H CH2CH2OCH3 N CH NHAc E1.733 H CH2CH2OCH3 CH NHAc E1.734 H CH2CH2OCH3 CH N NHAc Petition 870260106348, of 15 / 10 / 2026, pág. 62 / 266 57 / 245 Compostos R3 R4 A2a A2b R1a E1.735 H CH2CH2OCH3 CF CH NHAc E1.736 H CH2CH2OCH3 CF N NHAc E1.737 H CH2CH2OCH3 CCl CH NHAc E1.738 H CH2CH2OCH3 CCl N NHAc E1.739 H CH2CH2OCH3 CBr CH NHAc E1.740 H CH2CH2OCH3 CBr N NHAc E1.741 H CH2CH2OCH3 CCH3 CH NHAc E1.742 H CH2CH2OCH3 CCH3 N NHAc E1.743 H CH2CH2OCH3 CCH2CH3 CH NHAc E1.744 H CH2CH2OCH3 CCH2CH3 N NHAc E1.745 H CH2CH2OCH3 CCN CH NHAc E1.746 H CH2CH2OCH3 CCN N NHAc E1.747 H CH2CH2OCH3 COCH3 CH NHAc E1.748 H CH2CH2OCH3 COCH3 N NHAc E1.749 H CH2CN N CH NHAc E1.750 H CH2CN CH CH NHAc E1.751 H CH2CN CH N NHAc E1.752 H CH2CN CF CH NHAc E1.753 H CH2CN CF N NHAc E1.754 H CH2CN CCl CH NHAc E1.755 H CH2CN CCl N NHAc E1.756 H CH2CN CBr CH NHAc E1.757 H CH2CN CBr N NHAc E1.758 H CH2CN CCH3 CH NHAc E1.759 H CH2CN CCH3 N NHAc E1.760 H CH2CN CCH2CH3 CH NHAc E1.761 H CH2CN CCH2CH3 N NHAc E1.762 H CH2CN CCN CH NHAc Petition 870260106348, of 15 / 10 / 2026, pág. 63 / 266 58 / 245 Compostos R3 R4 A2a A2b R1a E1.763 H CH2CN CCN N NHAc E1.764 H CH2CN COCH3 CH NHAc E1.765 H CH2CN COCH3 N NHAc E1.766 H CH2CH2CN N CH NHAc E1.767 H CH2CH2CN CH CH NHAc E1.768 H CH2CH2CN CH N NHAc E1.769 H CH2CH2CN CF CH NHAc E1.770 H CH2CH2CN CF N NHAc E1.771 H CH2CH2CN CCl CH NHAc E1.772 H CH2CH2CN CCl N NHAc E1.773 H CH2CH2CN CBr CH NHAc E1.774 H CH2CH2CN CBr N NHAc E1.775 H CH2CH2CN CCH3 CH NHAc E1.776 H CH2CH2CN CCH3 N NHAc E1.777 H CH2CH2CN CCH2CH3 CH NHAc E1.778 H CH2CH2CN CCH2CH3 N NHAc E1.779 H CH2CH2CN CCN CH NHAc E1.780 H CH2CH2CN CCN N NHAc E1.781 H CH2CH2CN COCH3 CH NHAc E1.782 H CH2CH2CN COCH3 N NHAc E1.783 N CH NHAc E1.784 / TYJ CH CH NHAc E1.785 CH N NHAc E1.786 (LJ CF CH NHAc Petition 870260106348, of 15 / 10 / 2026, pág. 64 / 266 59 / 245 Compounds R3 R4 A2a A2b R1a E1.787 ,ν.., Y» flT J CF N NHAc E1.788 O;¾γ^' Υ» Y j 'Χ''XX CCl CH NHAc E1.789 χ,., NY“ QL JA <A2b^^ CCl N NHAc E1.790 Y“ Y j A'X'b'-X CBr CH NHAc E1.791 θχχ4· Υ» [[ j A<A2b^X CBr N NHAc E1.792 Y“ aT j XxA CCH3 CH NHAc E1.793 ο^Ά Y“ Y j A<A2b'XX CCH3 N NHAc E1.794 Q...X, Y“ (L J AvW CCH2CH3 CH NHAc E1.795 R'^XX^'XsX Y“ Y j Χα’'\Χ CCH2CH3 N NHAc E1.796 Y^ Y^ J ΑχΑΧ CCN CH NHAc E1.797 ο^_γ Υ^χχ,^ Y“ Y j CCN N NHAc E1.798 r2XX^ / n\ Υ» j A<A2bAxx COCH3 CH NHAc E1.799 O3%jX'1 Y“ flL J ^'‘xx’ COCH3 N NHAc E1.800 O—Z\ z. N CH NHAc Petition 870260106348, of 15 / 10 / 2026, p. 65 / 266 60 / 245 Compounds R3 R4 A2a A2b R1a E1.801 co—z^ ^Z— CH CH NHAc E1.802 c O—Z^ ^Z — CH N NHAc E1.803 zr YJ 1 ch3 CF CH NHAc E1.804 A^ [Γ5 E ch N^8 NHA2^ 'Υ- \—o ° y CCl CH NHAc E1.806 ζΓ ίΓ J Α^α2^νΑ 1 ch3 CCl N NHAc E1.807 c Ο—Z^ ^Z CBr CH NHAc E1.818 c Ο— OZ—Z^ NHA —if. CCH3 CH NHAc E1.810 co—z^ ^z— CCH3 N NHAc E1.811 co—z^ ^z— CCH2CH3 CH NHAc Petition 870260106348, dated 10 / 15 / 2026, p. 66 / 266 61 / 245 Compounds R3 R4 A2a A2b R1a E1.812 co—z^ ^Z— CCH2CH3 N NHAc E1.813 co—z^ ^z — CCN CH NHAc E1.814 zr Υ J a^a2^nA 1 ch3 CCN N NHAc E1.815 A2 [Γ J ^A2b^N^ 1 ch3 COCH3 CH NHAc E1.816 \—o ° y COCH3 N NHAc E1.817 H CH3 N CH CN E1.818 H CH3 CH CH CN E1.819 H CH3 CH N CN E1.820 H CH3 CF CH CN E1.821 H CH3 CF N CN E1.822 H CH3 CCl CH CN E1.823 H CH3 CCl N CN E1.824 H CH3 CBr CH CN E1.825 H CH3 CBr N CN E1.826 H CH3 CCH3 CH CN E1.827 H CH3 CCH3 N CN E1.828 H CH3 CCH2CH3 CH CN E1.829 H CH3 CCH2CH3 N CN E1.830 H CH3 CCN CH CN E1.831 H CH3 CCN N CN E1.832 H CH3 COCH3 CH CN Petition 870260106348, of 15 / 10 / 2026, pág. 67 / 266 62 / 245 Compounds R3 R4 A2a A2b R1a E1.833 H CH3 COCH3 N CN E1.834 H CH2CH3 N CH CN E1.835 H CH2CH3 CH CH CN E1.836 H CH2CH3 CH N CN E1.837 H CH2CH3 CF CH CN E1.838 H CH2CH3 CF N CN E1.839 H CH2CH3 CCl CH CN E1.840 H CH2CH3 CCl N CN E1.841 H CH2CH3 CBr CH CN E1.842 H CH2CH3 CBr N CN E1.843 H CH2CH3 CCH3 CH CN E1.844 H CH2CH3 CCH3 N CN E1.845 H CH2CH3 CCH2CH3 CH CN E1.846 H CH2CH3 CCH2CH3 N CN E1.847 H CH2CH3 CCN CH CN E1.848 H CH2CH3 CCN N CN E1.849 H CH2CH3 COCH3 CH CN E1.850 H CH2CH3 COCH3 N CN E1.851 H CH2OCH3 N CH CN E1.852 H CH2OCH3 CH CH CN E1.853 H CH2OCH3 CH N CN E1.854 H CH2OCH3 CF CH CN E1.855 H CH2OCH3 CF N CN E1.856 H CH2OCH3 CCl CH CN E1.857 H CH2OCH3 CCl N CN E1.858 H CH2OCH3 CBr CH CN E1.859 H CH2OCH3 CBr N CN E1.860 H CH2OCH3 CCH3 CH CN Petition 870260106348, of 15 / 10 / 2026, pág. 68 / 266 63 / 245 Compounds R3 R4 A2a A2b R1a E1.861 H CH2OCH3 CCH3 N CN E1.862 H CH2OCH3 CCH2CH3 CH CN E1.863 H CH2OCH3 CCH2CH3 N CN E1.864 H CH2OCH3 CCN CH CN E1.865 H CH2OCH3 CCN N CN E1.866 H CH2OCH3 COCH3 CH CN E1.867 H CH2OCH3 COCH3 N CN E1.868 H CH2CH2OCH3 N CH CN E1.869 H CH2CH2OCH3 CH CH CN E1.870 H CH2CH2OCH3 CH N CN E1.871 H CH2CH2OCH3 CF CH CN E1.872 H CH2CH2OCH3 CF N CN E1.873 H CH2CH2OCH3 CCl CH CN E1.874 H CH2CH2OCH3 CCl N CN E1.875 H CH2CH2OCH3 CBr CH CN E1.876 H CH2CH2OCH3 CBr N CN E1.877 H CH2CH2OCH3 CCH3 CH CN E1.878 H CH2CH2OCH3 CCH3 N CN E1.879 H CH2CH2OCH3 CCH2CH3 CH CN E1.880 H CH2CH2OCH3 CCH2CH3 N CN E1.881 H CH2CH2OCH3 CCN CH CN E1.882 H CH2CH2OCH3 CCN N CN E1.883 H CH2CH2OCH3 COCH3 CH CN E1.884 H CH2CH2OCH3 COCH3 N CN E1.885 H CH2CN N CH CN E1.886 H CH2CN CH CH CN E1.887 H CH2CN CH N CN E1.888 H CH2CN CF CH CN Petition 870260106348, of 15 / 10 / 2026, pág. 69 / 266 64 / 245 Compostos R3 R4 A2a A2b R1a E1.889 H CH2CN CF N CN E1.890 H CH2CN CCl CH CN E1.891 H CH2CN CCl N CN E1.892 H CH2CN CBr CH CN E1.893 H CH2CN CBr N CN E1.894 H CH2CN CCH3 CH CN E1.895 H CH2CN CCH3 N CN E1.896 H CH2CN CCH2CH3 CH CN E1.897 H CH2CN CCH2CH3 N CN E1.898 H CH2CN CCN CH CN E1.899 H CH2CN CCN N CN E1.900 H CH2CN COCH3 CH CN E1.901 H CH2CN COCH3 N CN E1.902 H CH2CH2CN N CH CN E1.903 H CH2CH2CN CH CH CN E1.904 H CH2CH2CN CH N CN E1.905 H CH2CH2CN CF CH CN E1.906 H CH2CH2CN CF N CN E1.907 H CH2CH2CN CCl CH CN E1.908 H CH2CH2CN CCl N CN E1.909 H CH2CH2CN CBr CH CN E1.910 H CH2CH2CN CBr N CN E1.911 H CH2CH2CN CCH3 CH CN E1.912 H CH2CH2CN CCH3 N CN E1.913 H CH2CH2CN CCH2CH3 CH CN E1.914 H CH2CH2CN CCH2CH3 N CN E1.915 H CH2CH2CN CCN CH CN E1.916 H CH2CH2CN CCN N CN Petition 870260106348, of 15 / 10 / 2026, pág. 70 / 266 65 / 245 Compounds R3 R4 A2a A2b R1a E1.917 H CH2CH2CN COCH3 CH CN E1.918 H CH2CH2CN COCH3 N CN E1.919 y N CH CN E1.920 y» li j CH CH CN E1.921 y» dl j CH N CN E1. E1.923 y CF N CN E1.924 y CCl N CN E1.925 y» it j CCl N CN E1.926 y» it j CCl N CN E1.926 y CBr CH CN E1.927 y CBr N CN E1.928 o. of j CCH2CH3 CH CN E1.931 and° of j CCH2CH3 N CN Petition 870260106348, of 15 / 10 / 2026, p. 71 / 266 66 / 245 Compounds R3 R4 A2a A2b R1a E1.932 of CCN CH CN E1.933 a*· flT j 'A''X^ CCN N CN E1.934 X COCH3 CH CN E1.935 X COCH3 N CN E1.936 XO—Z\ ZN CH 7 E1. CH CH CN E1.938 zr ίΓ J 1 ch3 CH N CN E1.939 XO—Z^ Z. “X. CF CH CN E1.940 °χχχ í” íL J xx 1 ch3 CF N CN E1.941 ti O—Z\ ^z — CC CH CN E1. CCl N CN E1.943 χ. O —Z^ ^Z — CBr CH CN Petition 870260106348, of 15 / 10 / 2026, p. 72 / 266 67 / 245 Compounds R3 R4 A2a A2b R1a E1.944 co—z^ ^Z— CBr N CN E1.945 c O—Z^ ^Z — CCH3 CH CN E1.946 a? YJA^A2b^N^ 1 ch3 CCH3 N CN E1.947 A^ [Γ J ^A2b^N^ 1 ch3 CCH2CH3 CH CN E1.948 \—O ° y CCH2CH3 N CN E1.949 A? !LJA^A2b^N^ 1 ch3 CCN CH CN E1.950 ij o—z^ ^z —*7. CCN N CN E1.951 c O—Z^ / Z— COCH3 CH CN E1.952 CO—Z\ ^z — COCH3 N CN

[0039] List 1.2 provides compounds E2.1 to E2.952 of formula (Ia), where R2 is H, R5 is CH3, A4 is N and R1a, R3, R4, A2a and A2b are as defined in Table 1.

[0040] List 1.3 provides compounds E3.1 to E3.952 of formula (Ia), where R2 is H, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a and A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, p. 73 / 266 68 / 245

[0041] List 1.4 provides compounds E4.1 to E4.952 of formula (Ia), where R2 is H, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0042] List 1.5 provides compounds E5.1 to E5.952 of formula (Ia), wherein R2 is H, R5 is cyclopropyl, A4 is CH and R R3, R4, A2a, A2b are as defined in Table 1.

[0043] List 1.6 provides compounds E6, 1 to E6, 952 of formula (Ia), wherein R2 is H, R5 is cyclopropyl, A4 is N and R R3, R4, A2a, A2b are as defined in Table 1.

[0044] List 1.7 provides compounds E7.1 to E7.952 of formula (Ia), wherein R2 is H, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0045] List 1.8 provides compounds E8.1 to E8.952 of formula (Ia), wherein R2 is H, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0046] List 1.9 provides compounds E9, 1 to E9, 952 of formula (Ia), wherein R2 is H, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0047] List 1.10 provides compounds E10.1 to E10.952 of formula (Ia), wherein R2 is H, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0048] List 1.11 provides compounds E11.1 to E11.952 of formula (Ia), wherein R2 is CH3, R5 is CH3, A4 is CH and R1a, R3,R A2a and A2b are as defined in Table 1.

[0049] List 1.12 provides compounds E12.1 to E12.952 of formula (Ia), wherein R2 is CH3, R5 is CH3, A4 is N and R1a, R3, R A2a and A2b are as defined in Table 1.

[0050] List 1.13 provides compounds E13.1 to E13.952 of formula (Ia), wherein R2 is CH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, page 74 / 266 69 / 245

[0051] List 1.14 provides compounds E14.1 to E14.952 of formula (Ia), wherein R2 is CH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0052] List 1.15 provides compounds E15.1 to E15.952 of formula (Ia), wherein R2 is CH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0053] List 1.16 provides compounds E16.1 to E16.952 of formula (Ia), wherein R2 is CH3, R5 is cyclopropyl, A4 is and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0054] List 1.17 provides compounds E17.1 to E17.952 of formula (Ia), wherein R2 is CH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0055] List 1.18 provides compounds E18.1 to E18.952 of formula (Ia), wherein R2 is CH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0056] List 1.19 provides compounds E19.1 to E19.952 of formula (Ia), wherein R2 is CH3, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0057] List 1.20 provides compounds E20.1 to E20.952 of formula (Ia), wherein R2 is CH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0058] List 1.21 provides compounds E21.1 to E21.952 of formula (Ia), wherein R2 is CH2CH3, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0059] List 1.22 provides compounds E22.1 to E22.952 of formula (Ia), wherein R2 is CH2CH3, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0060] List 1.23 provides compounds E23.1 to E23.952 of formula (Ia), wherein R2 is CH2CH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, page 75 / 266 70 / 245

[0061] List 1.24 provides compounds E24.1 to E24.952 of formula (Ia), wherein R2 is CH2CH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0062] List 1.25 provides compounds E25.1 to E25.952 of formula (Ia), wherein R2 is CH2CH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0063] List 1.26 provides compounds E26.1 to E26.952 of formula (Ia), wherein R2 is CH2CH3, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0064] List 1.27 provides compounds E27.1 to E27.952 of formula (Ia), wherein R2 is CH2CH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0065] List 1.28 provides compounds E28.1 to E28.952 of formula (Ia), wherein R2 is CH2CH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0066] List 1.29 provides compounds E29.1 to E29.952 of formula (Ia), wherein R2 is CH2CH3, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0067] List 1.30 provides compounds E30.1 to E30.952 of formula (Ia), wherein R2 is CH2CH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0068] List 1.31 provides compounds E31.1 to E31.952 of formula (Ia), wherein R2 is F, R5 is CH3, A4 is CH and R1a, R3, R4, A2a and A2b are as defined in Table 1.

[0069] List 1.32 provides compounds E32.1 to E32.952 of formula (Ia), wherein R2 is F, R5 is CH3, A4 is N and R1a, R3, R4, A2a and A2b are as defined in Table 1.

[0070] List 1.33 provides compounds E33.1 to E33.952 of formula (Ia), wherein R2 is F, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, page 76 / 266 71 / 245

[0071] List 1.34 provides compounds E34.1 to E34.952 of formula (Ia), wherein R2 is F, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0072] List 1.35 provides compounds E35.1 to E35.952 of formula (Ia), wherein R2 is F, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0073] List 1.36 provides compounds E36.1 to E36.952 of formula (Ia), wherein R2 is F, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0074] List 1.37 provides compounds E37.1 to E37.952 of formula (Ia), wherein R2 is F, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0075] List 1.38 provides compounds E38.1 to E38.952 of formula (Ia), wherein R2 is F, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0076] List 1.39 provides compounds E39.1 to E39.952 of formula (Ia), wherein R2 is F, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0077] List 1.40 provides compounds E40.1 to E40.952 of formula (Ia), wherein R2 is F, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0078] List 1.41 provides compounds E41.1 to E41.952 of formula (Ia), wherein R2 is Cl, R5 is CH3, A4 is CH and R1a, R3, R A2a and A2b are as defined in Table 1.

[0079] List 1.42 provides compounds E42.1 to E42.952 of formula (Ia), wherein R2 is Cl, R5 is CH3, A4 is N and R1a, R3, R A2a and A2b are as defined in Table 1.

[0080] List 1.43 provides compounds E43.1 to E43.952 of formula (Ia), wherein R2 is Cl, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, page 77 / 266 72 / 245

[0081] List 1.44 provides compounds E44.1 to E44.952 of formula (Ia), wherein R2 is Cl, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0082] List 1.45 provides compounds E45.1 to E45.952 of formula (Ia), wherein R2 is Cl, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0083] List 1.46 provides compounds E46.1 to E46.952 of formula (Ia), wherein R2 is Cl, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0084] List 1.47 provides compounds E47.1 to E47.952 of formula (Ia), wherein R2 is Cl, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0085] List 1.48 provides compounds E48.1 to E48.952 of formula (Ia), wherein R2 is Cl, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0086] List 1.49 provides compounds E49.1 to E49.952 of formula (Ia), wherein R2 is Cl, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0087] List 1.50 provides compounds E50.1 to E50.952 of formula (Ia), wherein R2 is Cl, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0088] List 1.51 provides compounds E51.1 to E51.952 of formula (Ia), wherein R2 is Br, R5 is CH3, A4 is CH and R1a, R3, R A2a and A2b are as defined in Table 1.

[0089] List 1.52 provides compounds E52.1 to E52.952 of formula (Ia), wherein R2 is Br, R5 is CH3, A4 is N and R1a, R3, R A2a and A2b are as defined in Table 1.

[0090] List 1.53 provides compounds E53.1 to E53.952 of formula (Ia), wherein R2 is Br, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, page 78 / 266 73 / 245

[0091] List 1.54 provides compounds E54.1 to E54.952 of formula (Ia), wherein R2 is Br, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0092] List 1.55 provides compounds E55.1 to E55.952 of formula (Ia), wherein R2 is Br, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0093] List 1.56 provides compounds E56.1 to E56.952 of formula (Ia), wherein R2 is Br, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0094] List 1.57 provides compounds E57.1 to E57.952 of formula (Ia), wherein R2 is Br, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0095] List 1.58 provides compounds E58.1 to E58.952 of formula (Ia), wherein R2 is Br, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0096] List 1.59 provides compounds E59.1 to E59.952 of formula (Ia), wherein R2 is Br, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0097] List 1.60 provides compounds E60.1 to E60.952 of formula (Ia), where R2 is Br, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0098] List 1.61 provides compounds E61.1 to E61.952 of formula (Ia), where R2 is CN, R5 is CH3, A4 is CH and R1a, R3, R A2a and A2b are as defined in Table 1.

[0099] List 1.62 provides compounds E62.1 to E62.952 of formula (Ia), where R2 is CN, R5 is CH3, A4 is N and R1a, R3,R A2a and A2b are as defined in Table 1.

[0100] List 1.63 provides compounds E63.1 to E63.952 of formula (Ia), where R2 is CN, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, p. 79 / 266 74 / 245

[0101] List 1.64 provides compounds E64.1 to E64.952 of formula (Ia), where R2 is CN, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0102] List 1.65 provides compounds E65.1 to E65.952 of formula (Ia), wherein R2 is CN, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0103] List 1.66 provides compounds E66.1 to E66.952 of formula (Ia), wherein R2 is CN, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0104] List 1.67 provides compounds E67.1 to E67.952 of formula (Ia), wherein R2 is CN, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0105] List 1.68 provides compounds E68.1 to E68.952 of formula (Ia), wherein R2 is CN, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0106] List 1.69 provides compounds E69.1 to E69.952 of formula (Ia), wherein R2 is CN, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0107] List 1.70 provides compounds E70.1 to E70.952 of formula (Ia), wherein R2 is CN, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0108] List 1.71 provides compounds E71.1 to E71.952 of formula (Ia), wherein R2 is OCH3, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0109] List 1.72 provides compounds E72.1 to E72.952 of formula (Ia), wherein R2 is OCH3, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0110] List 1.73 provides compounds E73.1 to E73.952 of formula (Ia), wherein R2 is OCH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, page 80 / 266 75 / 245

[0111] List 1.74 provides compounds E74.1 to E74.952 of formula (Ia), wherein R2 is OCH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0112] List 1.75 provides compounds E75.1 to E75.952 of formula (Ia), wherein R2 is OCH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0113] List 1.76 provides compounds E76.1 to E76.952 of formula (Ia), wherein R2 is OCH3, R5 is cyclopropyl, A4 is and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0114] List 1.77 provides compounds E77.1 to E77.952 of formula (Ia), wherein R2 is OCH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0115] List 1.78 provides compounds E78.1 to E78.952 of formula (Ia), wherein R2 is OCH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0116] List 1.79 provides compounds E79.1 to E79.952 of formula (Ia), wherein R2 is OCH3, R5 is NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0117] List 1.80 provides compounds E80.1 to E80.952 of formula (Ia), wherein R2 is OCH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0118] List 1.81 provides compounds E81.1 to E81.952 of formula (Ia), wherein R2 is OCH2CH3, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0119] List 1.82 provides compounds E82.1 to E82.952 of formula (Ia), wherein R2 is OCH2CH3, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0120] List 1.83 provides compounds E83.1 to E83.952 of formula (Ia), wherein R2 is OCH2CH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, page 81 / 266 76 / 245

[0121] List 1.84 provides compounds E84.1 to E84.952 of formula (Ia), wherein R2 is OCH2CH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0122] List 1.85 provides compounds E85.1 to E85.952 of formula (Ia), wherein R2 is OCH2CH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0123] List 1.86 provides compounds E86.1 to E86.952 of formula (Ia), wherein R2 is OCH2CH3, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0124] List 1.87 provides compounds E87.1 to E87.952 of formula (Ia), wherein R2 is OCH2CH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0125] List 1.88 provides compounds E88.1 to E88.952 of formula (Ia), wherein R2 is OCH2CH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0126] List 1.89 provides compounds E89.1 to E89.952 of formula (Ia), wherein R2 is OCH2CH3, R5NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0127] List 1.90 provides compounds E90.1 to E90.952 of formula (Ia), wherein R2 is OCH2CH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0128] List 1.91 provides compounds E91.1 to E91.952 of formula (Ia), wherein R2 is CO2CH3, R5 is CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0129] List 1.92 provides compounds E92.1 to E92.952 of formula (Ia), wherein R2 is CO2CH3, R5 is CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0130] List 1.93 provides compounds E93.1 to E93.952 of formula (Ia), wherein R2 is CO2CH3, R5 is OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1. Petition 870260106348, dated 10 / 15 / 2026, page 82 / 266 77 / 245

[0131] List 1.94 provides compounds E94.1 to E94.952 of formula (Ia), wherein R2 is CO2CH3, R5 is OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0132] List 1.95 provides compounds E95.1 to E95.952 of formula (Ia), wherein R2 is CO2CH3, R5 is cyclopropyl, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0133] List 1.96 provides compounds E96.1 to E96.952 of formula (Ia), wherein R2 is CO2CH3, R5 is cyclopropyl, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0134] List 1.97 provides compounds E97.1 to E97.952 of formula (Ia), wherein R2 is CO2CH3, R5 is CH2OCH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0135] List 1.98 provides compounds E98.1 to E98.952 of formula (Ia), wherein R2 is CO2CH3, R5 is CH2OCH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0136] List 1.99 provides compounds E99.1 to E99.952 of formula (Ia), wherein R2 is CO2CH3, R5NHCH2CH3, A4 is CH and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0137] List 1.100 provides compounds E100.1 to E100.952 of formula (Ia), where R2 is CO2CH3, R5 is NHCH2CH3, A4 is N and R1a, R3, R4, A2a, A2b are as defined in Table 1.

[0138] List 2.1 provides compounds F1.1 to F1.288 of Petition 870260106348, dated 10 / 15 / 2026, p. 83 / 266 78 / 245

[0139] where R2 is H, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2. More particularly, Table 2 also includes compounds where R3 and R4, considered together, form a ring. In this case, said ring is depicted in columns R3 and R4 (Table 2) merged into one another, along the amide atom bonded to the bicyclic nucleus of formula (Ic). For example, see columns R3 and R4 of compound F1. 217. Table 2: Definitions of substituents for R3, R4, A2a, A2be A4: Compostos R3 R4 A2a A2b A4 F1.1 H CH3 N CH CH F1.2 H CH3 N CH N F1.3 H CH3 NN CH F1.4 H CH3 NNN F1.5 H CH3 CH CH CH F1.6 H CH3 CH CH N F1.7 H CH3 CH N CH F1.8 H CH3 CH NN F1.9 H CH3 CF CH CH F1.10 H CH3 CF CH N F1.11 H CH3 CF N CH F1.12 H CH3 CF NN F1.13 H CH3 CCl CH CH F1.14 H CH3 CCl CH N F1.15 H CH3 CCl N CH F1.16 H CH3 CCl NN F1.17 H CH3 CBr CH CH F1.18 H CH3 CBr CH N F1.19 H CH3 CBr N CH Petição 870260106348, on October 15, 2026, pág. 84 / 266 79 / 245 F1.20 H CH3 CBr NN F1.21 H CH3 CCH3 CH CH F1.22 H CH3 CCH3 CH N F1.23 H CH3 CCH3 N CH F1.24 H CH3 CCH3 NN F1.25 H CH3 CCH2CH3 CH CH F1.26 H CH3 CCH2CH3 CH N F1.27 H CH3 CCH2CH3 N CH F1.28 H CH3 CCH2CH3 NN F1.29 H CH3 CCN CH CH F1.30 H CH3 CCN CH N F1.31 H CH3 CCN N CH F1.32 H CH3 CCN NN F1.33 H CH3 COCH3 CH CH F1.34 H CH3 COCH3 CH N F1.35 H CH3 COCH3 N CH F1.36 H CH3 COCH3 NN F1.37 H CH2CH3 N CH CH F1.38 H CH2CH3 N CH N F1.39 H CH2CH3 NN CH F1.40 H CH2CH3 NNN F1.41 H CH2CH3 CH CH CH F1.42 H CH2CH3 CH CH N F1.43 H CH2CH3 CH N CH F1.44 H CH2CH3 CH NN F1.45 H CH2CH3 CF CH CH F1.46 H CH2CH3 CF CH N F1.47 H CH2CH3 CF N CH F1.48 H CH2CH3 CF NN Petition 870260106348, 15 / 10 / 2026, p. 85 / 266 80 / 245 F1.49 H CH2CH3 CCl CH CH F1.50 H CH2CH3 CCl CH N F1.51 H CH2CH3 CCl N CH F1.52 H CH2CH3 CCl N N F1.53 H CH2CH3 CBr CH CH F1.54 H CH2CH3 CBr CH N F1.55 H CH2CH3 CBr N CH F1.56 H CH2CH3 CBr N N F1.57 H CH2CH3 CCH3 CH CH F1.58 H CH2CH3 CCH3 CH N F1.59 H CH2CH3 CCH3 N CH F1.60 H CH2CH3 CCH3 N N F1.61 H CH2CH3 CCH2CH3 CH CH F1.62 H CH2CH3 CCH2CH3 CH N F1.63 H CH2CH3 CCH2CH3 N CH F1.64 H CH2CH3 CCH2CH3 N N F1.65 H CH2CH3 CCN CH CH F1.66 H CH2CH3 CCN CH N F1.67 H CH2CH3 CCN N CH F1.68 H CH2CH3 CCN N N F1.69 H CH2CH3 COCH3 CH CH F1.70 H CH2CH3 COCH3 CH N F1.71 H CH2CH3 COCH3 N CH F1.72 H CH2CH3 COCH3 N N F1.73 H CH2OCH3 N CH CH F1.74 H CH2OCH3 N CH N F1.75 H CH2OCH3 N N CH F1.76 H CH2OCH3 N N N F1.77 H CH2OCH3 CH CH CH Petição 870260106348, de 15 / 10 / 2026, pág. 86 / 266 81 / 245 F1.78 H CH2OCH3 CH CH N F1.79 H CH2OCH3 CH N CH F1.80 H CH2OCH3 CH NN F1.81 H CH2OCH3 CF CH CH F1.82 H CH2OCH3 CF CH N F1.83 H CH2OCH3 CF N CH F1.84 H CH2OCH3 CF NN F1.85 H CH2OCH3 CCl CH CH F1.86 H CH2OCH3 CCl CH N F1.87 H CH2OCH3 CCl N CH F1.88 H CH2OCH3 CCl NN F1.89 H CH2OCH3 CBr CH CH F1.90 H CH2OCH3 CBr CH N F1.91 H CH2OCH3 CBr N CH F1.92 H CH2OCH3 CBr NN F1.93 H CH2OCH3 CCH3 CH CH F1.94 H CH2OCH3 CCH3 CH N F1.95 H CH2OCH3 CCH3 N CH F1.96 H CH2OCH3 CCH3 NN F1.97 H CH2OCH3 CCH2CH3 CH CH F1.98 H CH2OCH3 CCH2CH3 CH N F1.99 H CH2OCH3 CCH2CH3 N CH F1.100 H CH2OCH3 CCH2CH3 NN F1.101 H CH2OCH3 CCN CH CH F1.102 H CH2OCH3 CCN CH N F1.103 H CH2OCH3 CCN N CH F1.104 H CH2OCH3 CCN NN F1.105 H CH2OCH3 COCH3 CH CH F1.106 H CH2OCH3 COCH3 CH N Petition 870260106348, 15 / 10 / 2026, p. 87 / 266 82 / 245 F1.107 H CH2OCH3 COCH3 N CH F1.108 H CH2OCH3 COCH3 NN F1.109 H CH2CH2OCH3 N CH CH F1.110 H CH2CH2OCH3 N CH N F1.111 H CH2CH2OCH3 NN CH F1.112 H CH2CH2OCH3 NNN F1.113 H CH2CH2OCH3 CH CH CH F1.114 H CH2CH2OCH3 CH CH N F1.115 H CH2CH2OCH3 CH N CH F1.116 H CH2CH2OCH3 CH NN F1.117 H CH2CH2OCH3 CF CH CH F1.118 H CH2CH2OCH3 CF CH N F1.119 H CH2CH2OCH3 CF N CH F1.120 H CH2CH2OCH3 CF NN F1.121 H CH2CH2OCH3 CCl CH CH F1.122 H CH2CH2OCH3 CCl CH N F1.123 H CH2CH2OCH3 CCl N CH F1.124 H CH2CH2OCH3 CCl NN F1.125 H CH2CH2OCH3 CBr CH CH F1.126 H CH2CH2OCH3 CBr CH N F1.127 H CH2CH2OCH3 CBr N CH F1.128 H CH2CH2OCH3 CBr NN F1.129 H CH2CH2OCH3 CCH3 CH CH F1.130 H CH2CH2OCH3 CCH3 CH N F1.131 H CH2CH2OCH3 CCH3 N CH F1.132 H CH2CH2OCH3 CCH3 NN F1.133 H CH2CH2OCH3 CCH2CH3 CH CH F1.134 H CH2CH2OCH3 CCH2CH3 CH N F1.135 H CH2CH2OCH3 CCH2CH3 N CH Petition 870260106348, 15 / 10 / 2026, p. 88 / 266 83 / 245 F1.136 H CH2CH2OCH3 CCH2CH3 N N F1.137 H CH2CH2OCH3 CCN CH CH F1.138 H CH2CH2OCH3 CCN CH N F1.139 H CH2CH2OCH3 CCN N CH F1.140 H CH2CH2OCH3 CCN N N F1.141 H CH2CH2OCH3 COCH3 CH CH F1.142 H CH2CH2OCH3 COCH3 CH N F1.143 H CH2CH2OCH3 COCH3 N CH F1.144 H CH2CH2OCH3 COCH3 N N F1.145 H CH2CN N CH CH F1.146 H CH2CN N CH N F1.147 H CH2CN N N CH F1.148 H CH2CN N N N F1.149 H CH2CN CH CH CH F1.150 H CH2CN CH CH N F1.151 H CH2CN CH N CH F1.152 H CH2CN CH N N F1.153 H CH2CN CF CH CH F1.154 H CH2CN CF CH N F1.155 H CH2CN CF N CH F1.156 H CH2CN CF N N F1.157 H CH2CN CCl CH CH F1.158 H CH2CN CCl CH N F1.159 H CH2CN CCl N CH F1.160 H CH2CN CCl N N F1.161 H CH2CN CBr CH CH F1.162 H CH2CN CBr CH N F1.163 H CH2CN CBr N CH F1.164 H CH2CN CBr N N Petição 870260106348, de 15 / 10 / 2026, pág. 89 / 266 84 / 245 F1.165 H CH2CN CCH3 CH CH F1.166 H CH2CN CCH3 CH N F1.167 H CH2CN CCH3 N CH F1.168 H CH2CN CCH3 N N F1.169 H CH2CN CCH2CH3 CH CH F1.170 H CH2CN CCH2CH3 CH N F1.171 H CH2CN CCH2CH3 N CH F1.172 H CH2CN CCH2CH3 N N F1.173 H CH2CN CCN CH CH F1.174 H CH2CN CCN CH N F1.175 H CH2CN CCN N CH F1.176 H CH2CN CCN N N F1.177 H CH2CN COCH3 CH CH F1.178 H CH2CN COCH3 CH N F1.179 H CH2CN COCH3 N CH F1.180 H CH2CN COCH3 N N F1.181 H CH2CH2CN N CH CH F1.182 H CH2CH2CN N CH N F1.183 H CH2CH2CN N N CH F1.184 H CH2CH2CN N N N F1.185 H CH2CH2CN CH CH CH F1.186 H CH2CH2CN CH CH N F1.187 H CH2CH2CN CH N CH F1.188 H CH2CH2CN CH N N F1.189 H CH2CH2CN CF CH CH F1.190 H CH2CH2CN CF CH N F1.191 H CH2CH2CN CF N CH F1.192 H CH2CH2CN CF N N F1.193 H CH2CH2CN CCl CH CH Petição 870260106348, de 15 / 10 / 2026, pág. 90 / 266 85 / 245 F1.194 H CH2CH2CN CCl CH N F1.195 H CH2CH2CN CCl N CH F1.196 H CH2CH2CN CCl N N F1.197 H CH2CH2CN CBr CH CH F1.198 H CH2CH2CN CBr CH N F1.199 H CH2CH2CN CBr N CH F1.200 H CH2CH2CN CBr N N F1.201 H CH2CH2CN CCH3 CH CH F1.202 H CH2CH2CN CCH3 CH N F1.203 H CH2CH2CN CCH3 N CH F1.204 H CH2CH2CN CCH3 N N F1.205 H CH2CH2CN CCH2CH3 CH CH F1.206 H CH2CH2CN CCH2CH3 CH N F1.207 H CH2CH2CN CCH2CH3 N CH F1.208 H CH2CH2CN CCH2CH3 N N F1.209 H CH2CH2CN CCN CH CH F1.210 H CH2CH2CN CCN CH N F1.211 H CH2CH2CN CCN N CH F1.212 H CH2CH2CN CCN N N F1.213 H CH2CH2CN COCH3 CH CH F1.214 H CH2CH2CN COCH3 CH N F1.215 H CH2CH2CN COCH3 N CH F1.216 H CH2CH2CN COCH3 N N F1.217 X N CH CH F1.218 X N CH N F1.219 X N N CH Petição 870260106348, de 15 / 10 / 2026, pág. 91 / 266 86 / 245 F1.220 AA / NNN F1.221 ΟΧγ^Χ ζ” R\ / z\ / N\ X> CCl N CH F1.232 o..X ^ΧτΑχΑζ, A20 [LJ AVbAz CCl NN F1.233 °XxaX Petition 870260106348, 15 / 10 / 2026, pág. 92 / 266 87 / 245 F1.234 CBr CH N F1.235 °.A\ A· AJ CBr N CH F1.236 A2 1 J CBr NN F1.237 oA\ A° ίΓ j A^A2b^ / CCHa CH CH F1.238 A> it j A <a2bv^ ccha ch n f1.239 a2 !l j cch3 f1.240 q^ax a° a j a<a2ba\ f1.241 o^x\ aca2b^^ cch2ch3 f1.242 y f1.243 r2^^n. íl a<a2b'\ f1.244 o^a (l a^a2bv^ f1.245 o.a\ a· ccn f1.246 [l f1.247 ο^χχα r'\x^\x^ chPetition 870260106348, dated 10 / 15 / 2026, p. 93 / 266 88 / 245 F1.248 A2” IL J CCN NN F1.249 COCH3 CH CH F1.250 rX^\^n A2 'IJ COCH3 CH N F1.251 Οχ^ j» iT j AvX COCH3 N CH F1.252 o^^XX^ / . N 3 NN FX1 CO.3 CO. F1.254 XO—Z\ ^z —Y ~ N CH N F1.255 RXZXA A2” !L j xs^ 1 ch3 NN CH F1.256 X o—z^ ^Z— NNN F1.257 X o—z^ ^z CH CH CH F1—^^9 X F—z ^z — CH N CH Petition 870260106348, dated 10 / 15 / 2026, p. 94 / 266 89 / 245 F1.260 zT J 1 ch3 CH NN F1.261 c Ο—Z\ Z — CF CH CH F1.262 c O—Z^ CF CH N F1.263 c O—Z\ ^z — CF N CH F1.264 co—z^ ^z^Ç—2 CC6 NN F1. CH F1.266 c O—Z\ ^z "Y^ CCl CH N F1.267 Y» Y j 1 ch3 CCl N CH F1.268 c O—Z^ ^Z CCl NN F1.269 Y” Y j ^A2b^N^ 1 ch3 CBr CH^r CH— CB^ F1.2. Petition 870260106348, dated 10 / 15 / 2026, p. 95 / 266 90 / 245 F1.271 zT iT J Α^α2^ν^ 1 ch3 CBr N CH F1.272 c Ο—Z\ Z — CBr NN F1.273 c O—Z^ CCHa CH CH F1.274 c O—Z\ ^z — CCH3 CH N—CHÇ^275 co F1.276 co—z^ ^z^·^ CCH3 NN F1.277 c O—Z\ ^z "Y CCH2CH3 CH CH F1.278 Y» Y j 1 ch3 CCH2CH3 CH N F1.279 •rf o—z^ ^2z — CCH2CH3 N CH13 ch NN C”2. F1.281 o—z^ ^z— CCN CH CH Petition 870260106348, dated 10 / 15 / 2026, p. 96 / 266 91 / 245 F1.282 c ο—Z\ ^z^^ CCN CH N F1.283 co—z^ ^z — CCN N CH F1.284 c ο—z^ ^z^^ CCN NN F1.285 c O—Z^ ^Z "ξ. COCH3 CH CH3 CH—CH—F1.28 F1.287 co—z^ ^Z^Ç^ COCH3 N CH F1.288 co—z^ ^z — COCH3 NN

[0140] Listing 2.2 provides compounds F2.1 through F2.288 of formula (Ic), wherein R2 is H, R5é OCH3, and R3, R4, A2a, A2b, A4são as defined in Table 2.

[0141] Listing 2.3 provides compounds F3,1 to F3,288 of the formula (Ic), wherein R2é H, R5é cyclopropyl and R3, R4, A2a, A2b, A4são as defined in Table 2.

[0142] List 2.4 provides compounds F4.1 to F4.288 of formula (Ic), wherein R2 is H, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0143] List 2.5 provides compounds F5.1 to F5.288 of formula (Ic), wherein R2 is H, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2. Petition 870260106348, dated 10 / 15 / 2026, page 97 / 266 92 / 245

[0144] List 2.6 provides compounds F6.1 to F6.288 of formula (Ic) of formula (Ic), wherein R2 is CH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0145] List 2.7 provides compounds F7.1 to F7.288 of formula (Ic), wherein R2 is CH3, R5 is OCH3 and R3, R4, A2a, A2b, A are as defined in Table 2.

[0146] List 2.8 provides compounds F8.1 to F8.288 of formula (Ic), wherein R2 is CH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0147] List 2.9 provides compounds F9.1 to F9.288 of formula (Ic), wherein R2 is CH3, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0148] List 2.10 provides compounds F10.1 to F10.288 of formula (Ic), wherein R2 is CH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0149] List 2.11 provides compounds F11.1 to F11.288 of formula (Ic), wherein R2 is CH2CH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0150] List 2.12 provides compounds F12,1 to F12,288 of formula (Ic), wherein R2 is CH2CH3, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0151] List 2.13 provides compounds F13.1 to F13.288 of formula (Ic), wherein R2 is CH2CH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0152] List 2.14 provides compounds F14.1 to F14.288 of formula (Ic), wherein R2 is CH2CH3, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0153] List 2.15 provides compounds F15.1 to F15.288 of formula (Ic), wherein R2 is CH2CH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2. Petition 870260106348, dated 10 / 15 / 2026, page 98 / 266 93 / 245

[0154] List 2.16 provides compounds F16.1 to F16.288 of formula (Ic), wherein R2 is F, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0155] List 2.17 provides compounds F17,1 to F17,288 of formula (Ic), wherein R2 is F, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0156] List 2.18 provides compounds F18.1 to F18.288 of formula (Ic), wherein R2 is F, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0157] List 2.19 provides compounds F19.1 to F19.288 of formula (Ic), wherein R2 is F, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0158] List 2.20 provides compounds F20.1 to F20.288 of formula (Ic), wherein R2 is F, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0159] List 2.21 provides compounds F21.1 to F21.288 of formula (Ic), wherein R2 is Cl, R5 is CH3 and R3, R4, A2a, A2b, A are as defined in Table 2.

[0160] List 2.22 provides compounds F22.1 to F22.288 of formula (Ic), wherein R2 is Cl, R5 is OCH3 and R3, R4, A2a, A2b, A are as defined in Table 2.

[0161] List 2.23 provides compounds F23.1 to F23.288 of formula (Ic), wherein R2 is Cl, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0162] List 2.24 provides compounds F24.1 to F24.288 of formula (Ic), wherein R2 is Cl, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0163] List 2.25 provides compounds F25.1 to F25.288 of formula (Ic), wherein R2 is Cl, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2. Petition 870260106348, dated 10 / 15 / 2026, page 99 / 266 94 / 245

[0164] List 2.26 provides compounds F26.1 to F26.288 of formula (Ic), wherein R2 is Br, R5 is CH3 and R3, R4, A2a, A2b, A are as defined in Table 2.

[0165] List 2.27 provides compounds F27.1 to F27.288 of formula (Ic), wherein R2 is Br, R5 is OCH3 and R3, R4, A2a, A2b, A are as defined in Table 2.

[0166] List 2.28 provides compounds F28.1 to F28.288 of formula (Ic), wherein R2 is Br, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0167] List 2.29 provides compounds F29.1 to F29.288 of formula (Ic), wherein R2 is Br, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0168] List 2.30 provides compounds F30.1 to F30.288 of formula (Ic), wherein R2 is Br, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0169] List 2.31 provides compounds F31.1 to F31.288 of formula (Ic), wherein R2 is CN, R5 is CH3 and R3, R4, A2a, A2b, A are as defined in Table 2.

[0170] List 2.32 provides compounds F32,1 to F32,288 of formula (Ic), wherein R2 is CN, R5 is OCH3 and R3, R4, A2a, A2b, A are as defined in Table 2.

[0171] List 2.33 provides compounds F33.1 to F33.288 of formula (Ic), wherein R2 is CN, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0172] List 2.34 provides compounds F34.1 to F34.288 of formula (Ic), wherein R2 is CN, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0173] List 2.35 provides compounds F35.1 to F35.288 of formula (Ic), wherein R2 is CN, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2. Petition 870260106348, dated 10 / 15 / 2026, pp. 100 / 266 95 / 245

[0174] List 2.36 provides compounds F36.1 to F36.288 of formula (Ic), wherein R2 is OCH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0175] List 2.37 provides compounds F37.1 to F37.288 of formula (Ic), wherein R2 is OCH3, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0176] List 2.38 provides compounds F38.1 to F38.288 of formula (Ic), wherein R2 is OCH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0177] List 2.39 provides compounds F39.1 to F39.288 of formula (Ic), wherein R2 is OCH3, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0178] List 2.40 provides compounds F40.1 to F40.288 of formula (Ic), wherein R2 is OCH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0179] List 2.41 provides compounds F41.1 to F41.288 of formula (Ic), wherein R2 is OCH2CH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0180] List 2.42 provides compounds F42.1 to F42.288 of formula (Ic), wherein R2 is OCH2CH3, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0181] List 2.43 provides compounds F43.1 to F43.288 of formula (Ic), wherein R2 is OCH2CH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0182] List 2.44 provides compounds F44.1 to F44.288 of formula (Ic), wherein R2 is OCH2CH3, R5 is CH2OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0183] List 2.45 provides compounds F45.1 to F45.288 of formula (Ic), wherein R2 is OCH2CH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2. Petition 870260106348, dated 10 / 15 / 2026, page 101 / 266 96 / 245

[0184] List 2.46 provides compounds F46.1 to F46.288 of formula (Ic), wherein R2 is CO2CH3, R5 is CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0185] List 2.47 provides compounds F47.1 to F47.288 of formula (Ic), wherein R2 is CO2CH3, R5 is OCH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0186] List 2.48 provides compounds F48.1 to F48.288 of formula (Ic), wherein R2 is CO2CH3, R5 is cyclopropyl and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0187] List 2.49 provides compounds F49.1 to F49.288 of formula (Ic), wherein R2 is CO2CH3, R5 is CH2OCH3 and R3, R4, A2a, A2b and A4 are as defined in Table 2.

[0188] List 2.50 provides compounds F50.1 to F50.288 of formula (Ic), wherein R2 is CO2CH3, R5 is NHCH2CH3 and R3, R4, A2a, A2b, A4 are as defined in Table 2.

[0189] The compounds according to the invention may have any number of benefits including, inter alia, advantageous levels of biological activity to protect plants against diseases caused by fungi or superior properties for use as active agrochemical ingredients (e.g., higher biological activity, an advantageous spectrum of activity, an enhanced safety profile, improved physicochemical properties or increased biodegradability). The compounds according to the invention have particularly advantageous levels of biological activity to protect plants against oomycetes such as Phytophthora, Plasmopara and Pythium.

[0190] The compounds of formula (I), where Z is O, can be designed as shown in the following schemes 1 to 18, in Petition 870260106348, dated 10 / 15 / 2026, page 102 / 266 97 / 245 which, unless stated otherwise, the definition of each variable is as defined in the present invention.

[0191] The compounds of formula (I) can be prepared via Suzuki cross-coupling of compounds of formula (II), wherein X is Cl, Br or I, and a compound of formula (III), wherein any R6 is independently of each other, hydrokene, C1-g alkyl, or wherein two R6s together can form a C3s-cycloalkyl, in the presence of a base, such as CS2CO3, K2CO3 or NaOtBu, and a suitable palladium catalyst, such as tetraquistriphenylphosphinepalladium, [1,1bis(diphenylphosphino)ferrocene]dichloropalladium (II), bis(diphenylphosphine)palladium chloride, palladium dichloride or palladium acetate, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or aqua. Compounds of formula (III), in which any R6 is independently of each other a hydrokenonium, C1-g alkyl, or in which two R6s together can form a C3-8 cycloalkyl, are prepared by known methods or are commercially available. This transformation is depicted in Scheme 1. Scheme 1

[0192] The compounds of formula (II) can be prepared by reacting compounds of formula (IV), wherein X is Cl, Br or I, with a reagent of formula (V), wherein X1 is a good labile group, such as Cl, Br, I, triflate, tosyl or mesyl, Petition 870260106348, dated 10 / 15 / 2026, p. 103 / 266 98 / 245 in the presence of a base, such as CS2CO3, K2CO3, NaH or NaOtBu. A compound of formula (VI), wherein R7 is an electron-withdrawing group, such as a cyano or an ester, may alternatively be used to functionalize the amide nitrogen. Compounds of formula (IV), wherein X is Cl, Br or I, may be prepared by a peptide coupling reaction between a compound of formula (VII), wherein X is Cl, Br or I and X2 is OH, and an amine of formula (VIII) and activating the carboxylic acid function of the compounds of formula (VII), a process which usually occurs by converting the -OH of the carboxylic acid into a good labile group, such as a chloride group, for example, using (COCl)2 or SOCl2, before treatment with amines of formula (VIII), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25 °C and 60 °C and, optionally, in the presence of a base, such as triethylamine or N,N-diisopropylethylamine; or, alternatively, under conditions described in the literature for an amide coupling, such as cyclic 1-propanephosphonic acid anhydride (T3P), in a suitable solvent (e.g., acetonitrile), optionally in the presence of a base (e.g., triethylamine or N,N-diisopropylethylamine). For examples, see Chem. Soc. Rev. 2009, 38, 606 and Chem. Soc. Rev. 2011, 40, 5084. Alternatively, compounds of formula (II), wherein X is Cl, Br or I, can be obtained by an amide coupling transformation between compounds of formula (VII), wherein X2 is OH, and X is Cl, Br or I, and amines of formula (IX) using the conditions described above. These transformations are depicted in Scheme 2. Petition 870260106348, dated 10 / 15 / 2026, page 104 / 266 99 / 245 (V) OF M (I) (VH) Schema 2

[0193] The compounds of formula (IX) are commercially available or can be obtained by reacting compounds of formula (VIII) with a compound of formula (V), wherein X1 is a good labile group, such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base, such as CS2CO3, K2CO3, NaH or NaOtBu. Alternatively, the compounds of formula (IX) can also be synthesized by reacting compounds of formula (VIII) with compounds of formula (VI), wherein R7 is an electron-withdrawing group, such as cyano or ester, optionally in the presence of a base, such as triethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene.Alternatively, the compounds of formula (IX) can be obtained from amines of formula (VIII) by a reductive amination with aldehydes of formula (X), wherein R11 is C1-salkyl, C1-galkoxy-C1-salkyl, C1-scycloalkyl, C1-cycloalkyl-C1-salkyl, C2-salkenyl, C2-salquinyl, C1-salkoxy, C1-galkylsulfanyl-C1-salkyl, C1-galkylsulfynyl-C1-salkyl, C1-galkylsulfonyl-C1-salkyl, C1-galkoxycarbonyl-C1-salkyl, C1-galkylaminocarbonyl-C1-salkyl, diC1-galkylaminocarbonyl-C1-salkyl or CN, e.g., in the presence of NaBH(OAc)3 or NaBHsCN, in a suitable solvent, optionally in the presence of a Bronsted acid. Petition 870260106348, dated 10 / 15 / 2026, p. 105 / 266 100 / 245 or Lewis, such as acetic acid. Alternatively, another reagent system for reductive amination uses a combination of titanium isopropoxide and NaBH4. The synthesis of compounds of formula (IX) from amines of formula (VIII) is depicted in Scheme 3. (V) (VI) (X) Scheme 3

[0194] Alternatively, compounds of formula (II), wherein X is Cl, Br or I, may be prepared from the reaction of a compound of formula (X) and a halogenating agent, such as N-chlorosuccinimide, N-bromosuccinimide, niodosuccinimide or bromine, in a suitable solvent, such as dichloromethane, chloroform, tetrahydrofuran or acetonitrile. The compounds of formula (XI) can be obtained by an amide coupling transformation of amines of formula (IX) with compounds of formula (XII), wherein X2 is OH, and activating the carboxylic acid function of the compounds of formula (XII), a process that usually occurs by converting the -OH of the carboxylic acid into a good labile group, such as a chloride group, for example, using (COCl)2 or SOCl2, before treatment with amines of formula (IX), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25 °C and 60 °C and, optionally, in the presence of a base, such as triethylamine or N,N-diisopropylethylamine; or, alternatively, under conditions described in the literature for a. Petition 870260106348, dated 10 / 15 / 2026, p. 106 / 266 101 / 245 amide coupling, such as cyclic 1-propanephosphonic acid anhydride (T3P) in a suitable solvent (e.g., acetonitrile), optionally in the presence of a base (e.g., triethylamine or N,N-diisopropylethylamine). Alternatively, compounds of formula (XI) can be obtained by alkylation of compounds of formula (XIII) with compounds of formula (V), wherein X1 is a good labile group, such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base, such as CS2CO3, K2CO3, NaH or NaOtBu. Alternatively, compounds of formula (XI) can also be synthesized by reacting compounds of formula (XIII) with compounds of formula (VI), wherein R7 is an electron-withdrawing group, such as cyano or ester, optionally in the presence of a base, such as triethylamine or 1,8-diazabicyclo[5.4.0]undec7-ene.The compounds of formula (XIII) can be prepared by a peptide coupling transformation from compounds of formula (XII), where X2 is OH, with amines of formula (VIII) using the conditions described above. These transformations are depicted in Scheme 4. Scheme 4 Petition 870260106348, dated 10 / 15 / 2026, p. 107 / 266 102 / 245

[0195] Alternatively, compounds of formula (XI) can be synthesized by reacting compounds of formula (XIV), where X is Cl, Br or I, with amines of formula (IX) and carbon monoxide in the presence of a catalyst, such as [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II) and, optionally, a base, such as triethylamine. This transformation is depicted in Scheme 5. (IX) (XIV) (XI) Scheme 5

[0196] The compounds of formula (Xlla), wherein each R1 is independently selected from hydrogen, hydroxyl, halogen, CN, C1-g-alkyl, C3-s-cycloalkyl, C1-alkoxy-C1-g-alkyl, C3-6-cycloalkyl-C1-4-alkyl, C1-alkylsulfanyl, C1-g-alkylsulfonyl, C1-g-alkylsulfonyl, C1-galkoxy, amino and NHC(O)C1-g-alkyl, and X2 is OH, can be prepared by hydrolysis of esters of formula (XVa), wherein any R1 is independently selected from hydrogen, hydroxyl, halogen, CN, C1-g-alkyl, C3-cycloalkyl, C1-galkoxy-C1-g-alkyl, C1-s-cycloalkyl-C1-g-alkyl, C1-s-cycloalkyl-C1-4-alkyl, C1-g-alkylsulfanyl, C1-g-alkylsulfonyl, C1-alkylsulfonyl, C1-galkoxy, amino and NHC (O) C1-g alkyl, and R9 is C1-6 alkyl, for example, using a base, such as lithium hydroxide or sodium hydroxide.The compounds of formula (XVa), wherein any R1 is independently selected from hydrogen, hydroxyl, halogen, CN, C1-g-alkyl, C3-s-cycloalkyl, C1-galkoxy-C1-g-alkyl, C36-cycloalkyl-O1-4-alkyl, C1-g-alkylsulfanyl, C1. Petition 870260106348, dated 10 / 15 / 2026, page 108 / 266 103 / 245 ealkylsulfinyl, C1-ealkylsulfonyl, C1-ealkoxy, amino and NHC(O)C1-6-alkyl, and R9 is C1-ealkyl, can be obtained from compounds of formula (XVIa), wherein X is Cl, Br or I, by a cross-coupling transformation with a compound of formula (XVII), wherein any R6 is independently hydrogen, C1-ealkyl, or wherein two R6s together can form a C1-8-cycloalkyl (Suzuki cross-coupling), or a compound of formula (XVIII) (Stille cross-coupling). Suzuki cross-couplings can be achieved using a suitable palladium catalyst, such as tetraquistriphenylphosphinopalladium, [1,1bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphino)palladium(II) chloride, palladium dichloride or palladium acetate, in the presence of a base, such as CsaCOa, K2CO3 or NaOtBu, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water.Stille couplings can be achieved using a suitable palladium catalyst, such as tetraquistriphenylphosphinopalladium, tris(dibenzylideneacetone)dipalladium, palladium dichloride or palladium acetate, in the presence of a base, such as Cs2CO3 or sodium acetate, in a suitable solvent, such as dimethylformamide, dioxane or acetonitrile. The compounds of formula (XVII), in which any R6 is independently hydrogen, C1-e alkyl, or in which two R6s together can form a C3-8 cycloalkyl, and the compounds of formula (XVIII) are prepared by known methods or are commercially available. These transformations are depicted in Scheme 6. Petition 870260106348, dated 10 / 15 / 2026, page 109 / 266 104 / 245 {XVIII) Scheme 6

[0197] Alternatively, compounds of formula (XVa), wherein each R1 is independently selected from hydrokene, hydroxy, halokene, CN, C1-g-alkyl, C3g-cycloalkyl, C1-galkoxy-C1-g-alkyl, C5-s-cycloalkyl-C1 4-alkyl, C1-g-alkylsulfanila, C1-g-alkylsulfinyl, C1-g-alkylsulfonyl, C1-galkoxyamino, and NHC(O)C1-g-alkyl, and R9 is C1-6-alkyl, can be obtained from compounds of formula (XIXa), wherein R9 is C1-g-alkyl, by reaction with a compound of formula (XX), wherein X is Cl or Br and R8 is C1-g-alkyl, in the presence of a base, such as pyridine or diisopropylethylamine. Amines of formula (XIXa), wherein R9 is C1-6-alkyl, can be prepared by treating compounds of formula (XXIa), wherein R9 is C1-6-alkyl, with an acid, typically hydrochloric acid, or with sodium acetate and hydroxyamine hydrochloride in a protic solvent, such as methanol.Compounds of formula (XXIa), wherein R9 is C1-g-alkyl, can be synthesized by reacting compounds of formula (XVIa), wherein X is Cl, Br or I, and R9 is C1-g-alkyl, with diphenylmethanimine (CAS number 1013-88-3) in the presence of a catalyst, such as palladium acetate or tris(dibenzylideneacetone)dipalladium, optionally a liquand, such as 1,1'-[1,1'-binaphthalene]-2,2'-diPetition 870260106348, 15 / 10 / 2026, p. 110 / 266. 105 / 245 ylbis[1,1-diphenylphosphine] or (9,9-dimethyl-9H-xanthene-4,5-di-yl)bis(diphenylphosphane), and in the presence of a base, such as cesium carbonate or sodium tert-butoxide. These transformations are depicted in Scheme 7. (XVIa) (XXIa) (XlXa) where X is Cl, Br or by condensation Scheme 7

[0198] The compounds of formula (XVIa), in I, and R9é Ci-galkyl, can be synthesized: of a compound of formula (XXIIa), wherein X is Cl, Br, or I, and R9 is C1-g alkyl, with a compound of formula (XXIII), wherein X is Cl, Br, or I, or its corresponding acetal of formula (XXIV), wherein X is Cl, Br, or I, and any R10 is, independently of each other, C1-g alkyl, or wherein two R10s together can form a C5-s-cycloalkyl, in a solvent such as aqua, ethanol, acetone, or acetonitrile. In some cases, the reaction response may be improved by using a base, such as sodium bicarbonate or potassium carbonate, or by using an acid, such as p-toluenesulfonic acid or hydrogen bromide. The compounds of formula (XXIIa), wherein X is Cl, Br, or I, and R9 is C1-g alkyl, the compounds of formula (XXIII), Petition 870260106348, dated 10 / 15 / 2026, p. 111 / 266 106 / 245 wherein X is Cl, Br or I, and compounds of formula (XXIV), wherein X is Cl, Br or I, and any R10 is independently of each other C1-g alkyl, or wherein two R10s together can form a C1s-s cycloalkyl, are commercially available or are prepared using methods known to those skilled in the art. These transformations are depicted in Scheme 8. (XXIV) Scheme 8

[0199] Compounds of formula (XlVa), wherein X is Cl, Br or I, and any R1 is independently selected from hydrogen, hydroxy, halogen, CN, C1-g alkyl, C3-g cycloalkyl, C1-6 alkoxy-C1-6 alkyl, C5-5 cycloalkyl-C14 alkyl, C1-g alkylsulfanilyl, C1-g alkylsulfonyl, C1-g alkylsulfonyl, C1-g alkoxy, amino, and NHC(O)C1-g alkyl, are commercially available or can be prepared by condensation of an amine of formula (XXVa), wherein X is Cl, Br or I, with a compound of formula (XXIII), wherein X is Cl, Br or I, or its corresponding acetal of formula (XXIV), wherein X is Cl, Br or I, and any R10 is independently C1-g alkyl, or wherein two R10s together They can form a Cs-scycloalkyl group in a solvent such as water, ethanol, acetone, or acetonitrile. In some cases, the reaction response can be improved by using a base, such as sodium bicarbonate or potassium carbonate, or by using a Petition 870260106348, dated 10 / 15 / 2026, p. 112 / 266 107 / 245 acid, such as p-toluenesulfonic acid or hydrogen bromide. Compounds of the formula (XXVa), wherein X is Cl, Br, or I, are commercially available or are prepared using methods known to those skilled in the art. (XXIV) Scheme 9

[0200] The compounds of formula (XVb), wherein R9 is C1-6 alkyl, can be prepared by condensation of compounds of formula (XXVI), wherein R9 is C1-6 alkyl, with compounds of formula (XXVII), using a solvent such as toluene, and by heating, optionally in the presence of an acid such as acetic acid. The compounds of formula (XXVI), wherein R9 is C1-6 alkyl, and the compounds of formula (XXVII) are commercially available or can be synthesized using methods known to those skilled in the art. This transformation is depicted in Scheme 10. (XXVI) (XXVII) (XVb) Scheme 10

[0201] Compounds of the formula (XVc) , where R9 is C-alkyl, are commercially available or can be Petition 870260106348, dated 10 / 15 / 2026, p. 113 / 266 108 / 245 prepared by condensation of an amine of formula (XXVIII), wherein R9 is C1-g-alkyl, with a compound of formula (XXIII), wherein X is Cl, Br or I, or its corresponding acetal of formula (XXIV), wherein X is Cl, Br or I, and any R10 is independently C1-g-alkyl, or wherein two R10s together may form a C5-s-cycloalkyl, in a solvent such as aqua, ethanol, acetone or acetonitrile. In some cases, the reaction response may be improved by using a base such as sodium bicarbonate or potassium carbonate, or by using an acid such as p-toluenesulfonic acid or hydrogen bromide. Compounds of formula (XXVIII), wherein R9 is C1-g-alkyl, are commercially available or are prepared using methods known to those skilled in the art. These transformations are depicted in Scheme 11. (XXIV) Scheme 11

[0202] The compounds of formula (VII), wherein X is Cl, Br or I and X2 is OH, can be prepared by hydrolysis of esters of formula (XXIX), wherein X is Cl, Br or I, and R9 is C1-6 alkyl, for example, using a base such as lithium hydroxide or sodium hydroxide. The esters of formula (XXIX), wherein X is Cl, Br or I and R9 is C1-6 alkyl, can be obtained by halogenation of compounds of formula (XV), wherein R9 is C1-6 alkyl, using a halogenating agent such as N Petition 870260106348, dated 10 / 15 / 2026, p. 114 / 266 109 / 245 chlorosuccinimide, N-bromosuccinimide, N-iodosuccinimide or bromine, in a suitable solvent, such as dichloromethane, chloroform, tetrahydrofuran or acetonitrile. These transformations are depicted in Scheme 12.

[0203] Alternatively, compounds of formula (I) can be prepared by an amide coupling transformation of amines of formula (IX) with compounds of formula (XXX), wherein X2 is OH, and activating the carboxylic acid function of the compounds of formula (XXX), a process which usually occurs by converting the -OH of the carboxylic acid into a good labile group, such as a chloride group, for example, using (COCl)2 or SOCl2, before treatment with amines of formula (IX), preferably in a suitable solvent (e.g., N-methylpyrrolidone, acetonitrile, dimethylacetamide, dichloromethane or tetrahydrofuran), preferably at temperatures between 25 °C and 60 °C and, optionally, in the presence of a base, such as triethylamine or N,N-diisopropylethylamine; or, alternatively, under conditions described in the literature for amide coupling, such as cyclic 1-propanephosphonic acid anhydride (T3P) in a suitable solvent (e.g., acetonitrile), optionally in the presence of a base (e.g., triethylamine or N,N-diisopropylethylamine). The compounds of formula (I) can alternatively be prepared by alkylation of compounds of formula (XXXI) with compounds of formula (V), where X1 is a. Petition 870260106348, dated 10 / 15 / 2026, p. 115 / 266 110 / 245 good labile group, such as Cl, Br, I, triflate, tosyl or mesyl, in the presence of a base, such as CS2CO3, K2CO3, NaH or NaOtBu. Alternatively, compounds of formula (I) can also be synthesized by reacting compounds of formula (XXXI) with compounds of formula (VI), wherein R7 is an electron-withdrawing group, such as cyano or ester, optionally in the presence of a base, such as triethylamine or 1,8-diazabicyclo[5.4.0]undec-7-ene. Compounds of formula (XXXI) can be synthesized by a peptide coupling transformation from compounds of formula (XXX), wherein X2 is OH, and amines of formula (VIII) using the conditions described above. These transformations are depicted in Scheme 13. Scheme 13

[0204] Compounds of formula (XXX), where X2 is OH, can be obtained by ester hydrolysis of compounds of formula (XXXII), where R9 is C1-6 alkyl. Compounds of formula (XXXII), where R9 is C1-6 alkyl, can result from Petition 870260106348, dated 10 / 15 / 2026, p. 116 / 266 111 / 245 a Suzuki cross-coupling reaction between compounds of formula (XXIX), wherein X is Cl, Br or I and R9 is C1-6 alkyl, and compounds of formula (III), wherein any R6 is independently of each other, hydrokene, C1-1 alkyl, or wherein two R6s together can form a C5-5 cycloalkyl in the presence of a base, such as CS2CO3, K2CO3 or NaOtBu, and a suitable palladium catalyst, such as tetraquistriphenylphosphinopalladium, [1,1bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(diphenylphosphino)palladium(II) acetate, palladium dichloride or palladium acetate, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or aqua. These transformations are (XXtX) (llf) (XXX) Scheme 14

[0205] Alternatively, compounds of formula (I) can be synthesized by reacting compounds of formula Petition 870260106348, dated 10 / 15 / 2026, p. 117 / 266 112 / 245 (XXXIII), where X is Cl, Br or I, with amines of formula (IX) and carbon monoxide in the presence of a catalyst, such as [1,1-bis(diphenylphosphino)ferrocene]dichloropalladium(II), and optionally a base, such as triethylamine.Compounds of formula (XXXIII), wherein X is Cl, Br or I, can be prepared from compounds of formula (XXXIV), wherein any X is independently Cl, Br or I, by means of a Suzuki cross coupling with compounds of formula (III), wherein any R6 is independently hydrogen, C1-6 alkyl, or wherein two R6s together can form a C3-8 cycloalkyl, in the presence of a base, such as Cs2CO3, K2CO3 or NaO t Bu, and a suitable palladium catalyst, such as tetraquistriphenylphosphinopalladium, [1,1bis(diphenylphosphino)ferrocene]dichloropalladium (II), bis(diphenylphosphino)palladium chloride, palladium dichloride or palladium acetate, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water. These transformations are depicted in Diagram 15. Petition 870260106348, dated 10 / 15 / 2026, p. 118 / 266 113 / 245 (XXXIV) catalyst (XXXIII) (IX) catalyst CO

[0206] Alternatively, compounds of formula (I) can be prepared by reacting a compound of formula (XXXV) with compounds of formula (XXXVI), wherein X2 is OH, in a peptide coupling transformation, using the conditions described above. Compounds of formula (XXXV) can be prepared via Suzuki cross-coupling of a Petition 870260106348, dated 10 / 15 / 2026, p. 119 / 266 114 / 245 compound of formula (II) and a compound of formula (XXXVII), wherein any R6 is independently hydrogen, C1-g alkyl, or wherein two R6s together can form a C3s cycloalkyl, in the presence of a base, such as CS2CO3, K2CO3 or NaOtBu, and a suitable palladium catalyst, such as tetraquistriphenylphosphinepalladium, [1,1bis(diphenylphosphino)ferrocene]dichloropalladium (II), bis(diphenylphosphine)palladium chloride, palladium dichloride or palladium acetate, in a suitable solvent, such as dimethylformamide, dioxane, tetrahydrofuran, ethanol or water. Compounds of formula (XXXVII), in which any R6 is independently hydrogen, C1-g alkyl, or in which two R6s together can form a C5-s cycloalkyl, are prepared by known methods or are commercially available. These transformations are depicted in Scheme 16. (II) (XXXV lí) Scheme 16 Petition 870260106348, dated 10 / 15 / 2026, pp. 120 / 266 115 / 245

[0207] Compounds of formula (Ib), wherein Z is S, can be prepared by reacting a compound of formula (I), wherein Z is O, with phosphorus pentasulfide or Lawesson's reagent (CAS: 19172-47-5) in a suitable solvent, such as toluene, xylene, or dichloromethane. This transformation is Scheme 17

[0208] Alternatively, compounds of formula (Ib), wherein Z is S, can be prepared by reacting a compound of formula (XXXVb) with compounds of formula (XXXVI), wherein X2 is OH, in a peptide coupling transformation, using the conditions described above. Compounds of formula (XXXVb) can be prepared by reacting a compound of formula (XXXV) with phosphorus pentasulfide or Lawesson's reagent (CAS: 19172-47-5) in a suitable solvent, such as toluene, xylene, or dichloromethane. This transformation is depicted in Scheme 18. Petition 870260106348, dated 10 / 15 / 2026, pp. 121 / 266 116 / 245 Scheme 18

[0209] A person skilled in the art understands that the amide coupling reactions described above between an acid, an amine, and a coupling agent could also be performed using the corresponding acid chloride and amine. The transformation of an acid into its corresponding acid chloride is well known to a person skilled in the art.

[0210] When the term "compound / compounds according to the invention" is used, it refers to compounds according to the present invention.

[0211] Alternatively, the compounds according to the present invention can be obtained using standard synthesis techniques known to those skilled in the art. Non-exhaustive examples include oxidation reactions, reduction reactions, hydrolysis reactions, coupling reactions, nucleophilic or electrophilic aromatic substitution reactions, reactions of Petition 870260106348, dated 10 / 15 / 2026, pp. 122 / 266 117 / 245 nucleophilic substitution, nucleophilic addition reactions, olefination reactions, oxime formation, alkylation and halogenation reactions.

[0212] A compound according to the present invention can be converted in a manner known per se into another compound according to the present invention by replacing one or more substituents of the initial compound according to the present invention in the usual manner with another substituent(s) according to the invention.

[0213] Depending on the choice of reaction conditions and starting materials that are suitable in each case, it is possible, for example, in one reaction step, to replace only one substituent with another, according to the invention, or a plurality of substituents can be replaced by other substituents, according to the invention, in the same reaction step.

[0214] The salts of the compounds according to the present invention can be prepared in a manner known per se. Thus, for example, acid addition salts of the compounds according to the present invention are obtained by treatment with a suitable acid, or a suitable ion exchange reagent and salts with bases are obtained by treatment with a suitable base or with a suitable ion exchange reagent.

[0215] The salts of the compounds according to the present invention can be converted in the usual manner into free compounds, acid addition salts, for example, by treatment with a suitable basic compound or with a suitable ion exchange reagent, and salts with bases, for example, Petition 870260106348, dated 10 / 15 / 2026, pp. 123 / 266 118 / 245 by treatment with a suitable acid or with a suitable ion exchange reagent.

[0216] The salts of the compounds according to the present invention can be converted in a manner known per se into other salts of the compounds according to the present invention, acid addition salts, for example, by treating an inorganic acid salt, such as hydrochloride, with a suitable metal salt, such as a sodium, barium or silver salt, of an acid, for example, with silver acetate, in a suitable solvent, in which an inorganic salt that is formed, for example, silver chloride, is insoluble and thus precipitates from the reaction mixture.

[0217] Depending on the procedure or reaction conditions, the compounds according to the present invention that have salt-forming properties can be obtained in free form or in salt form.

[0218] The compounds according to the present invention and, where appropriate, their tautomers, in each case in free form or in salt form, may be present in the form of one of the possible stereoisomers or as a mixture thereof, for example, in the form of pure stereoisomers, such as antipodes and / or diastereomers, or as mixtures of stereoisomers, such as mixtures of enantiomers, for example, racemates, mixtures of diastereomers or mixtures of racemates, depending on the number, absolute and relative configuration of the asymmetric carbon atoms occurring in the molecule and / or the configuration of the non-aromatic double bonds occurring in the molecule; the invention relates to pure stereoisomers and also to all the Petition 870260106348, dated 10 / 15 / 2026, pp. 124 / 266 119 / 245 mixtures of stereoisomers are possible and must be understood, in each case, in the sense described above and below, even when stereochemical details are not specifically mentioned in each case.

[0219] Mixtures of diastereomers or mixtures of racemates of the compounds, according to the present invention, in free form or in salt form, which can be obtained depending on the starting materials and procedures chosen, can be separated in a known manner into pure diastereomers or racemates based on the physicochemical differences of the components, for example, by fractional crystallization, distillation and / or chromatography.

[0220] Mixtures of enantiomers, such as racemates, which can be obtained in a similar manner, can be resolved at the optical antipodes by known methods, for example, by recrystallization from an optically active solvent, by chromatography on chiral adsorbents, for example, high-performance liquid chromatography (HPLC) on acetylcellulose, with the aid of suitable microorganisms, by cleavage with specific immobilized enzymes via the formation of inclusion compounds, for example, using chiral crown ethers, where only one enantiomer forms a complex, or by conversion into diastereomeric salts, for example, reacting a basic end-product racemate with an optically active acid, such as a carboxylic acid, for example, camphoric, tartaric or malic acid, or a sulfonic acid, for example, camphorsulfonic acid, and separating the mixture of diastereomers that can be obtained. of that. Petition 870260106348, dated 10 / 15 / 2026, pp. 125 / 266 120 / 245 manner, for example, by fractional crystallization based on their different solubilities, to provide diastereoisomers, from which the desired enantiomer can be released by the action of suitable agents, for example, basic agents.

[0221] It is possible to obtain pure diastereomers or enantiomers, according to the invention, not only by separating mixtures of suitable stereoisomers, but also by means of generally known methods of diastereoselective or enantioselective synthesis, for example, by carrying out the process, according to the invention, with starting materials of a suitable stereochemistry.

[0222] N-oxides can be prepared by reacting a compound according to the present invention with a suitable oxidizing agent, for example, the H2O2 / urea adduct in the presence of an acid anhydride, e.g. trifluoroacetic anhydride. These oxidations are known from the literature, for example, in J. Med. Chem., 32 (12), 2561-73, 1989 or WO 00 / 15615.

[0223] It is advantageous to isolate or synthesize, in each case, the stereoisomer, for example, enantiomer or diastereoisomer, or the mixture of stereoisomers, for example, a mixture of enantiomers or diastereomers, that is biologically more effective if the individual components have different biological activity.

[0224] The compounds according to the present invention and, where appropriate, their tautomers, in each case in free form or in salt form, may, where appropriate, also be obtained in the form of hydrates and / or include other solvents, for example, those that may have been used for the Petition 870260106348, dated 10 / 15 / 2026, pp. 126 / 266 121 / 245 crystallization of compounds found in solid form.

[0225] The following Examples illustrate, but do not limit, the invention.

[0226] The present invention also provides useful intermediates for the preparation of compounds according to the present invention.

[0227] The intermediates below form another aspect of the invention. compound of the formula (XXX)

[0228] One (XXX) preferably one or one A1 is N and one A1 is CR1; and A1é N is an A1 is CR1; R1s are selected independently from among hydrogen, hydroxyl, halogen, CN, C1-6 alkyl, C3-6 cycloalkyl C16alkoxy-C1-6alkyl, C3-6cycloalkyl-C1-4alkyl, C16alkylsulfonyl, C1-6alkoxy, amino and -NHC(O)C1-6alkyl; and, preferably, R1 are independently selected from hydrogen and C1-6alkyl; A4 is CH or N; and R5 is selected from C1-alkyl, C1-6-alkoxy, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-6-alkyl, C1-6-alkoxyC16alkyl, C1-6-alkylamino, diC1-6-alkylamino, C1-6-alkoxyamino and C1-6 alkyl C1-6 alkoxyamino, wherein each of the C1 groups Petition 870260106348, dated 10 / 15 / 2026, pp. 127 / 266 122 / 245 ealkyl, C1-ealkoxy, C3-6cycloalkyl, C3-ecycloalkyl-C16alkyl, C1-6alkoxyC1-6alkyl, C1-6alkylamino, diC1ealkylamino, C1-6alkoxyamino and C1-6alkylC1-6alkoxyamino is optionally replaced by one to three substituents independently selected from halogen and CN; or a salt or N-oxide thereof.

[0229] A compound of formula (XI) (XI) wherein each A1 is N or one A1 is N and one A1 is CR1; preferably an Aié N and an Aié CRi; R1s are independently selected from hydrogen, hydroxyl, halogen, CN, C1-alkyl, C3-6-cycloalkyl, C1-6 alkoxy-C1-6 alkyl, C3-cycloalkyl-C1-4-alkyl, C1-alkylsulfonyl, C1-alkoxy, amino and -NHC(O)C1-alkyl; and preferably, independently selected from hydrogen and C1-6-alkyl; A2 are independently CR2 or N, provided that no more than three A2 are N, preferably all four A2 are CR2; R2 are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkoxy, C3-6 cycloalkyl, C1-6 alkylsulfonyl, C1-6 alkoxycarbonyl, C1-6 alkylaminocarbonyl, diC1-6 alkylaminocarbonyl and C1-6 alkylcarbonyl, wherein each of the groups C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkoxy, C3-6 cycloalkyl, C1-6 alkylsulfonyl, C1-6 alkoxycarbonyl, C1-6 Petition 870260106348, dated 10 / 15 / 2026, pp. 128 / 266 123 / 245 ealkylaminocarbonyl, diCi-6alkylaminocarbonyl and Ci6alkylcarbonyl is optionally replaced by one to three substituents selected from halogen, hydroxyl and CN; and, preferably, R2 are independently selected from hydrogen, halogen, CN, Ci-ealkyl, Ci-6alkoxy and Ci-ealkoxy-Ci-e-alkyl; A3é CR3ou N; R3 is selected from hydrogen, halogen, CN, C16 alkyl, C16-alkoxy, C16-alkoxy-C16 alkyl, C36-cycloalkyl, C16-alkylsulfonyl, amino, C16-alkylamino, diC16-alkylamino and C36-cycloalkylamino, wherein each of the C16-alkyl, C16-alkoxy, C16-alkoxy-C16 alkyl, C36-cycloalkyl, C16-alkylsulfonyl, amino, C16-alkylamino, diC16-alkylamino and C36-cycloalkylamino groups is optionally replaced by one to three substituents selected from halogen, hydroxy and CN; and preferably R3 is hydrogen;R4 is selected from Ci-alkyl, Ci-alkoxy-Ci-alkyl, C3ecycloalkyl, C3-ecycloalkyl-Ci-4alkyl, C2-ealkenyl, C2ealkynyl, Ci-ealkoxy, Ci-ealkylsulfonyl-Ci-ealkyl, Ciealkoxycarbonyl-Ci-ealkyl, Ci-ealkylaminocarbonyl-Cyealkyl, diCi-ealkylaminocarbonyl-Ci-ealkyl and CN, wherein each of the groups C1-ealkyl, C1-ealkoxy-C1-ealkyl, C3-ecycloalkyl, C3-ecycloalkyl-C1-4alkyl, C2-ealkenyl, C2ealkynyl, Ci-ealkoxy, Ci-ealkylsulfonyl-Ci-ealkyl, Cyealkoxycarbonyl-Ci-ealkyl, C1-e-alkylaminocarbonyl-C1-e-alkyl and diC1-e-alkylaminocarbonyl-C1-e-alkyl are optionally substituted by one to three substituents selected from halogen and CN; and preferably R4 is selected from C1-e-alkyl, C1-e-alkoxy-C1-e-alkyl, C3-e-cycloalkyl, C3-e-cycloalkyl-C1-4-alkyl and C1-e-alkoxy, in; Petition 870260106348, dated 10 / 15 / 2026, pp. 129 / 266 124 / 245 wherein each of the C1-alkyl, C1-6 alkoxy-C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl and C1-alkoxy groups is optionally substituted by one to three substituents selected independently from halogen and CN; and wherein A3 and R4, considered together, optionally form a ring, preferably a 6-membered heterocycle; or a salt or N-oxide thereof.

[0230] A compound of formula (II) (II) wherein each Aié N or an Aié N and an Aié CRi; preferably an Aié N and an Aié CRi; R1s are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6 alkyl, C3-6 cycloalkyl, C1-6 alkoxy-C1-6 alkyl, C3-6-cycloalkyl-C1-4-alkyl, C1ealkylsulfonyl, C1ealkoxy, amino and -NHC(O)C1ealkyl; and, preferably, R1 are independently selected from hydrogen and C1ealkyl; A2s are independently CR2 or N, provided that no more than three A2s are N, preferably all four A2s are CR2; R2s are independently selected from hydrogen, hydroxyl, halogen, CN, C1-alkyl, C1-alkoxy, C1-alkoxy-C1-alkyl, C1-alkoxy-C1-alkoxy, C3-cycloalkyl, C1-alkylsulfonyl, C1-alkoxycarbonyl, C1-alkylaminocarbonyl, diC1-alkylaminocarbonyl and C1-alkylaminocarbonyl Petition 870260106348, dated 10 / 15 / 2026, pp. 130 / 266 125 / 245 ealkylcarbonyl, wherein each of the C1-ealkyl, C16-alkoxy, C1-ealkoxy-C1-ealkyl, C1-ealkoxy-C1-ealkoxy, C3-ecycloalkyl, C1-ealkylsulfonyl, C1-ealkoxycarbonyl, C1-ealkylaminocarbonyl, diC1-ealkylaminocarbonyl and C1-ealkylcarbonyl groups is optionally substituted by one to three substituents selected from halogen, hydroxy and CN; and, preferably, R2 are independently selected from hydrogen, halogen, CN, C1-ealkyl, C1-ealkoxy and C1-ealkoxy-C1-e-alkyl; A3é CR3ou N; R3 is selected from hydrogen, halogen, CN, C1-alkyl, C1-alkoxy, C1-alkoxy-C1-alkyl, C3-cycloalkyl, C1-alkylsulfonyl, amino, C1-alkylamino, diC1-alkylamino and C3-cycloalkylamino, wherein each of the C1-alkyl, C1-alkoxy, C1-alkoxy-C1-alkyl, C3-cycloalkyl, C1-alkylsulfonyl, amino, C1-alkylamino, diC1-alkylamino and C3-cycloalkylamino groups is optionally replaced by one to three substituents selected from halogen, hydroxy and CN; and preferably R3 is hydrogen;R4 is selected from Ci-ealkyl, Ci-ealkoxy-Ci-ealkyl, C3ecycloalkyl, C3-ecycloalkyl-Ci-4alkyl, C2-ealkenyl, C2ealkynyl, Ci-ealkoxy, Ci-ealkylsulfonyl-Ci-ealkyl, Ciealkoxycarbonyl-Ci-ealkyl, Ci-ealkylaminocarbonyl-Ciealkyl, diCi-ealkylaminocarbonyl-Ci-ealkyl and CN, wherein each of the groups Ci-ealkyl, Ci-ealkoxy-Ci-ealkyl, C3ecycloalkyl, C3-ecycloalkyl-Ci-4alkyl, C2-ealkenyl, C2ealkynyl, Ci-ealkoxy, Ci-ealkylsulfonyl-Ci-ealkyl, Cyealkoxycarbonyl-Ci-ealkyl, Cyl-ealkylaminocarbonyl-Cyealkyl and diCi-ealkylaminocarbonyl-Ci-ealkyl are optionally replaced by one to three substituents; Petition 870260106348, dated 10 / 15 / 2026, pp. 131 / 266 126 / 245 selected from halogen and CN; and preferably R4 is selected from C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, C3e cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl and C1-6 alkoxy, wherein each of the C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, C3e cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl and C1-alkoxy groups is optionally substituted by one to three substituents selected independently from halogen and CN; where A3 and R4, considered together, optionally form a ring, preferably a heterocycle with 6 members; and X is Cl, Br, or I; or a salt or N-oxide of them.

[0231] The compounds of formula (I), as defined in the present invention, can be used in the agricultural sector and related areas of use, e.g., as active ingredients to control plant pathogens or in non-living materials to control microorganisms that cause deterioration or organisms potentially harmful to humans. The new compounds are distinguished by excellent activity at low application rates, by being well tolerated by plants, and by being environmentally safe. They have very useful curative, preventive, and systemic properties and can be used to protect numerous cultivated plants. The compounds of formula (I), as defined in the present invention, can be used to inhibit or destroy pathogens occurring in plants or plant parts (fruits, flowers, leaves, stems, tubers, roots) of different useful plant crops, while also protecting the plant parts that grow subsequently, e.g., of phytopathogenic microorganisms. Petition 870260106348, dated 10 / 15 / 2026, pp. 132 / 266 127 / 245

[0232] It is also possible to use compounds of formula (I), as defined in the present invention, as a fungicide. The term fungicide, as used herein, means a compound that controls, modifies or prevents the growth of fungi. The term effective amount in fungicidal terms means the amount of that compound or combination of those compounds that is able to produce an effect on fungal growth. Control or modification effects include any deviation from natural development, such as death, retardation and the like, and prevention includes barriers, or other defensive formations, on or over a plant to prevent fungal infection.

[0233] It is also possible to use compounds of formula (I), as defined in the present invention, as coating agents for the treatment of plant propagation material, e.g., seeds, such as fruits, tubers or grains, or plant cuttings (e.g., rice), for protection against fungal infections, as well as against phytopathogenic fungi occurring in the soil. The propagation material can be treated with a composition comprising a compound of formula (I), as defined in the present invention, before planting: the seed, for example, can be coated before being sown. The compounds of formula (I), as defined in the present invention, can also be applied to grains (coating), either by impregnating the seeds in a liquid formulation or by coating them with a solid formulation. The composition can also be applied at the planting site when the propagation material is being planted, for example, in the seed furrow during sowing.The invention also relates to these methods of material treatment. Petition 870260106348, dated 10 / 15 / 2026, pp. 133 / 266 128 / 245 plant propagation and with plant propagation material thus treated.

[0234] Furthermore, the compounds of formula (I), as defined in the present invention, can be used to control fungi in related areas, for example, in the protection of technical materials, including wood and wood-related technical products, in food storage, and in hygiene management.

[0235] Furthermore, the invention could be used to protect non-living materials against fungal attack, e.g., sawn timber, wall panels and paint.

[0236] The compounds of formula (I), as defined in the present invention, and fungicidal compositions containing them can be used to control plant diseases caused by a broad spectrum of fungal plant pathogens. They are effective in controlling a broad spectrum of plant diseases, such as foliar pathogens of ornamental crops, grasses, vegetables, agricultural crops, cereals and fruits.

[0237] These fungi and fungal disease vectors, as well as phytopathogenic bacteria and viruses, that can be controlled are, for example:

[0238] Absidia corymbifera, Alternaria spp, Aphanomyces spp, Ascochyta spp, Aspergillus spp. including A. flavus, A. fumigatus, A. nidulans, A. niger, A. terrus, Aureobasidium spp. including A. pullulans, Blastomyces dermatitidis, Blumeria graminis, Bremia lactucae, Botryosphaeria spp. including B. dothidea, B. obtusa, Botrytis spp. including B. cinerea, including Candida spp. including C. albicans, C. glabrata, C. krusei, C. lusitaniae, C. parapsilosis, C. Petition 870260106348, dated 15 / 10 / 2026, p. 134 / 266 129 / 245 tropicalis, Cephaloascus fragrans, Ceratocystis spp, Cercospora spp. including C. arachidicola, Cercosporidium personatum, Cladosporium spp, Claviceps purpurea,

[0239] Coccidioides immitis, Cochliobolus spp, Colletotrichum spp. including C. musae,

[0240] Cryptococcus neoformans, Diaporthe spp, Didymella spp, Drechslera spp, Elsinoe spp,

[0241] Epidermophyton spp, Erwinia amylovora, Erysiphe spp. including E. cichoracearum,

[0242] Eutypa lata, Fusarium spp. including F. culmorum, F. graminearum, F. langsethiae, F. moniliforme, F. oxysporum, F. proliferatum, F. subglutinans, F. solani, Gaeumannomyces graminis, Gibberella fujikuroi, Gloeodes pomigena, Gloeosporium musarum, Glomerella cingulate, Guignardia bidwellii, Gymnosporangium juniperi-virginianae, Helminthosporium spp, Hemileia spp, Histoplasma spp.including H. capsulatum, Laetisaria fuciformis, Leptographium lindbergi, Leveillula taurica, Lophodermium seditiosum, Microdochium nivale, Microsporum spp, Monilinia spp, Mucor spp, Mycosphaerella spp. including M. graminicola, M. pomi, Oncobasidium theobromaeon, Ophiostoma piceae, Paracoccidioides spp, Penicillium spp. including P. digitatum, P. italicum, Petriellidium spp, Peronosclerospora spp. including P. maydis, P. philippinensis s and P. sorghi, Peronospora spp, Phaeosphaeria nodorum, Phakopsora pachyrhizi, Phellinus igniarus, Phialophora spp, Phoma spp, Phomopsis viticola, Phytophthora spp. including P. infestans, Plasmopara spp. including P. halstedii, P. viticola, Pleospora spp., Podosphaera spp. including P. leucotricha, Polymyxa graminis, Polymyxa betae, Petition 870260106348, dated 15 / 10 / 2026, p. 135 / 266 130 / 245 Pseudocercosporella herpotrichoides, Pseudomonas spp, Pseudoperonospora spp. including P. cubensis, P. humuli, Pseudopeziza tracheiphila, Puccinia Spp. including P. hordei, P. recondita, P. striiformis, P. triticina, Pyrenopeziza spp, Pyrenophora spp, Pyricularia spp. including P. oryzae, Pythium spp. including P. ultimum, Ramularia spp, Rhizoctonia spp, Rhizomucor pusillus, Rhizopus arrhizus, Rhynchosporium spp, Scedosporium spp. including S. apiospermum and S. prolificans, Schizothyrium pomi,

[0243] Sclerotinia spp, Sclerotium spp, Septoria spp, including S. nodorum, S. tritici, Sphaerotheca macularis, Sphaerotheca fusca (Sphaerotheca fuliginea), Sporothorix spp, Stagonospora nodorum, Stemphylium spp,. Stereum hirsutum, Thanatephorus cucumeris, Thielaviopsis basicola, Tilletia spp, Trichoderma spp. including T. harzianum, T. pseudokoningii, T. viride,

[0244] Trichophyton spp, Typhula spp, Uncinula necator, Urocystis spp, Ustilago spp, Venturia spp. including V.inaequalis, Verticillium spp, and Xanthomonas spp.

[0245] In particular, the compounds of formula (I), as defined in the present invention, and fungicidal compositions containing them, can be used to control plant diseases caused by a broad spectrum of fungal plant pathogens of the classes Basidiomycetes, Ascomycetes, Oomycetes and / or Deuteromycetes. Blasocladiomycetes, Critidiomycetes, Glomeromycetes and / or Mucoromycetes. More particularly, the compounds of formula (I), as defined in the present invention, can be used to control oomycetes. Petition 870260106348, dated 10 / 15 / 2026, pp. 136 / 266 131 / 245

[0246] These pathogens may include: Oomycetes including Phytophthora diseases such as those caused by Phytophthora capsici, Phytophthora infestans, Phytophthora sojae, Phytophthora fragariae, Phytophthora nicotianae, Phytophthora cinnamomi, Phytophthora citricola, Phytophthora citrophthora and Phytophthora erythroseptica; Pythium diseases such as those caused by Pythium aphanidermatum, Pythium arrhenomanes, Pythium graminicola, Pythium irregulare, Pythium sylvaticum and Pythium ultimum; diseases caused by Peronosporales such as Peronospora destructor, Peronospora parasitica, Plasmopara viticola, Plasmopara halstedii, Pseudoperonospora cubensis, Albugo candida, Sclerophthora macrospora and Bremia lactucae and others such as Aphanomyces cochlioides, Labyrinthula zosterae, Peronosclerospora sorghi and Sclerospora graminicola.

[0247] Ascomycetes, including rice spot, blotch, blast or aphid diseases and / or rots, for example, those caused by Pleosporales, such as Stemphylium solani, Stagonospora tainanensis, Spilocaea oleaginea, Setosphaeria turcica, Pyrenochaeta lycoperisici, Pleospora herbarum, Phoma destructiva, Phaeosphaeria herpotrichoides, Phaeocryptocus gaeumannii, Ophiosphaerella graminicola, Ophiobolus graminis, Leptosphaeria maculans, Hendersonia creberrima, Helminthosporiumtriticirepentis, Setosphaeria turcica, Drechslera glycines, Didymella bryoniae, Cycloconium oleagineum, Corynespora cassiicola, Cochliobolus sativus, Bipolaris cactivera, Venturia inaequalis, Pyrenophora teres, Pyrenophora tritici-repentis, Alternaria Petition 870260106348, dated 15 / 10 / 2026, p. 137 / 266 132 / 245 alternata, Alternaria brassicicola, Alternaria solani and Alternaria tomatophila, Capnodiales , such as Septoria tritici, Septoria nodorum, Septoria glycines, Cercospora arachidicola, Cercospora sojina, Cercospora zeae-maydis, Cercosporella capsellae and Cercosporella herpotrichoides, Cladosporium carpophilum, Cladosporium effusum, Passalora fulva, Cladosporium oxysporum, Dothistroma septosporum, Isariopsis clavispora, Mycosphaerella fijiensis, Mycosphaerella graminicola, Mycovellosiella koepkeii, Phaeoisariopsis bataticola, Pseudocercospora vitis, Pseudocercosporella herpotrichoides, Ramularia beticola, Ramularia collo-cygni, Magnaporthales , such as Gaeumannomyces graminis, Magnaporthe grisea, Pyricularia oryzae, Diaporthales, such as Anisogramma anomala, Apiognomonia errabunda, Cytospora platani, Diaporthe phaseolorum, Discula destructiva, Gnomonia fructicola, Greeneria uvicola, Melanconium juglandinum, Phomopsis viticola, Sirococcus clavigignenti-juglandacearum,Tubakia dryina, Dicarpella spp., Valsa ceratosperma, and others, such as Actinothyrium graminis, Ascochyta pisi, Aspergillus flavus, Aspergillus fumigatus, Aspergillus nidulans, Asperisporium caricae, Blumeriella jaapii, Candida spp., Capnodium ramosum, Cephaloascus spp., Cephalosporium gramineum, Ceratocystis paradoxa, Chaetomium spp., Hymenoscyphus pseudoalbidus, Coccidioides spp., Cylindrosporium padi, Diplocarpon malae, Drepanopeziza campestris, Elsinoe ampelina, Epicoccum nigrum, Epidermophyton spp., Eutypa lata, Geotrichum candidum, Gibellina cerealis, Gloeocercospora sorghi, Gloeodes pomigena, Gloeosporium perennans; Gloeotinia temulenta, Petition 870260106348, dated 15 / 10 / 2026, p. 138 / 266 133 / 245 Griphospaeria corticola, Kabatiella lini, Leptographium microsporum, Leptosphaerulinia crassiasca, Lophodermium seditiosum, Marssonina graminicola, Microdochium nivale, Monilinia fructicola, Monographella albescens, Monosporascus cannonballus, Naemacyclus spp., Ophiostoma novo-ulmi, Paracoccidioides brasiliensis, Penicillium expansum, Pestalotia rhododendri, Petriellidium spp., Pezicula spp., Phialophora gregata, Phyllachora pomigena, Phymatotrichum omnivora, Physalospora abdita, Plectosporium tabacinum, Polyscytalum pustulans, Pseudopeziza medicaginis, Pyrenopeziza brassicae, Ramulispora sorghi, Rhabdocline pseudotsugae, Rhynchosporium secalis, Sacrocladium oryzae, Scedosporium spp., Schizothyrium pomi, Sclerotinia sclerotiorum, Sclerotinia minor; Sclerotium spp., Typhula ishikariensis, Seimatosporium mariae, Lepteutypa cupressi, Septocyta ruborum, Sphaceloma perseae, Sporonema phacidioides, Stigmina palmivora, Tapesia yallundae, Taphrina bullata, Thielviopsis basicola, Trichoseptoria fructigena, Zygophiala jamaicensis; powdery mildew diseases, for example, those caused by Erysiphales, such as Blumeria graminis, Erysiphe polygoni, Uncinula necator, Sphaerotheca fuligena, Podosphaera leucotricha, Podospaera macularis Golovinomyces cichoracearum, Leveillula taurica, Microsphaera diffusa, Oidiopsis gossypii, Phyllactinia guttata and Oidium arachidis; molds, for example, those caused by Botryosphaeriales, such as Dothiorella aromatica, Diplodia seriata, Guignardia bidwellii, Botrytis cinerea, Botryotinia allii, Botryotinia fabae, Fusicoccum amygdali, Lasiodiplodia theobromae, Macrophoma theicola, Macrophomina phaseolina, Phyllosticta cucurbitacearum; anthracnoses, for. Petition 870260106348, dated 15 / 10 / 2026, p. 139 / 266 134 / 245 example, those caused by Glommerelales, such as Colletotrichum gloeosporioides, Colletotrichum lagenarium, Colletotrichum gossypii, Glomerella cingulata, and Colletotrichum graminicola; and wilts or aphids, for example, those caused by Hypocreales, such as Acremonium strictum, Claviceps purpurea, Fusarium culmorum, Fusarium graminearum, Fusarium virguliforme, Fusarium oxysporum, Fusariumsubglutinans, Fusarium oxysporum f.sp. cubense, Gerlachia nivale, Gibberella fujikuroi, Gibberella zeae, Gliocladium spp., Myrothecium verrucaria, Nectria ramulariae, Trichoderma viride, Trichothecium roseum, and Verticillium theobromae.

[0248] Basidiomycetes, including sooty molds, for example, those caused by Ustilaginales, such as Ustilaginoidea virens, Ustilago nuda, Ustilago tritici, Ustilago zeae, rusts, for example, those caused by Pucciniales, such as Cerotelium fici, Chrysomyxa arctostaphyli, Coleosporium ipomoeae, Hemileia vastatrix, Puccinia arachidis, Puccinia cacabata, Puccinia graminis, Puccinia recondita, Puccinia sorghi, Puccinia hordei, Puccinia striiformis f.sp. Hordei, Puccinia striiformis f.sp. Secalis, Pucciniastrum coryli, or Uredinales, such as Cronartium ribicola, Gymnosporangium juniperi-viginianae, Melampsora medusae, Phakopsora pachyrhizi, Phragmidium mucronatum, Physopella ampelosidis, Tranzschelia discolor and Uromyces viciae-fabae; and other diseases such as those caused by Cryptococcus spp., Exobasidium vexans, Marasmiellus inoderma, Mycena spp., Sphacelotheca reiliana, Typhula ishikariensis, Urocystis agropyri, Itersonilia perplexans, Corticium invisum, Laetisaria fuciformis, Waitea circinata,. Petition 870260106348, dated 10 / 15 / 2026, pp. 140 / 266 135 / 245 Rhizoctonia solani, Thanetephorus cucurmeris, Entyloma dahliae, Entylomella microspora, Neovossia moliniae and Tilletia caries.

[0249] Blastocladiomycetes, such as Physoderma maydis.

[0250] Mucoromycetes, such as Choanephora cucurbitarum.; Mucor spp.; Rhizopus arrhizus.

[0251] As well as diseases caused by other species and genera closely related to those listed above.

[0252] In addition to their fungicidal activity, the compounds and compositions comprising compounds of formula (I), as defined in the present invention, may also have activity against bacteria, such as Erwinia amylovora, Erwinia caratovora, Xanthomonas campestris, Pseudomonas syringae, Streptomyces scabies, and other related species, as well as certain protozoa.

[0253] Within the scope of the present invention, the target crops and / or useful plants to be protected typically comprise perennial and annual crops, such as berry plants, for example, blackberries, blueberries, cranberries, raspberries and strawberries; cereals, for example, barley, maize (corn), millet, oats, rice, rye, sorghum, triticale and wheat; fiber plants, for example, cotton, flax, hemp, jute and sisal; agricultural crops, for example, sugar beet and fodder beet, coffee, hops, mustard, oilseed rapeseed (canola), poppy, sugar cane, sunflower, tea and tobacco; fruit trees, for example, apple, apricot, avocado, banana, cherry, citrus fruits, nectarine, peach, pear and plum; Grasses, for example, Bermuda grass, bluegrass, thorngrass, centipede grass, fescue, ryegrass, St. Augustine grass, and Zoysia grass; aromatic herbs, such as Petition 870260106348, dated 10 / 15 / 2026, pp. 141 / 266 136 / 245 basil, borage, chives, coriander, lavender, lovage, mint, oregano, parsley, rosemary, sage and thyme; legumes, for example, beans, lentils, peas and soybeans; nuts, for example, almonds, cashews, peas, hazelnuts, peanuts, pecans, pistachios and walnuts; palms, for example, palm oil; ornamental plants, for example, flowers, shrubs and trees; other trees, for example, cacao, coconut, olive and rubber trees; vegetables, for example, asparagus, eggplant, broccoli, cabbage, carrots, cucumbers, garlic, lettuce, pumpkin, melon, okra, onions, peppers, potatoes, butternut squash, rhubarb, spinach and tomatoes; and vines, for example, grapes.

[0254] Useful plants and / or target crops according to the invention include conventional varieties as well as genetically improved or manipulated varieties, such as, for example, insect-resistant varieties (e.g., Bt and VIP varieties), as well as disease-resistant, herbicide-tolerant varieties (e.g., glyphosate- and glufosinate-resistant varieties commercially available under the trade names RoundupReady® and LibertyLink®) and nematode-tolerant varieties. By way of example, suitable varieties of genetically improved or manipulated crops include the Stoneville 5599BR and Stoneville 4892BR cotton varieties.

[0255] The terms "useful plants" and / or "target crops" must be understood as also including useful plants that have been made tolerant to herbicides such as bromoxynil or classes of herbicides (such as, for example, HPPD inhibitors, ALS inhibitors, for example, primisulfurone, prosulfurone and trifloxysulfurone, EPSPS inhibitors (5 Petition 870260106348, dated 10 / 15 / 2026, pp. 142 / 266 137 / 245 enol-pyrovil-shikimate-3-phosphate-synthase), GS (glutamine synthetase) inhibitors, or PPO (protoporphyrinogen oxidase) inhibitors as a result of conventional breeding methods or genetic manipulation. An example of a crop that has been made tolerant to imidazolinones, e.g., imazamox, through conventional breeding methods (mutagenesis) is Clearfield® summer rapeseed (Canola). Examples of crops that have been made tolerant to herbicides or herbicide classes through genetic manipulation methods include glyphosate- and glufosinate-resistant maize varieties commercially available under the trade names RoundupReady®, Herculex I®, and LibertyLink®.

[0256] The terms "useful plants" and / or "target crops" must be understood as including those that are naturally or have been made resistant to harmful insects. This includes plants transformed by the use of recombinant DNA techniques, for example, to synthesize one or more selectively acting toxins, such as those known, for example, from toxin-producing bacteria. Examples of toxins that can be expressed include δendotoxins, vegetative insecticidal proteins (Vip), insecticidal proteins from nematode-colonizing bacteria, and toxins produced by scorpions, arachnids, wasps, and fungi. An example of a crop that has been modified to express the Bacillus thuringiensis toxin is Bt KnockOut® (Syngenta Seeds). An example of a crop comprising more than one gene encoding insecticide resistance and thus expressing more than one toxin is VipCot® (Syngenta Seeds). The crops or their seed material Petition 870260106348, dated 10 / 15 / 2026, pp. 143 / 266 138 / 245 can also be resistant to multiple types of pests (so-called stacked transgenic events when created by genetic modification). For example, a plant may have the ability to express an insecticidal protein while also being tolerant to herbicides, for example, Herculex I® (Dow AgroSciences, Pioneer Hi-Bred International).

[0257] The terms "useful plants" and / or "target crops" must be understood as also including useful plants that have been transformed using recombinant DNA techniques that can synthesize antipathogenic substances with selective action, such as, for example, the so-called "pathogenesis-related proteins" (PRPs), see, e.g., EP-A-0 392 225. Examples of these antipathogenic substances and transgenic plants that can synthesize these antipathogenic substances are known, for example, from EP-A-0 392 225, WO 95 / 33818 and EP-A-0 353 191. The methods of producing these transgenic plants are generally known to those skilled in the art and described, for example, in the publications mentioned above.

[0258] Toxins that can be expressed by transgenic plants include, for example, insecticidal proteins from Bacillus cereus or Bacillus popilliae; or insecticidal proteins from Bacillus thuringiensis, such as δendotoxins, e.g., Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), e.g., Vip1, Vip2, Vip3 or Vip3A; or insecticidal proteins from nematode-colonizing bacteria, for example, Photorhabdus spp. or Xenorhabdus spp., such as Photorhabdus luminescens, Xenorhabdus Petition 870260106348, dated 10 / 15 / 2026, pp. 144 / 266 139 / 245 nematophilus; toxins produced by animals, such as scorpion toxins, arachnid toxins, wasp toxins and other insect-specific neurotoxins; toxins produced by fungi, such as Streptomycetes toxins, plant lectins, such as pea lectins, barley lectins or white bellflower lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin inhibitors, cystatin, papain; ribosome-inactivating proteins (RIPs), such as ricin, maize RIP, abrin, lufin, saporin or briodin; Enzymes involved in steroid metabolism, such as 3-hydroxysteroid oxidase, ecdysteroid-UDP glycosyltransferase, cholesterol oxidases, ecdysone inhibitors, HMG-CoA reductase, ion channel blockers such as sodium or calcium channel blockers, juvenile hormone esterase, diuretic hormone receptors, stilbene synthase, bibenzyl synthase, chitinases, and glucanases.

[0259] Furthermore, in the context of the present invention, δ-endotoxins must be understood to mean, for example, Cry1Ab, Cry1Ac, Cry1F, Cry1Fa2, Cry2Ab, Cry3A, Cry3Bb1 or Cry9C, or vegetative insecticidal proteins (Vip), for example, Vip1, Vip2, Vip3 or Vip3A, expressly also hybrid toxins, truncated toxins and modified toxins. Hybrid toxins are recombinantly produced by a novel combination of different domains of these proteins (see, for example, WO 02 / 15701). Truncated toxins, for example, a truncated Cry1Ab, are known. In the case of modified toxins, one or more amino acids of the naturally occurring toxin are substituted. In these amino acid substitutions, Petition 870260106348, dated 10 / 15 / 2026, pp. 145 / 266 140 / 245 Preferably, protease recognition sequences not naturally present are inserted into the toxin, such as, for example, in the case of Cry3A055, where a cathepsin G recognition sequence is inserted into a Cry3A toxin (see WO03 / 018810).

[0260] More examples of these toxins or transgenic plants that can synthesize these toxins are revealed, for example, in documents EP-A-0 374 753, WO93 / 07278, WO95 / 34656, EP-A-0 427 529, EP-A-451 878 and WO03 / 052073.

[0261] The processes for preparing these transgenic plants are generally known to those skilled in the art and described, for example, in the publications mentioned above. CryI-type deoxyribonucleic acids and their preparation are known, for example, from documents WO 95 / 34656, EP-A-0 367 474, EP-A-0 401 979 and WO 90 / 13651.

[0262] The toxin contained in transgenic plants gives the plants tolerance to harmful insects. These insects can occur in any taxonomic group of insects, but are especially commonly found in beetles (Coleoptera), two-winged insects (Diptera) and butterflies (Lepidoptera).

[0263] Transgenic plants containing one or more genes that encode insecticide resistance and express one or more toxins are known, and some of them are commercially available. Examples of such plants are: YieldGard® (a maize variety that expresses the Cry1Ab toxin); YieldGard Rootworm® (a maize variety that expresses the Cry3Bb1 toxin); YieldGard Plus® (a maize variety that expresses both the Cry1Ab and Cry3Bb1 toxins); Starlink® Petition 870260106348, dated 10 / 15 / 2026, pp. 146 / 266 141 / 245 (corn variety expressing Cry9C toxin); Herculex I® (corn variety expressing Cry1Fa2 toxin and the enzyme phosphinothricin N-acetyltransferase (PAT) to achieve tolerance to the herbicide glufosinate ammonium); NuCOTN 33B® (cotton variety expressing Cry1Ac toxin); Bollgard I® (cotton variety expressing Cry1Ac toxin); Bollgard II® (cotton variety expressing Cry1Ac and Cry2Ab toxins); VipCot® (cotton variety expressing Vip3A and Cry1Ab toxins); NewLeaf® (potato variety expressing Cry3A toxin); NatureGard®, Agrisure® GT Advantage (glyphosate-tolerant trait GA21), Agrisure® CB Advantage (corn borer (CB) trait Bt11) and Protecta®.

[0264] Other examples of these transgenic crops are: 1. Bt11 maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F31 790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. Genetically modified Zea mays that has been made resistant to attack by the European maize borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a truncated Cry1Ab toxin. Bt11 maize also transgenically expresses the PAT enzyme to achieve tolerance to the herbicide glufosinate ammonium. 2. Bt176 maize from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. Genetically modified Zea mays that has been made resistant to attack by the European maize borer (Ostrinia nubilalis and Sesamia nonagrioides) by transgenic expression of a Cry1Ab toxin. Bt176 maize also transgenically expresses the PAT enzyme to achieve tolerance to the herbicide glufosinate ammonium. Petition 870260106348, dated 10 / 15 / 2026, pp. 147 / 266 142 / 245 3. Mais MIR604 from Syngenta Seeds SAS, Chemin de l'Hobit 27, F-31 790 St. Sauveur, France, registration number C / FR / 96 / 05 / 10. Mais that has been made insect-resistant by transgenic expression of a modified Cry3A toxin. This toxin is Cry3A055 modified by the insertion of a cathepsin G protease recognition sequence. The preparation of these transgenic Mais plants is described in document WO 03 / 018810. 4. More MON 863 from Monsanto Europe SA 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / DE / 02 / 9. MON 863 expresses a Cry3Bb1 toxin and has resistance to certain Coleoptera insects. 5. IPC 531 Cotton from Monsanto Europe SA, 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / ES / 96 / 02. 6. Plus 1507 from Pioneer Overseas Corporation, Avenue Tedesco, 7 B-1160 Brussels, Belgium, registration number C / NL / 00 / 10. Plus genetically modified to express the Cry1F protein to achieve resistance to certain Ledidoptera insects and the PAT protein to achieve tolerance to the herbicide glufosinate ammonium. 7. Mais NK603 x MON 810 from Monsanto Europe SA, 270-272 Avenue de Tervuren, B-1150 Brussels, Belgium, registration number C / GB / 02 / M3 / 03. It consists of conventionally bred hybrid maize varieties by crossing the genetically modified varieties NK603 and MON 810. The NK603 χ MON 810 maize transgenically expresses the CP4 EPSPS protein, obtained from the CP4 Agrobacterium sp. strain, which confers tolerance to the herbicide Roundup® (contains glyphosate), and also a Cry1Ab toxin obtained from Bacillus thuringiensis subsp. Kurstaki that... Petition 870260106348, dated 10 / 15 / 2026, pp. 148 / 266 143 / 245 confers tolerance to certain Lepidoptera, including the European corn borer.

[0265] The term locus, as used herein, means fields in or on which plants are growing, where seeds of cultivated plants are sown, or where seed will be placed in the soil. The same includes soil, seeds and seedlings, as well as established vegetation.

[0266] The term plants refers to all the physical parts of a plant, including seeds, seedlings, shoots, roots, tubers, stems, trunks, foliage and fruits.

[0267] The term plant propagation material is understood to denote generative parts of the plant, such as seeds, which can be used for the multiplication of the latter, and vegetative material, such as cuttings or tubers, for example, potatoes. It is possible that, for example, seeds (in the strict sense), roots, fruits, tubers, bulbs, rhizomes and plant parts may be mentioned. Likewise, germinated plants and young plants, which are intended to be transplanted after germination or after emergence from the soil, may be mentioned. These young plants may be protected before transplanting by total or partial immersion treatment. Preferably, plant propagation material is understood to denote seeds.

[0268] The pesticide agents referred to here using their common name are known, for example, from The Pesticide Manual, 19th Ed., British Crop Protection Council 2021.

[0269] The compounds of formula (I), as defined in the present invention, may be used in unmodified form or, preferably, together with the adjuvants Petition 870260106348, dated 10 / 15 / 2026, pp. 149 / 266 144 / 245 conventionally employed in the formulation technique. For this purpose, they can be conveniently formulated in a known manner as emulsifiable concentrates, coating pastes, directly sprayable or dilutable solutions or suspensions, dilute emulsions, wettable powders, soluble powders, dusts, granules, and also encapsulations, e.g., in polymeric substances. As with the type of compositions, the application methods, such as spraying, atomizing, dusting, spreading, coating, or pouring, are chosen according to the intended objectives and existing circumstances. To obtain special effects, the compositions may also contain other adjuvants, such as stabilizers, antifoaming agents, viscosity regulators, binders or adhesive agents, as well as fertilizers, micronutrient donors, or other formulations.

[0270] Suitable carriers and / or adjuvants, e.g., for agricultural use, may be solid or liquid and are substances useful in formulation technology, e.g., natural or regenerated mineral substances, solvents, dispersants, wetting agents, adhesives, thickeners, binders or fertilizers. These carriers are, for example, described in WO 97 / 33890.

[0271] Suspension concentrates are aqueous formulations in which finely divided solid particles of the active compound are suspended. These formulations include anti-settling agents and dispersing agents and may also include a wetting agent to enhance activity, as well as an anti-foaming agent and a growth inhibitor. Petition 870260106348, dated 10 / 15 / 2026, pp. 150 / 266 145 / 245 crystals. In use, these concentrates are diluted in water and typically applied as a spray to the area to be treated. The amount of active ingredient can vary from 0.5% to 95% of the concentrate.

[0272] Wettable powders are in the form of finely divided particles that readily disperse in water or other liquid vehicles. The particles contain the active ingredient retained in a solid matrix. Typical solid matrices include Fuller's earth, kaolin clays, silicas, and other readily wettable organic or inorganic solids. Wettable powders typically contain 5% to 95% of the active ingredient plus a small amount of wetting agent, dispersant, or emulsifier.

[0273] Emulsifiable concentrates are homogeneous liquid compositions dispersible in water or another liquid and may consist entirely of the active compound with a liquid or solid emulsifying agent or may also contain a liquid carrier, such as xylene, heavy aromatic naphthas, isophorone and other non-volatile organic solvents. In use, these concentrates are dispersed in water or another liquid and normally applied as a spray to the area to be treated. The amount of active ingredient may vary from 0.5% to 95% of the concentrate.

[0274] Granular formulations include both extrudates and relatively coarse particles and are usually applied undiluted to the area where treatment is required. Typical vehicles for granular formulations include sand, Fuller's earth, attapulgite clay, bentonite clays, montmorillonite clay, vermiculite, perlite, calcium carbonate, brick, pumice, pyrophyllite, Petition 870260106348, dated 10 / 15 / 2026, pp. 151 / 266 146 / 245 kaolin, dolomite, gypsum, wood flour, crushed corn cobs, crushed peanut shells, sugars, sodium chloride, sodium sulfate, sodium silicate, sodium borate, magnesia, mica, iron oxide, zinc oxide, titanium oxide, antimony oxide, cryolite, gypsum, diatomaceous earth, calcium sulfate and other organic or inorganic materials that absorb or can be coated with the active compound. Granular formulations typically contain 5% to 25% active ingredients which may include surfactants such as heavy aromatic naphthas, kerosene and other petroleum fractions, or vegetable oils; and / or adhesives such as dextrins, glue or synthetic resins.

[0275] Dusts are free-flowing mixtures of the active ingredient with finely divided solids, such as talc, clays, flours, and other organic and inorganic solids that act as dispersants and carriers.

[0276] Microcapsules are typically droplets or granules of the active ingredient confined within an inert porous shell that allows the confined material to escape into the surroundings at controlled rates. Encapsulated droplets typically have a diameter of 1 to 50 micrometers. The confined liquid typically constitutes 50 to 95% of the capsule's weight and may include solvent in addition to the active compound. Encapsulated granules are generally porous with porous membranes sealing the granule pore openings, retaining the active species in liquid form within the granule pores. The diameter of the granules typically ranges from 1 millimeter to 1 centimeter and preferably from 1 to 2 millimeters. The granules are formed by extrusion, agglomeration, or prilling (spherolization) or occur Petition 870260106348, dated 10 / 15 / 2026, pp. 152 / 266 147 / 245 naturally. Examples of these materials are vermiculite, sintered clay, kaolin, attapulgite clay, sawdust, and granular carbon. Shell or membrane materials include natural and synthetic rubbers, cellulosic materials, styrene-butadiene copolymers, polyacrylonitriles, polyacrylates, polyesters, polyamides, polyureas, polyurethanes, and starch xanthates.

[0277] Other useful formulations for agrochemical applications include simple solutions of the active ingredient in a solvent in which it is completely soluble at the desired concentration, such as acetone, alkylated naphthalenes, xylene, and other organic solvents. Similarly, pressurized sprayers can be used, in which the active ingredient is dispersed in finely divided form as a result of the vaporization of a dispersing solvent vehicle with a low boiling point.

[0278] Suitable agricultural adjuvants and / or carriers that are useful in formulating the compositions of the invention in the formulation types described above are well known to those skilled in the art.

[0279] Liquid vehicles that may be employed include, for example, water, toluene, xylene, petroleum naphtha, vegetable oil, acetone, methyl ethyl ketone, cyclohexanone, acetic anhydride, acetonitrile, acetophenone, amyl acetate, 2-butanone, chlorobenzene, cyclohexane, cyclohexanol, alkyl acetates, diacetone alcohol, 1,2-dichloropropane, diethanolamine, p-diethylbenzene, diethylene glycol, diethylene glycol abietate, diethylene glycol butyl ether, diethylene glycol ethyl ether, diethylene glycol methyl ether, N,N-dimethylformamide, sulfoxide Petition 870260106348, dated 10 / 15 / 2026, pp. 153 / 266 148 / 245 dimethyl, 1,4-dioxane, dipropylene glycol, dipropylene glycol methyl ether, dipropylene glycol dibenzoate, diproxitol, alkyl pyrrolidinone, ethyl acetate, 2-ethylhexanol, ethylene carbonate, 1,1,1-trichloroethane, 2-heptanone, alpha-pinene, d-limonene, ethylene glycol, ethylene glycol butyl ether, ethylene glycol methyl ether, gamma-butyrolactone, glycerol, glycerol diacetate, glycerol monoacetate, glycerol triacetate, hexadecane, hexylene glycol, isoamyl acetate, isobornyl acetate, iso-octane, isophorone, isopropylbenzene, isopropyl myristate, lactic acid, lauryl sulfate, oxide mesityl, methoxypropanol, methylisoamyl ketone, methylisobutyl ketone, methyl laurate, methyl octanoate, methyl oleate, methylene chloride, m-xylene, n-hexane, n-octylamine, octadecanoic acid, octylamine acetate, oleic acid, oleylamine, o-xylene, phenol, polyethylene glycol (PEG400), propionic acid, propylene glycol, propylene glycol monoethyl ether,p-xylene, toluene, triethyl phosphate, triethylene glycol, xylenesulfonic acid, paraffin, mineral oil, trichloroethylene, perchloroethylene, ethyl acetate, amyl acetate, butyl acetate, methanol, ethanol, isopropanol and higher molecular weight alcohols such as amyl alcohol, tetrahydrofurfuryl alcohol, hexanol, octanol, etc., ethylene glycol, propylene glycol, glycerin and N-methyl-2-pyrrolidinone. For diluting concentrates, water is generally chosen as the vehicle.

[0280] Suitable solid carriers include, for example, talc, titanium dioxide, pyrophyllite clay, silica, attapulgite clay, kieselguhr, chalk, diatomaceous earth, lime, calcium carbonate, bentonite clay, earth of Petition 870260106348, dated 10 / 15 / 2026, pp. 154 / 266 149 / 245 Fuller's starch, cottonseed hulls, wheat flour, soy flour, pumice stone, wood flour, walnut shell flour, and lignin.

[0281] A wide range of surfactants is advantageously employed in both liquid and solid compositions, especially those designed to be diluted with a vehicle before application. These agents, when used, typically comprise 0.1% to 15% by weight of the formulation. They may be anionic, cationic, nonionic, or polymeric in character and be used as emulsifying, wetting, suspending, or other agents. Typical surfactants include alkyl sulfate salts, such as diethanolammonium lauryl sulfate; alkylaryl sulfonate salts, such as calcium dodecylbenzene sulfonate; alkylphenol alkylene oxide addition products, such as nonylphenol ethoxylate C.sub. 18; and alkylene alcohol oxide addition products, such as tridecyl alcohol ethoxylate C.sub.16; soaps, such as sodium stearate; alkylnaphthalenesulfonate salts, such as sodium dibutylnaphthalenesulfonate; dialkyl esters of sulfosuccinate salts, such as sodium di(2-ethylhexyl)sulfosuccinate; sorbitol esters, such as sorbitol oleate; quaternary amines, such as lauryltrimethylammonium chloride; polyethylene glycol esters of fatty acids, such as polyethylene glycol stearate; block copolymers of ethylene oxide and propylene oxide; and salts of mono- and dialkyl phosphate esters. Petition 870260106348, dated 10 / 15 / 2026, pp. 155 / 266 150 / 245

[0282] Other adjuvants commonly used in agricultural compositions include crystallization inhibitors, viscosity modifiers, suspending agents, spray droplet modifiers, pigments, antioxidants, foaming agents, antifoaming agents, light-blocking agents, compatibilizing agents, antifoaming agents, sequestering agents, neutralizing agents and buffers, corrosion inhibitors, colorants, flavorings, spreading agents, penetration aids, micronutrients, emollients, lubricants and adhesive agents.

[0283] In addition, other active ingredients or compositions in terms of biocides may be combined with the compositions of the invention and used in the methods thereof and applied simultaneously or sequentially with them. When applied simultaneously, these other active ingredients may be formulated together with the compositions of the invention or mixed, for example, in the spray tank. These other active ingredients in terms of biocides may be fungicides, herbicides, insecticides, bactericides, acaricides, nematicides, plant growth regulators and / or biologicals.

[0284] The following combinations of a compound of formula I with another active substance in a weight ratio of 1:1 are preferred (wherein the abbreviation TX means "a compound selected from the compounds defined in Lists 1.1 to 1.100 and Lists 2.1 to 2.50, as well as in Table 11): (7E,9Z)-dodeca-7,9-dien-1-yl acetate + TX, (9Z,11E)-tetradeca-9,11-dien-1-yl acetate + TX, (9Z,12E)-tetradeca-9,12-dien-1-yl acetate + TX, (E)-6-methyl-hept-2-en-4-ol + TX, (E)-dec-5-en-1-yl acetate with (E)-dec-5-en-1-yl + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 156 / 266 151 / 245 acetate of (E)-tridec-4-en-1-yl + TX, acetate of (E,Z)tetradeca-4,10-diene-1-yl + TX, acetate of (Z)-dodec-7-en-1yl + TX, acetate of (Z)-hexadec-TX-1-11 (Z)-hexadec11-enal + TX, acetate of (Z)-hexadec-13-en-11-in-1-ila + TX, (Z)-icos-13-en-10-ona + TX, (Z)-tetradec-7-en-1-al + TX, (Z)-ol +tetradec-1ac-9 (Z)-tetradec-9-en1-yla + TX, 1,2-dibromo-3-chloropropane + TX, 1,2dichloropropane + TX, 1,2-dichloropropane com 1,3dichloropropane + TX, 1,3-dichloropropene,1-methyloctade + TX, 14 1-hydroxy-1H-pyridine-2-thione + TX, 2-(octylthio)ethanol + TX, N-methylcarbamate of 2-chlorophenyl (CPMC) + TX, 3-(4-chlorophenyl)-5-methylrhodanone + TX, 1,1diothiotrioxide +hydrophenote TX, TX 4(quinoxalin-2-ylamine)benzenosulfonamide + TX, 4methylnonan-5-ol with 4-methylnonan-5-one + TX, acid 5-methyl6-thioxo-1,3,5-thiadiazinan-3-ylacetic + TX, sulnohydroxy +purine dechypentenilamy8, TX TX, abamectin + TX, acequinocil + TX, acetamipride + TX,acetoprol + TX, acrinatrine + TX, acinonapir + TX, Adoxophyes orana GV + TX, afidopyropeno + TX, afoxolaner + TX, Agrobacterium radiobacter + TX, AKD-3088 + TX, alanicarb + TX, aldicarb + TX, aldoxicarb + TX, allethrin + TX, alfacypermethrin + TX, alphamethrin + TX, alpha-multistriatin + TX, Amblyseius spp. + TX, amidoflumete + TX, amino acids + TX, aminocarb + TX, Anagrapha falcifera NPV + TX, Anagrus atomus + TX, Aphelinus abdominalis + TX, Aphidius colemani + TX, Aphidoletes aphidimyza + TX, afolio + TX, Autographa californica NPV + TX, AZ 60541 + TX, azadirachtin + TX, azociclotin + TX, Bacillus aizawai + TX, Bacillus chitinosporus AQ746 (Accession number NRRL B-21 618) + TX, Petition 870260106348, dated 15 / 10 / 2026, p. 157 / 266 152 / 245 Bacillus firmus + TX, Bacillus kurstaki + TX, Bacillus mycoides AQ726 (Accession No. NRRL B-21664) + TX, Bacillus pumilus (Accession No. NRRL B-30087) + TX, Bacillus pumilus AQ717 (Accession No. NRRL B-21662) + TX, Bacillus sp. AQ175 (ATCC Accession No. 55608) + TX, Bacillus sp. AQ177 (N.° de Accessed ATCC 55609) + TX, Bacillus sp. AQ178 (ATCC Accession No. 53522) + TX, Bacillus sphaericus Neide + TX, Bacillus subtilis AQ153 (ATCC Accession No. 55614) + TX, Bacillus subtilis AQ30002 (NRRL Accession No. B-50421) + TX, Bacillus subtilis AQ30004 (NRRL Accession No. B- 50455) + TX, Bacillus subtilis AQ713 (NRRL Accession No. B-21661) + TX, Bacillus subtilis AQ743 (NRRL Accession No. B-21665) + TX, Bacillus subtilis not specified + TX, Bacillus thuringiensis AQ52 (NRRL Accession No. B-21619) + TX, Bacillus thuringiensis BD#32 (NRRL Accession No. B-21530) + TX, Bacillus thuringiensis Berliner + TX, Bacillus thuringiensis subsp. Aizawai + TX, Bacillus thuringiensis subsp. Israelensis + TX, Bacillus thuringiensis subsp. Japonensis + TX, Bacillus thuringiensis subsp. Kurstaki + TX, Bacillus thuringiensis subsp. Tenebrionis + TX, Bacillus thuringiensis subspec.course BMP 123 + TX, Beauveria bassiana + TX, Beauveria brongniartii + TX, benclothiase + TX, benomyl + TX, bensultape + TX, benzoximate + TX, benzpirimoxane + TX, betaciflutrine + TX, beta-cypermetrine + TX, TX, TX, biphene + TX bifenthrin + TX, binapacril + TX, bioalethrin + TX, bioresmethrin + TX, bis(tributylestane) oxide + TX, bisazir + TX, bistrifluron + TX, bissulfuphen + TX, brevicomine + TX, broflanilide + TX, broflutrinate + TX, + acetate bromide, + TX TX, bronopol + TX, busulfan + TX, butocarboxim + TX, butopyrnoxil + TX,. Petition 870260106348, of 15 / 10 / 2026, p. 158 / 266 153 / 245 butoxy(polypropylene glycol) + TX, butylpyridaben + TX, cadusafos + TX, calcium arsenate + TX, carbaryl + TX, carbofuran + TX, carbon disulfide + TX, carbosulfan + TX, cartap + TX, CAS number: 1594624-87-9 + TX, CAS number: 1922957-47-8 + TX, CAS number: 1255091-74-7 + TX, CAS number: 1365070-72-9 + TX, CAS number: 1445683-71-5 + TX, CAS number: 1445684-82-1 + TX, CAS number: 1594626-19-3 + TX, CAS number: 1594637-65-6 + TX, CAS number: 1632218-008 + TX, CAS number: 1808115-49-2 + TX, CAS number: 192295746-7 + TX, CAS number: 1922957-48-9 + TX, CAS number: 1956329-03-5 + TX, CAS number: 1990457-52-7 + TX, CAS number: 1990457-55-0 + TX, CAS number: 1990457-57-2 + TX, CAS number: 1990457-66-3 + TX, CAS number: 1990457-77-6 + TX, CAS number: 1990457-85-6 + TX, CAS number: 2032403-97-5 + TX, CAS number: 2044701-44-0 + TX, CAS number: 2095470-94-1 + TX, CAS number: 2128706-04-5 + TX, CAS number: 2128706-05-6 + TX, CAS number: 2133042-31-4 + TX,CAS number: 2133042-44-9 + TX, CAS number: 2171099-09-3 + TX, CAS number: 2220132-55-6 + TX, CAS number: 2396747-83-2 + TX, CAS number: 2408220-91-5 + TX, CAS number: 2408220-94-8 + TX, CAS number: 2415706-16-8 + TX, Piperflanilide (CAS number: 2615135-05-0) + TX, CAS number: 2719848-60-7 + TX, CAS number: RNA (Leptinotarsa ​​decemlineata specific recombinant double-stranded interfering GS2) + TX, chlorantraniliprole + TX, chlordane + TX, chlorfenapyr + TX, chloropicrin + TX, chloropralethrin + TX, chlorpyrifos + TX, cromafenozide + TX, Chrysoperla carnea + TX, clenpyrin + TX, chloretocarb + TX, clothianidin + TX, codlelure + TX, codlemone + TX, copper acetoarsenite + TX, copper dioctanoate + TX, copper hydroxide + TX, sulfate copper + TX, cresol + TX, crufomate + TX, Cryptolaemus montrouzieri + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 159 / 266 154 / 245 cuelure + TX, cyanofenphos + TX, cyantraniliprole + TX, cybutrin + TX, cyclaniliprol + TX, cyclobutrifluram + TX, cycloprothrin + TX, cycloxapride + TX, Cydia pomonella GV + TX, cyenopyrafen + TX, cietpyrafen + TX, cyflumetofen + TX, cyfluthrin + TX, cialodiamide + TX, cyclohalothrin + TX, cypermethrin + TX, cyphenothrin + TX, ciproflanilide + TX, cyromazine + TX, cytokinins + TX, Dacnusa sibirica + TX, dazomet + TX, DBCP + TX, DCIP + TX, deltamethrin + TX, diafenthiuron + TX, dialifos + TX, diamidafos + TX, dibrom + TX, dibutyl adipate + TX, dibutyl phthalate + TX, dibutyl succinate + TX, diclofenthion + TX, diclone + TX, dichlorophene + TX, diclifos + TX, dichloromesotiaz + TX, diethyltoluamide + TX, diflubenzuron + TX, Diglyphus isaea + TX, dimatife + TX, dimethoate + TX, dimethyl carbato + TX, dimethyl phthalate + TX, dimpropiridaz + TX, dynactin + TX, dinocape + TX, dinotefuran + TX, dioxabenzofos + TX, dipyrithione + TX, disparlure + TX, D-limonene + TX,dodec-8-en-1-yl acetate + TX, dodec-9-en-1-yl acetate + TX, dodec-8,10-dien-1-yl acetate + TX, dodicin + TX, dominicalure + TX, doramectin + TX, emamectin + TX, emamectin benzoate + TX, empentrin + TX, Encarsia formosa + TX, endotal + TX, endrin + TX, eprinomectin + TX, epsilon - momfluorothrin + TX, epsilon-metofluthrin + TX, Eretmocerus eremicus + TX, esfenvalerate + TX, ethione + TX, etiprola + TX, etoprofos + TX, ethyl 4-methyloctanoate + TX, hexanediol ethyl + TX, ethylene dibromide + TX, etofenprox + TX, ethoxazole + TX, etpiraphene + TX, eugenol + TX, seaweed extract and molasses-derived fermentation product + TX, seaweed extract and molasses-derived fermentation product containing urea + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 160 / 266 155 / 245 Seaweed extract and fermented plant products + TX, Seaweed extract and fermented plant products containing phytohormones, vitamins, copper, zinc and iron chelated by EDTA + TX, famfur + TX, fenaminosulfe + TX, fenamifos + TX, fenazaquin + TX, fenfluthrin + TX, fenitrothiona + TX, fenmezoditiaz + TX, fenobucarb + TX, fenothiocarb + TX, fenoxicarb + TX, fenpropathrin + TX, fenpirade + TX, fenpiroximate + TX, fensulfothiona + TX, fenthiona + TX, fentina + TX, fentinacetate + TX, fenvalerate + TX, ferric phosphate + TX, fipronil + TX, flomethoquine + TX, flonicamide + TX, fluacripirim + TX, fluazaindolizine + TX, fluazuron + TX, flubendiamide + TX, flubenzimine + TX, fluchlordiniliprol + TX, flucitrinate + TX, flucicloxuron + TX, flucitrinate + TX, fluensulfone [318290-98-1] + TX, fluensulfone + TX, flufenerim + TX, flufenprox + TX, flufiprol + TX, fluhexafon + TX, flumethrin + TX, fluopyram + TX, flupyradifurone + TX, flupyrimine + TX, flupyroxystrobin + TX,fluralaner + TX, fluvalinate + TX, fluxamethamide + TX, formaldehyde + TX, fostiazate + TX, fostietane + TX, frontalin + TX, furfural + TX, gamma-cyhalothrin + TX, Gossyplure® (1:1 mixture of (Z,E) and (Z,Z) isomers of hexadeca-7,11-dien-1-yl-acetate) + TX, grandlure + TX, grandlure I + TX, grandlure II + TX, grandlure III + TX, grandlure IV + TX, Granulovirus + TX, guadipir + TX, GY81 + TX, halfenprox + TX, halofenozide + TX, Harpin + TX, Helicoverpa armigera nucleopolyhedrovirus + TX, Helicoverpa zea NPV + TX, Helicoverpa zea Nucleopolyhedrovirus + TX, Heliothis punctigera Nucleopolyhedrovirus + TX, Heliothis virescens Nucleopolyhedrovirus + TX, hemel + TX, hempa + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 161 / 266 156 / 245 heptaflutrina + TX, heterofos + TX, Heterorhabditis bacteriophora e H.megidis + TX, hexalure + TX, hexamide + TX, hexithiazox + TX, Hippodamia convergens + TX, hydramethylnon + TX, hydrargafen + TX, cal hydratada + TX, imiciafos + TX, imidacloprid + TX, imiprotrin + TX, indazapiroxamete + TX, indoxacarb + TX, iodomethane + TX, iprodione + TX, ipsdienol + TX, ipsenol + TX, isamidophos + TX, isazofos + TX, isocicloseram + TX, Isoflualanam (CAS number: 2892524-05-7) + TX, isothioate + TX, ivermectin + TX, japonilure + TX, capa-bifenthrin + TX, capa-tefluthrin + TX, casugamicin + TX, casugamicin hydrochloride hydrate + TX, kinetin + TX, lambda-cyalothrin + TX, ledpron + TX, lepimectin + TX, Leptomastix dactylopii + TX, lineatina + TX, litlure + TX, looplure + TX, lotilaner + TX, lufenuron + TX, Macrolophus caliginosus + TX, Mamestra brassicae NPV + TX, mecarfon + TX, medlure + TX, megatomóico acid + TX, metaflumizone + TX, metaldehyde + TX, metam + TX, metampotassium + TX, metam-sódio + TX, Metaphycus helvolus + TX, Metarhizium anisopliae var.acridum + TX, Metarhizium anisopliae var. anisopliae + TX, Metarhizium spp. + TX, metepa + TX, methiocarb + TX, methiotepa + TX, methomyl + TX, methoquin-butyl + TX, methoxyfenozide + TX, methyl afolate + TX, methyl bromide + TX, methyl eugenol + TX, methyl isothiocyanate + TX, methylneodecanamide + TX, metofluthrin + TX, metolcarb + TX, mexacarbate + TX, milbemectin + TX, milbemycin oxime + TX, monfluorothrin + TX, morzide + TX, moxidectin + TX, muscalure + TX, Muscodor albus 620 (Accessory No. NRRL 30547) + TX, Muscodor roseus A3-5 (Accessory No. NRRL 30548) + TX, Myrothecium verrucaria composition + TX, nabam + TX, NC-184 + TX,. Petition 870260106348, dated 10 / 15 / 2026, pp. 162 / 266 157 / 245 produtos à base de árvore de nim + TX, Neodiprion sertifer NPV e N. lecontei NPV + TX, bis(dimetilditiocarbamato) de níquel + TX, niclosamida + TX, niclosamida-olamina + TX, nicofluprol + TX, nitenpiram + TX, nitiacina + TX, nitrapirina + TX, acetato de octadeca-2,13-dien-1-ila + TX, acetato de octadeca-3,13-dien-1-ila + TX, octilinona + TX, omethoato + TX, orfralure + TX, Orius spp. + TX, orictalure + TX, ostramona + TX, oxamate + TX, oxamil + TX, oxazosulfil + TX, oxolínic acid + TX, oxytetracycline + TX, Paecilomyces fumosoroseus + TX, Paecilomyces lilacinus + TX, parationa-etila + TX, Pasteuria nishizawae + TX, Pasteuria penetrans + TX, Pasteuria ramosa + TX, Pasteuria thornei + TX, Pasteuria usgae + TX, P-cimeno + TX, penfluron + TX, pentachlorophenol + TX, permethrin + TX, phenothrin + TX, phorate + TX, phosphamidona + TX, fosfocarbe + TX, Phytoseiulus persimilis + TX, picaridin + TX, pioxaniliprol + TX, piperazine + TX, piperonyl butóxido + TX, pirimicarbe + TX,pirimiphos-ethyl + TX, pirimiphos-methyl + TX, Plutella xylostella granulosa virus + TX, Plutella xylostella nucleopolydrovirus + TX, polyhedrosis virus + TX, manganese chelated with potassium and molybdenum and EDTA + TX, ethyl xylose + TX, potassium sulfate TX potassium hydroxyquinoline + TX, praletrin + TX, probenazole + TX, profenofos + TX, profluthrin + TX, propargite + TX, propetanfos + TX, propoxur + TX, prothiofos + TX, protriffenbute + TX, piflubumide + TX, pimetrozine + TX, pyrophosphate + TX + TX, pyrethro + TX, pyridaben + TX, pyridalyl + TX, pyridine-4-amine + TX, pyrifluquinazone + TX, pyrimidiphene + TX, pyriminostrobin + TX, pyriprol [39473071-3] + TX, pyriprol + TX, pyriproxine + TX, Quma, 40 Petition 870260106348, of 15 / 10 / 2026, p. 163 / 266 158 / 245 (a mixture of terpenoids) + TX, QRD 452 (a mixture of terpenoids) + TX, QRD 460 (a mixture of terpenoids) + TX, Quillaja saponaria + TX, quinoclamine + TX, quinonamide + TX, resmethrin + TX, Rhodococcus globerulus AQ719 (Accessory No. NRRL B-21663) + TX, sarolaner + TX, S-bioalethrin + TX, sebufos + TX, selamectin + TX, siglure + TX, silafluofen + TX, simazine + TX, sodium pentachlorophenoxide + TX, sordidine + TX, spidoxamate + TX, spinetoram + TX, spinosad + TX, spirobudifene + TX, spirodiclofen + TX, spiromesifen + TX, spiropidiona + TX, spirotetramate + TX, Spodoptera exigua multicapsid nuclear polyhedrosis virus + TX, Spodoptera frugiperda nucleopolyhedrovirus + TX, Steinernema bibionis + TX, Steinernema carpocapsae + TX, Steinernema feltiae + TX, Steinernema glaseri + TX, Steinernema riobrave + TX, Steinernema riobravis + TX, Steinernema scapterisci + TX, Steinernema spp. + TX, Streptomyces galbus (Accessory No. NRRL 30232) + TX, Streptomyces sp.(NRRL Accession No. B-30145) + TX, streptomycin + TX, streptomycin sesquisulfate + TX, strychnine + TX, sulcatol + TX, sulfiflumin (CAS number: 2377084-09-6) + TX, sulfoxaflor + TX, tazimcarb + TX, tebufenozide + TX, tebufenpyrad + TX, tebupirimiphos + TX, tecloftalam + TX, tefluthrin + TX, temefos + TX, tepa + TX, terbam + TX, terbufos + TX, terpenoid mixture + TX, tetrachlorantraniliprole + TX, tetrachlorothiophene + TX, tetradec-11-en-1-yl acetate + TX, tetradifone + TX, tetramethrin + TX, tetramethylfluthrin + TX, tetranactin + TX, tetraniliprol + TX, teta-cypermethrin + TX, thiacloprid + TX, thiafenox + TX, thiamethoxam + TX, thiocyclam + TX, thiodicarb + TX, thiofanox + TX, thioempa + TX, thimerosal +. Petition 870260106348, dated 10 / 15 / 2026, pp. 164 / 266 159 / 245 TX, thiometone + TX, thionazine + TX, thiophanate + TX, thiosultape + TX, thiotepa + TX, tigolaner + TX, thiorantraniliprole + TX, thioxazafen + TX, tolfenpyrad + TX, toxaphene + TX, tralomethrin + TX, transfluthrin + TX, tretamine + TX, triazamate + TX, triazophos + TX, triazurone + TX, tributyltin oxide + TX, trichlorfon + TX, trichlorfonate + TX, trichlorfon + TX, Trichogramma spp. + TX, trifenmorphe + TX, trifluenfuronate + TX, triflumezopirim + TX, trimedlure + TX, trimedlure A + TX, trimedlure B1 + TX, trimedlure B2 + TX, trimedlure C + TX, trimetacarb + TX, triphenyltin acetate + TX, triphenyltin hydroxide + TX, trunc-call + TX, ticlopyrazoflor + TX, Typhlodromus occidentalis + TX, uredepa + TX, Verticillium lecanii + TX, Verticillium spp. + TX, xylenóis + TX, YI-5302 + TX, zeatin + TX, zeta-Cypermethrin + TX; N-[(1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoroquinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3-chloro-1-methyl-but-3-enyl]-8-fluoro-quinoline-3-carboxamide + TX, Netyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)tetrahydrofuran-2-yl]phenyl]-N-methyl-formamidine (these compounds can be prepared from the methods described in WO2019 / 110427) + TX, (3',4',5'-trifluoro-biphenyl-2-yl)amide + TX, (3-methylisoxazol-5-yl)-[4-[5-(trifluoromethyl)1,2,4-oxadiazol-3-yl]phenyl]methanone (these compounds can be prepared from the methods described in WO 2017 / 220485) + TX, 2-amino-6-methyl-pyridino-3-carboxylate of (4-phenoxyphenyl)methyl (this compound can be prepared from the methods described in WO 2014 / 006945) + TX, (5-methyl-2-pyridyl)-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3yl]phenyl]methanone + TX, (7E,9Z)-dodeca-7,9-diene acetate Petition 870260106348, dated 10 / 15 / 2026, pp. 165 / 266 160 / 245 1-yl + TX, acetate of (9Z,11E)-tetradeca-9,11-diene-1-yl + TX, acetate of (9Z,12E)-tetradeca-9,12-diene-1-yl + TX, (E)6-methyl-hept-2-en-4-deol-acet de (TX-5) (E)-dec-5-en-1-ol + TX, acetate of (E)-tridec-4-en-1-yl + TX, acetate of (E,Z)-tetradeca-4,10-diene-1-yl, + TX, (R)3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindane-4yl]pyrazol-4-carboxamide + TX, acetate of (Z)-dodec-7-en-1yl + TX, acetate of (Z)-hexadec-11-en-deal (TX,1-Zyl) + acetate of (Z)-hexadec-13-en-11-in-1yla + TX, (Z)-icos-13-en-10-ona + TX, (Z)-tetradec-7-en-1al + TX, (Z)-tetradec-9-en-1-ol + TX1, acetadec-TX, (Z)yla +9-tete (Z,2E)-5-[1-(2,4dichlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethylpent-3-enamide (this compound can be prepared from two methods described in WO 2018 / 153707) + TX (Z,2E)-5-[1(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-N,3-dimethylpent-3-enamide + TX, , [2-[3-[2-[1-[2-[3,5bis(difluoromethyl)pyrazol-1-yl]acetyl]-4-piperidyl]thiazol4-yl]-4,5-di-hydroisoxazol-5-yl]-3-chlorophenyl]methanesulfonate + TX, 1-(4,5-dimethylbenzimidazol-1yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(4,5dimethylbenzimidazol-1-yl)-4,4-difluoro-3,3-dimethylisoquinoline + TX, 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3yl)-4,4,5-trifluoro-3,3-dimethyl-isoquinoline + TX, 1-(6,7dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4,6-trifluoro-3,3dimethyl-isoquinoline + TX, 1-(6-chloro-7-methyl-pyrazolo[1,5a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-isoquinoline (these compounds can be prepared according to the methods described in WO2017 / 025510) + TX, 1,1-bis(4-chlorophenyl)-2ethoxyethanol + TX, 1,1-dichloro-2,2-bis(4-ethylphenyl)ethane +, Petition 870260106348, 15 / 10 / 2026, pág. 166 / 266 161 / 245 TX, 1,2-dibromo-3-chloropropane + TX, 1,2-dichloropropane com 1,3-dichloropropene + TX, 1,3-dichloropropene + TX, 1,3dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3yl]phenyl]methyl]ureia + TX, 1-[2-[[1-(4-chlorophenyl)pyrazol3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl-tetrazol-5-ona + TX, 10-dien-1-yl acetate + TX, 14-methyloctadec-1-eno + TX, 1-bromo-2-chloroethane + TX, 1-dichloro-1-nitroethane + TX, 1hidroxy-1H-pyridino-2-thione + TX, 1-methoxy-3-methyl-1-[[4[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]ureia + TX, 1-methyl-4-[3-methyl-2-[[2-methyl-4-(3,4,5trimethylpyrazol-1-yl)phenoxy]methyl]phenyl]tetrazol-5-ona + TX, 2-(difluoromethyl)-N-((3R)-1,1,3-trimethylindan-4yl)pyridino-3-carboxamida + TX, 2-(difluoromethyl)-N-((3R)1,1,3-trimethylindan-4-yl)pyridino-3-carboxamida + TX, dimethylcarbamate de 2-(1,3-dithiolan-2-yl)phenyl + TX, 2-(2-butoxyethoxy)ethyl piperonylate + TX, 2-(2-butoxyethoxy)ethyl thiocyanate + TX, 2-(4,5dimethyl-1,3-dioxolan-2-yl)phenyl methylcarbamate + TX, 2-(4-chloro-3,5xylyloxy)ethanol + TX, 2-(difluoromethyl)-N-(3-ethyl-1,1dimethyl-indan-4-yl)pyridine-3-carboxamide + TX, 2(difluoromethyl)-N-[(3R)-3-ethyl-1,1-dimethyl-indan-4yl]pyridine-3-carboxamide + TX, 2-(difluoromethyl)-N-[(3S)3-ethyl-1,1-dimethyl-indan-4-yl]pyridine-3-carboxamide (this compound can be prepared from the methods described in WO 2014 / 095675) + TX, 2-(difluoromethyl)-N-[3-ethyl-1,1dimethyl-indan-4-yl]pyridine-3-carboxamide + TX, 2(octylthio)ethanol + TX, Ethyl 2,2,2-trichloro-1-(3,4dichlorophenyl)acetate + TX, 2,2-dichlorovinyl 2-ethylsulfinylethylmethylphosphate + TX, 2,2difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4-oxadiazolePetition 870260106348, from 10 / 15 / 2026, p. 167 / 266, 162 / 245 3-yl]phenyl]acetamide + TX, 2,4-dichlorophenyl benzenesulfonate + TX, 2,6-dimethyl-1H,5H-[1,4]dithiino[2,3c:5,6-c']dipyrrole-1,3,5,7(2H,6H)-tetrone (this compound can be prepared from the methods described in WO 2011 / 138281) + TX, 2-[2-fluoro-6-[(8-fluoro-2-methyl-3-quinolyl)oxy]phenyl]propan-2-ol + TX, 2-[6-(4-bromophenoxy)2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol (this compound can be prepared from the methods described in WO 2017 / 029179) + TX, 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol (this compound can be prepared from the methods described in WO 2017 / 029179) + TX, 2-chlorovinyldiethyl phosphate + TX, 2-fluoro-N-methyl-N-1-naphthylacetamide + TX, 2-imidazolidone + TX, 2-isovalerildan-1,3-dione + TX, 2-methyl(prop-2-ynyl)aminophenyl methylcarbamate + TX, 2-oxo-N-propyl-2-[4-[5-trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]acetamide (this compound can be prepared using the methods described in WO 2018 / 065414) + TX, 2-thiocyanatoethyl laurate + TX, 3-(4,4-difluoro-3,3-dimethyl-1-isoquinolyl)-7,8-dihydro-6Hcyclopenta[e]benzimidazole (these compounds can be prepared using the methods described in WO2016 / 156085) + TX, 3-(4,4-difluoro-3,4-dihydro-3,3-dimethylisoquinolin-1-yl)quinolone + TX, 3-(4-chlorophenyl)-5-methylrhodane + TX, 3-(difluoromethyl)-1-methyl-N-[1,1,3-trimethylindan-4-yl]pyrazole-4-carboxamide + TX, 1,1-dioxide of 3,4-dichlorotetrahydrothiophene + TX, 3-[2-(1-chlorocyclopropyl)3-(2-fluorophenyl)-2-hydroxypropyl]imidazole-4-carbonitrile (this compound can be prepared from the methods described in WO 2016 / 156290) + TX, 3-[2-(1, Petition 870260106348, dated 10 / 15 / 2026, pp. 168 / 266 163 / 245 chlorocyclopropyl)-3-(3-chloro-2-fluorophenyl)-2-hydroxypropyl]imidazol-4-carbonitrile (this compound can be prepared from the methods described in WO 2016 / 156290) + TX, 3-bromo-1-chloroprop-1-ene + TX, 3-chloro-6-methyl-5-phenyl-4-(2,4,6-trifluorophenyl)pyridazine + TX, 3-difluoromethyl-1-methyl-1H-pyrazol-4-carboxylic acid + TX, 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3yl]phenyl]methyl]urea + TX, 3-methyl-1-phenylpyrazol-5-yl dimethylcarbamate + TX, 4-(2-bromo-4- fluorophenyl)-N-(2chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine + TX, 4-(2,6-difluorophenyl)-6-methyl-5-phenyl-pyridazine-3carbonitrile + TX, 4-(2-bromo-4-fluoro-phenyl)-N-(2-chloro-6fluoro-phenyl)-2,5-dimethyl-pyrazol-3-amine + TX, 4(quinoxalin-2-ylamino)benzenesulfonamide + TX, 4,4difluoro-1-(5-fluoro-4-methyl-benzimidazol-1-yl)-3,3dimethyl-isoquinoline + TX, 4,4-difluoro-3,3-dimethyl-1-(6methylpyrazolo[1,5-a]pyridin-3-yl)isoquinoline + TX, 4,4difluoro-3,3-dimethyl-1-(7-methylpyrazolo[1,5-a]pyridin-3yl)isoquinoline + TX, 4,4-dimethyl-2-[[4-[5(trifluoromethyl)-1,2,4-oxadiazol-3yl]phenyl]methyl]isoxazolidin-3-one + TX, 4-[[6-[2-(2,4difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1,2,4-triazol-1yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4-[[6-[2-(2,4difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-sulfanyl-1,2,4triazol-1-yl)propyl]-3-pyridyl]oxy]benzonitrile + TX, 4[[6-[2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5thioxo-4H-1,2,4-triazol-1-yl)propyl]-3pyridyl]oxy]benzonitrile + TX, 4-chloro-2-(2-chloro-2-methylpropyl)-5-[(6-iodo-3-pyridyl)methoxy]pyridazin-3-one + TX, 4-chlorophenylphenylsulfone + TX, methylcarbamate of 4, Petition 870260106348, de 15 / 10 / 2026, pág. 169 / 266 164 / 245 methyl(prop-2-ynyl)amino-3,5-xylyl + TX, 4-methylnonan-5-ol with 4-methylnonan-5-one + TX, 5-(1,3-benzodioxol-5-yl)-3hexylcyclohex-2-enone + TX, 5,5-dimethyl-2-[[4-[5(trifluoromethyl)-1,2,4-oxadiazol-3yl]phenyl]methyl]isoxazolidin-3-one + TX, 5,5-dimethyl-3-oxocyclohex-1-enyl dimethylcarbamate + TX, 5amino-1,3,4-thiadiazol-2-thiol zinc salt (2:1) + TX, acid 5-methyl-6thioxo-1,3,5-thiadiazinan-3-ylacetic + TX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(2,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide (may be prepared from the methods described in WO 2020 / 109391) + TX, 6-chloro-3-(3-cyclopropyl-2-fluorophenoxy)-N-[2-(3,4-dimethylphenyl)-2,2-difluoroethyl]-5-methylpyridazine-4-carboxamide (may be prepared from the methods described in WO 2020 / 109391) + TX, 6-chloro-4,4-difluoro-3,3-dimethyl-1-(4-methylbenzimidazol-1-yl)isoquinoline + TX, 6chloro-N-[2-(2-chloro-4-methyl-phenyl)-2,2-difluoro-ethyl]-3-(3-cyclopropyl-2-fluoro-phenoxy)-5-methyl-pyridazine-4-carboxamide (may be prepared from the methods described in WO 2020 / 109391) + TX, 6-ethyl-5,7-dioxopyrrolo[4,5][1,4]dithiino[1,2-c]isothiazol-3-carbonitrile + TX, 6-isopentenylaminopurine + TX, 8-fluoro-N-[(1R)-1-[(3fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide + TX, 8-fluoro-N-[(1S)-1-[(3fluorophenyl)methyl]-1,3-dimethylbutyl]quinoline-3-carboxamide + TX, 8-hydroxyquinoline sulfate + TX, acethione + TX, acetoprol + TX, acibenzolar + TX, acibenzolarS-methyl + TX, acrylonitrile + TX, Adoxophyes orana GV + TX, Agrobacterium radiobacter + TX, aldoxycarb + TX, aldrin + TX, alosamidin + TX, alixicarb + TX, alpha-chlorohydrin + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 170 / 266 165 / 245 alpha-ecdysone + TX, alpha-multistriatin + TX, aluminum phosphate + TX, Amblyseius spp. + TX, amectotractine + TX, ametoctradine + TX, amidition + TX, amidothioate + TX, aminocarbe + TX, aminopyrifene + TX, amisulbrome + TX, amiton + TX, amiton hydrogen oxalate + TX, amitraz + TX, anabasin + TX, Anabasin NPV + TX, NPV atomus + TX, ancimidol + TX, anilazine + TX, anisiflupurine + TX, anthraquinone + TX, ant + TX, Aphelinus abdominalis + TX, Aphidius colemani + TX, Aphidoletes aphidimyza + TX, afolato + TX, aramita + TX, oxygenation + TX, arsenide + TX, TX californica NPV + TX, azaconazole + TX, azamethiphos + TX, azobenzene + TX, nitroate + TX, azoxystrobin + TX, Bacillus sphaericus Neide + TX, Bacillus thuringiensis delta endotoxins + TX, barium carbonate + TX, TX hexafluoric fluoride, polysulfide + TX + TX, bartrina + TX, Bayer 22 / 190 + TX, Bayer 22408 + TX, Beauveria brongniartii + TX, benalaxil + TX, benclothiase + TX,benomyl + TX, benoxafos + TX, bentiavalicarbe + TX, benzothiostrobin + TX, benzovindiflupyr + TX, benzyl benzoate + TX, beta-cyfluthrin + TX, beta-cypermethrin + TX, betoxazine + TX, bioethanometryn + TX, biopermethrin + Tila ethanol + biosynthesis TX, bis(tributylestane) oxide + TX, bisazir + TX, bistiosemide + TX, bitertanol + TX, bixafen + TX, blasticidin-S + TX, borax + TX, burgundy lime + TX, boscalide + TX, brevicomine + TX, brodifacume +, TX, bromide + bromide + bromide TX, bromethalin + TX, bromophenvinphos + TX, bromoacetamide + TX, bromocycline + TX, bromo-DDT + TX, bromophos + TX, bromopropylate + TX, bromuconazole + TX, bronopol + TX, bufencarbe + TX, bupirimatofe + TX, TX, buprofane, TX + buszine, + TX N-[6-[[(Z)-[(1, Petition 870260106348, of 15 / 10 / 2026, p. 171 / 266 166 / 245 methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]but-3-ynyl carbamate + TX, butacarbe + TX, butatiofos + TX, butocarboxim + TX, butonate + TX, butopyronoxyl + TX, butoxy(polypropylene glycol) + TX, butoxycarboxim + TX, butylpyridaben + TX, calcium arsenate + TX, calcium cyanide + TX, calcium polysulfide + TX, camphenechlor + TX, captafol + TX, captan + TX, carbanolate + TX, carbendazim + TX, carbon disulfide + TX, carbon tetrachloride + TX, carbenothione + TX, carboxin + TX, cartap hydrochloride + TX, CAS Number: 2132414-04-9 + TX, CAS Number: 2344721-61-3 + TX, cevadine + TX, quinomethionate + TX, chloralose + TX, chlorbenside + TX, chlorbicycline + TX, chlordane + TX, chlordecone + TX, chlordimeform + TX, chlordimeform hydrochloride + TX, chlorfenetol + TX, chlorfenson + TX, chlorfensulfide + TX, chlorobenzilate + TX, chloroform + TX, chloroinconazide + TX, chlormeboform + TX, chlormethiron + TX, chloroneb + ​​TX, chlorphacinone + TX, chloropicrin + TX,chloropropylate + TX, chlorothalonil + TX, chlorfoxime + TX, chlorprazofos + TX, chlortiofos + TX, clozolinate + TX, cholecalciferol + TX, Chrysoperla carnea + TX, cinerina I + TX, cinerina II + TX, cinerinas + TX, cismethrin + TX, cis-resmethrin + TX, clocitrina + TX, closantel + TX, codlelure + TX, codlemona + TX, acetoarsenito de cobre + TX, arseniato de cobre + TX, dioctanoato de cobre + TX, hidróxido de cobre + TX, naftenato de cobre + TX, oleato de cobre + TX, óxido de cobre + TX, oxycloreto de cobre + TX, sulfato de cobre + TX, coumachlor + TX, coumafuril + TX, coumafos + TX, coumatetralil + TX, cumetoxistrobin (jiaxiangjunzhi) + TX, coumitoate + TX, coumoxistrobin + TX, cresol + TX, crimidine + TX, crotamiton, Petition 870260106348, 15 / 10 / 2026, pág. 172 / 266 167 / 245 + TX, crotoxifos + TX, crufomate + TX, cryolita + TX, Cryptolaemus montrouzieri + TX, CS 708 + TX, cuelure + TX, cufranebe + TX, cyanophenfos + TX, cyanophos + TX, cyanthoate + TX, cyazofamide + TX, cybutrin + TX, cycloethrin + TX, ciclobutrifluram + TX, Cydia pomonella GV + TX, ciflufenamida + TX, cimiazol + TX, cimoxanil + TX, ciproconazol + TX, ciprodinil + TX, citioate + TX, cytocininas + TX, Dacnusa sibirica + TX, DAEP + TX, dazomete + TX, DCIP + TX, DCPM + TX, DDT + TX, debacarb + TX, decarbofuran + TX, demefion + TX, demefion-O + TX, demefion-S + TX, demeton-methyl + TX, demeton-O + TX, demeton-O-methyl + TX, demeton-S + TX, demeton-S-methyl + TX, demeton-S-methylsulfon + TX, diamidafos + TX, dibutyl adipate + TX, dibutyl phthalate + TX, dibutyl succinate + TX, dicaptone + TX, diclobentiazox + TX, diclofenthion + TX, diclofluanide + TX, diclona + TX, dichlorophene + TX, dichlorvos + TX, diclozoline + TX, diclifos + TX, diclocimete + TX, diclomezine + TX,dicloran + TX, dicresyl + TX, dicyclanil + TX, dicyclopentadiene + TX, dieldrin + TX, dienochlor + TX, dietofencarb + TX, 5-methylpyrazol-3-yl diethyl phosphate + TX, diethyltoluamide + TX, difenacume + TX, difenoconazole + TX, difethialone + TX, diflovidazine + TX, Diglyphus isaea + TX, dilor + TX, dimatife + TX, dimefluthrin + TX, dimefox + TX, dimetane + TX, dimethymol + TX, dimethomorph + TX, dimethrin + TX, dimethyl carbamate + TX, dimethyl phthalate + TX, dimethylvinphos + TX, dimethylane + TX, dimoxystrobin + TX, dinex + TX, dinex-diclexin + TX, diniconazole + TX, dinocape-4 + TX, dinocape-6 + TX, dinoctone + TX, dinopenton + TX, dinoprope + TX, dinosam + TX, dinosebe + TX, dinosulfon + TX, dinoterbon + TX, diofenolan + TX, Petition 870260106348, dated 15 / 10 / 2026, p. 173 / 266 168 / 245 dioxabenzophos + TX, dioxation + TX, diphacinone + TX, diphenyl sulfone + TX, dipimethitrone + TX, dipyrithione + TX, disparlure + TX, disulfiram + TX, dithionone + TX, diticrophos + TX, DNOC + TX, acetic acid dodec-8-en-1-yla + TX, dodec-9-en-1-yla + TX, dodeca-8 + TX, dodemorpho + TX, dodicine + TX, dodine + TX, dofenapine + TX, dominicalure + TX, doramectin + TX, DSP + TX, d-Xtetra + TX, TX + edisterone, + TX TX, EI 1642 + TX, EMPC + TX, Encarsia formosa + TX, endotal + TX, endothion + TX, enestroburin + TX, enoxastrobin + TX, EPBP + TX, epoxiconazole + TX, eprinomectin + TX, Eretmocerus eremicus + TXol, efergo + TX + TX TX, etaboxam + TX, ethiophencarbe + TX, ethymol + TX, etoate-methyl + TX, 1-[[4[ (Z) -2-ethoxy-3,3,3-trifluoro-prop-1enoxy]phenyl]methyl]pyrazole-3-ethyl carboxylate (can be prepared by the two WO methods described 2020 / 056090) + TX, 1-[[4-[[2-(trifluoromethyl)-1,Ethyl 3-dioxolan-2yl]methoxy]phenyl]methyl]pyrazol-3-carboxylate (can be prepared by the methods described in WO 2020 / 056090) + TX, ethyl 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3yl]phenyl]methyl]pyrazol-4-carboxylate + TX, Ethyl 1-[[5[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]-2thienyl]methyl]pyrazol-4-carboxylate (this compound can be prepared from the methods described in WO 2018 / 158365) + TX, ethyl 4-methyloctanoate + TX, ethyl formate + TX, ethyl hexanediol + TX, ethylene dibromide + TX, ethylene dichloride + TX, ethylene oxide + TX, etridiazole + TX, etrifos + TX, eugenol + TX, EXD + TX, famoxadone + TX, farnesol + TX, farnesol with nerolidol + TX, fenamidone + TX, phenaminosulfate + TX, fenaminestrobin +, Petition 870260106348, dated 10 / 15 / 2026, pp. 174 / 266 169 / 245 TX, fenarimol + TX, fenazaflor + TX, fenbuconazole + TX, fenbutatin oxide + TX, fenchlorphos + TX, fenetacarb + TX, fenfuram + TX, fenexamide + TX, fenitrothion + TX, fenothiocarb + TX, fenoxacrim + TX, fenoxanil + TX, fenpiclonil + TX, fenpicoxamide + TX, fenpyritrine + TX, fenpropidine + TX, fenpropimorph + TX, fenpyrad + TX, fenpyrazamine + TX, fenpyroximate + TX, fenson + TX, fensulfothione + TX, fenthion + TX, fenthion-ethyl + TX, fentin + TX, fentriphanil + TX, ferbam + TX, ferimzone + TX, ferric phosphate + TX, flocoumaphene + TX, florylpicoxamide + TX, fluazinam + TX, flubenetram + TX, flubenzimine + TX, flucofurone + TX, flucicloxuron + TX, fludioxonil + TX, fluenetil + TX, flufenoxadiazam + TX, flufenoxystrobin + TX, fluindapyr + TX, flumethylsulforim + TX, flumorph + TX, fluopicolide + TX, fluopimomide + TX, fluopiram + TX, fluorbenside + TX, fluoroacetamide + TX, fluoroimide + TX, fluoxapiproline + TX, fluoxastrobin + TX, fluoxythioconazole + TX, flupropadine + TX,flupropadina hydrochloride + TX, fluquinconazole + TX, flusilazole + TX, flusulfamide + TX, flutianil + TX, flutolanil + TX, flutriafol + TX, fluxapyroxade + TX, FMC 1137 + TX, folpete + TX, formaldehyde + TX, formetanate + TX, formetanate hydrochloride + TX, formparanate + TX, fosetyl-aluminium + TX, fosmethylan + TX, phospirate + TX, fostietan + TX, frontalin + TX, fuberidazole + TX, furalaxil + TX, furametpir + TX, furathiocarb + TX, furetrin + TX, furfural + TX, gamma-HCH + TX, gliodin + TX, grandlure + TX, grandlure I + TX, grandlure II + TX, grandlure III + TX, grandlure IV + TX, guazatina + TX, guazatina acetates + TX, halfenprox + TX, HCH + TX, hemel + TX, hempa + TX, HEOD + TX, heptachlor + TX, heterofos +, Petition 870260106348, dated 15 / 10 / 2026, p. 175 / 266 170 / 245 TX, Heterorhabditis bacteriophora and H. megidis + TX, hexaconazole + TX, hexadecyl cyclopropanecarboxylate + TX, hexalure + TX, hexamide + TX, HHDN + TX, Hippodamia convergens + TX, hydragraphene + TX, hydrated lime + TX, hydrogen cyanide + TX, himexazole + TX, hiquincarb + TX, imanine + TX, imazalil + TX, imibenconazole + TX, iminoctadine + TX, inpirfluxam + TX, ipconazole + TX, ipfentrifluconazole + TX, ipflufenoquin + TX, iprobenfos + TX, iprodione + TX, iprovalicarb + TX, ipsdienol + TX, ipsenol + TX, IPSP + TX, isamidofos + TX, isazofos + TX, isobenzano + TX, isocarbofos + TX, isodrine + TX, isofenphos + TX, isofetamid + TX, isoflucipram + TX, isolano + TX, isoprothiolan + TX, isopyrazame + TX, isothianil + TX, isoxation + TX, japonilure + TX, jasmoline I + TX, jasmoline II + TX, jodfenfos + TX, juvenile hormone I + TX, juvenile hormone II + TX, juvenile hormone III + TX, cadetrin + TX, casugamicin + TX, casugamicin hydrochloride hydrate + TX, kelevan + TX, kinetin + TX,cynoprene + TX, kresoximmethyl + TX, lead arsenate + TX, Leptomastix dactylopii + TX, leptophos + TX, lindane + TX, lineatin + TX, lirimphos + TX, litlure + TX, looplure + TX, lvbenmixianan + TX, litidation + TX, Macrolophus caliginosus + TX, magnesium phosphide + TX, malonobene + TX, Mamestra brassicae NPV + TX, mancobre + TX, mancozeb + TX, mandestrobin + TX, mandipropamide + TX, maneb + ​​TX, mazidox + TX, m-cumenyl methylcarbamate + TX, mecarbam + TX, mecarfon + TX, medlure + TX, mefentrifluconazole + TX, megatomoic acid + TX, menazon + TX, mepanipirim + TX, meperfluthrina + TX, mefosfolan + TX, mepronil + TX, mercury oxide + TX, mercury chloride + TX, mesulfen + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 176 / 266 171 / 245 mesulfenfos + TX, metalaxyl + TX, metam + TX, metam-potassium + TX, metam-sodium + TX, Metaphycus helvolus + TX, Metarhizium anisopliae var. acridum + TX, Metarhizium anisopliae var. anisopliae + TX, metarilpicoxamida + TX, metconazol + TX, metepa + TX, metacrifos + TX, methanesulfonyl fluoride + TX, metasulfocarbe + TX, metiotepa + TX, metocrotofos + TX, metoprene + TX, metoquin-butyl + TX, metotrin + TX, methoxychlor + TX, (Z)-2-(5-cyclohexyl-2-methylphenoxy)-3-methoxyprop-2-enoate methyl + TX, (Z)-2-(5-cyclopentyl-2-methylphenoxy)-3-methoxyprop-2-enoate methyl (these compounds can be prepared from the methods described in WO2020 / 193387) + TX, Methyl (Z)-2-[5-(3-isopropylpyrazol-1-yl)2-methyl-phenoxy]-3-methoxy-prop-2-enoate + TX, (Z) Methyl 3-methoxy-2-[2-methyl-5-(3-propylpyrazol-1-yl)phenoxy]prop-2-enoate + TX, Methyl (Z)-3-methoxy-2-[2-methyl-5-(4propyltriazol-2-yl)phenoxy]prop-2-enoate + TX,(Z)3-methoxy-2-[2-methyl-5-[3-(trifluoromethyl)pyrazol-1-yl]phenoxy]prop-2-enoate methyl (these compounds can be prepared from the methods described in WO2020 / 079111) + TX, (Z)-3-methoxy-2-[2-methyl-5-[4-(trifluoromethyl)triazol2-yl]phenoxy]prop-2-enoate methyl + TX, methyl afolate + TX, methyl bromide + TX, methyl eugenol + TX, methyl isothiocyanate + TX, N-[[4-[1-(2,6-difluoro-4-isopropylphenyl)pyrazol-4-yl]-2-methylphenyl]methyl]carbamate methyl (can be prepared by the methods described in WO 2020 / 097012) + TX, N-[[4-[1-(4-cyclopropyl-2,6-difluorophenyl)pyrazol-4-yl]-2-methylphenyl]methyl]methyl carbamate (may be prepared by the methods described in WO 2020 / 097012) + TX, N-[[5-[4-(2,4-dimethylphenyl)triazol-2yl]-2-methylphenyl]methyl]methyl carbamate + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 177 / 266 172 / 245 methylchloroform + TX, methylene chloride + TX, methylneodecanamide + TX, metiram + TX, metolcarb + TX, metominostrobin + TX, methoxadiazone + TX, metrafenone + TX, methyltetraprol + TX, MGK 264 + TX, milbemycin oxime + TX, mipafox + TX, mirex + TX, monocrotofos + TX, morphothiona + TX, morzide + TX, moxidectin + TX, muscalure + TX, myclobutanil + TX, myclozolin + TX, Myrothecium verrucaria composition + TX, N-((1R)-1-benzyl-3-chloro-1-methyl-but-3-enyl)-8-fluoro-quinoline-3-carboxamide (these compounds can be prepared from of the methods described in WO2017 / 153380) + TX, N-((1S)-1-benzyl-3-chloro-1-methylbut-3-enyl)-8-fluoro-quinoline-3-carboxamide (these compounds can be prepared from the methods described in WO2017 / 153380) + TX, N'-(2,5-dimethyl-4-phenoxyphenyl)-Netyl-N-methyl-formamidine + TX, N'-(2-chloro-5-methyl-4-phenoxyphenyl)-N-ethyl-N-methyl-formamidine + TX, N,2-dimethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3yl]phenyl]methyl]propanamide + TX, N,N-dimethyl-1-[[4-[5(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-1,2,4-triazol-3-amine (these compounds can be prepared from the methods described in WO 2017 / 055473, WO 2017 / 055469, WO 2017 / 093348 and WO 2017 / 118689) + TX, N-[(1R)1-benzyl-1,3-dimethylbutyl]-7,8-difluoroquinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-1,3-dimethylbutyl]-8-fluoroquinoline-3-carboxamide + TX, N-[(1R)-1-benzyl-3,3,3-trifluoro-1-methylpropyl]-8-fluoroquinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-1,3-dimethyl-butyl]-7,8difluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl1,3-dimethyl-butyl]-8-fluoro-quinoline-3-carboxamide + TX, N-[(1S)-1-benzyl-3,3,3-trifluoro-1-methyl-propyl]-8-fluoro, Petition 870260106348, dated 10 / 15 / 2026, pp. 178 / 266 173 / 245 quinoline-3-carboxamide + TX, N-[(E)-methoxyiminomethyl]-4[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX, N[(Z)-methoxy-iminomethyl]-4-[5-(trifluoromethyl)-1,2,4oxadiazol-3-yl]benzamide + TX, N-[[4-[5-(trifluoromethyl)1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX, N-[2[2,4-dichloro-phenoxy]phenyl]-3-(difluoromethyl)-1-methylpyrazol-4-carboxamide + TX, N-[2-[2-chloro-4(trifluoromethyl)phenoxy]phenyl]-3-(difluoromethyl)-1-methylpyrazol-4-carboxamide + TX, N'-[2-chloro-4-(2-fluorophenoxy)5-methylphenyl]-N-ethyl-N-methylformamidine (this compound can be prepared using the methods described in WO 2016 / 202742) + TX, N'-[4-(4,5-dichlorothiazol-2-yl)oxy-2,5-dimethylphenyl]-N-ethyl-N-methylformamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxyethoxy)-3-pyridyl]-Netyl-N-methylformamidine + TX, N'-[5-bromo-2-methyl-6-(1-methyl-2-propoxyethoxy)-3-pyridyl]-N-isopropyl-N-methylformamidine (these compounds can be prepared using the methods described in WO2015 / 155075) + TX,N'-[5-bromo-2-methyl-6-(2-propoxypropoxy)-3-pyridyl]-N-ethyl-N-methylformamidine (this compound can be prepared from the methods described in IPCOM000249876D) + TX, N'-[5-bromo-2-methyl-6-[(1R)-1-methyl-2-propoxyethoxy]-3-pyridyl]-N-ethyl-N-methylformamidine + TX, N'-[5-bromo-2-methyl-6-[(1S)-1-methyl-2-propoxyethoxy]-3-pyridyl]-N-ethyl-N-methylformamidine + TX, N'-[5-chloro-2-methyl-6-(1-methyl-2-propoxyethoxy)-3-pyridyl]-N-ethyl-N-methylformamidine + TX, N-[N-methoxy-C-methyl-carbonimidoyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide (these compounds can be prepared from the methods described in WO 2018 / 202428) + TX, N'-[4-(1-cyclopropyl-2,2,2-trifluoro-1-hydroxyethyl), Petition 870260106348, dated 10 / 15 / 2026, pp. 179 / 266 174 / 245 5-methoxy-2-methyl-phenyl]-N-isopropyl-N-methyl-formamidine (these compounds can be prepared from the methods described in WO2018 / 228896) + TX, nabam + TX, naphthalophos + TX, nalede + TX, naphthalene + TX, NC-170 + TX, Neodiprion sertifer NPV and N. lecontei NPV + TX, nerolidol + TX, N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide + TX, N-ethyl-N'-[5-methoxy-2-methyl-4-[(2-trifluoromethyl)oxetan-2-yl]phenyl]-N-methylformamidine + TX, nickel bis(dimethyldithiocarbamate) + TX, niclosamide-olamine + TX, nicotine + TX, nicotine sulfate + TX, nifluridide + TX, nikkomycins + TX, N-isopropyl-N'[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenylethyl)phenyl]-N-methyl-formamidine + TX, nithiazine + TX, nitrapyrin + TX, nitrilacarb + TX, zinc chloride:nitrilocarb complex, 1:1 + TX, nitrotal-isopropyl + TX, Nmethoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3yl]phenyl]methyl]cyclopropanecarboxamide + TX, N-methyl-4-[5(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide + TX, Nmethyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3yl]benzenecarbothioamide + TX, norbormide + TX, nuarimol + TX, O,O,O',O'-tetrapropyl dithiopyrophosphate + TX, octadeca-2,13-dien-1-yl acetate + TX, octadeca-3,13dien-1-yl acetate + TX, octilinone + TX, ofurace + TX, oleic acid + TX, omethoate + TX, orfralure + TX, Orius spp. +TX, orictalure + TX, orisastrobin + TX, ostramone + TX, oxadixil + TX, oxamate + TX, oxathiapiproline + TX, copper oxynoxine + TX, oxolinic acid + TX, oxycarboxin + TX, oxideprofos + TX, oxydisulfoton + TX, oxytetracycline + TX, paclobutrazol + TX, Paecilomyces fumosoroseus + TX, para-dichlorobenzene + TX, parathion + TX, methyl parathion + TX, perfurazoate + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 180 / 266 175 / 245 penconazole + TX, pencicuron + TX, penflufen + TX, penfluron + TX, pentachlorophenol + TX, pentachlorophenyl laurate + TX, penthiopyrad + TX, permethrin + TX, PH 60-38 + TX, fenamacril + TX, fenkapton + TX, fosacetim + TX, fosalone + TX, phosphediphene + TX, phospholane + TX, phosglycine + TX, phosnichlor + TX, phosfamidon + TX, phosphine + TX, phosphorus + TX, phoximemethyl + TX, phthalide + TX, Phytoseiulus persimilis + TX, picarbutrazox + TX, picaridin + TX, picoxystrobin + TX, pindone + TX, piperazine + TX, butoxide piperonyl + TX, piprotal + TX, pirimetaphos + TX, polychlorodicyclopentadiene isomers + TX, polychloroterpenes + TX, polynactins + TX, polyoxins + TX, potassium arsenite + TX, potassium ethylxanthate + TX, potassium hydroxyquinoline sulfate + TX, potassium thiocyanate + TX, pp'-DDT + TX, precocene I + TX, precocene II + TX, precocene III + TX, primidofos + TX, probenazole + TX, prochloraz + TX, proclonol + TX, procymidone + TX, profluthrin + TX, promacil + TX,promecarbe + TX, propamocarbe + TX, propiconazole + TX, propinebe + TX, propoxur + TX, propyl isomer + TX, proquinazide + TX, protidation + TX, prothioconazole + TX, prothiophos + TX, protoate + TX, piriflume + TX, TX, pyramidal + TX pyramethostrobin + TX, pyraoxystrobin + TX, pyrapropoin + TX, pyraziflumide + TX, pyrazophos + TX, pyresmethrin + TX, pyrethrin I + TX, pyrethrin II + TX, pyrethrins + TX, pyribencarbe + TX, pyridaclomethyl + TX, pyridaphenone + TX, pyridine + TX-4-amine pyrifhenox + TX, pyrimethanil + TX, pyrimitate + TX, pyrimorph + TX, pyrinurone + TX, pyriophenone + TX, pyrisoxazole + TX, pyroquilon + TX, quassia + TX, quinalphos + TX, quinalphos-methyl + TX, quinoclamine + TX, TX, quinone, TX Petition 870260106348, of 15 / 10 / 2026, p. 181 / 266 176 / 245 quinothione + TX, quinoxifene + TX, quintiofos + TX, quintozene + TX, R-1492 + TX, rafoxanide + TX, resmethrin + TX, Reynoutria sachalinensis extract + TX, ribavirin + TX, Rmetalaxyl + TX, rotenone + TX, ryania + TX, ryanodine + TX, S421 + TX, sabadilla + TX, schradan + TX, sciliroside + TX, seboctilamine + TX, sebufos + TX, sedaxane + TX, selamectin + TX, sesamex + TX, sesasmolin + TX, SI-0009 + TX, siglure + TX, simazine + TX, simeconazole + TX, sodium arsenite + TX, cyanide sodium + TX, sodium fluoride + TX, sodium fluoroacetate + TX, sodium hexafluorosilicate + TX, sodium pentachlorophenoxide + TX, sodium selenate + TX, sodium tetrathiocarbonate + TX, sodium thiocyanate + TX, somide + TX, sordidine + TX, spiroxamine + TX, SSI121 + TX, Steinernema bibionis + TX, Steinernema carpocapsae + TX, Steinernema feltiae + TX, Steinernema glaseri + TX, Steinernema riobrave + TX, Steinernema riobravis + TX, Steinernema scapterisci + TX, Steinernema spp.+ TX, streptomycin + TX, streptomycin sesquisulfate + TX, strychnine + TX, sulcatol + TX, sulcofuron + TX, sulcofuronsodium + TX, sulfiram + TX, sulfluramide + TX, sulfotepe + TX, sulfoxide + TX, sulfur + TX, sulfuryl fluoride + TX, sulprophos + TX, tar oils + TX, tau-fluvalinate + TX, tazimcarb + TX, TDE + TX, tebuconazole + TX, tebufloquine + TX, tebupirimphos + TX, tecloftalam + TX, temephos + TX, tepa + TX, TEPP + TX, teralethrin + TX, terbam + TX, Tert-butyl N-[6-[[[(1-methyltetrazol-5-yl)-phenylmethylene]amino]oxymethyl]-2-pyridyl]carbamate + TX, tetrachloroethane + TX, tetrachlorothiophene + TX, tetraconazole + TX, tetradec-11-en-1-yl acetate + TX, tetradifon + TX, tetramethylfluthrin + TX, tetrasul + TX,. Petition 870260106348, dated 10 / 15 / 2026, pp. 182 / 266 177 / 245 thallium sulfate + TX, thiabendazole + TX, thiafenox + TX, tiapronil + TX, ticrofos + TX, tifluzamide + TX, thiocarboxymethylcellulose + TX, thiocyclam + TX, thiocyclam hydrogen oxalate + TX, cupric thiodiazole + TX, thiofanox + TX, thioempa + TX, thimerosal + TX, thiomethone + TX, thionazine + TX, thiophanate + TX, thiophanate-methyl + TX, thioquinox + TX, thiosultap + TX, thiosultap-sodium + TX, thiotepa + TX, thiram + TX, thuringiensis + TX, thiadinil + TX, tolclofos-methyl + TX, tolprocarb + TX, tolylfluanide + TX, tralomethrin + TX, transpermethrin + TX, tretamine + TX, triadimefon + TX, triadimenol + TX, triamiphos + TX, triaratene + TX, triazamate + TX, triazophos + TX, triazoxide + TX, triazuron + TX, tributyltin oxide + TX, trichlormetaphos-3 + TX, trichloronate + TX, Trichogramma spp.+ TX, triclopiricarb + TX, triciclazole + TX, tridemorph + TX, trifenmorph + TX, triphenofos + TX, trifloxystrobin + TX, triflumizole + TX, triforine + TX, trimedlure + TX, trimedlure A + TX, trimedlure B1 + TX, trimedlure B2 + TX, trimedlure C + TX, trimetacarb + TX, trinactin + TX, trinexapac + TX, triphenyltin acetate + TX, triphenyltin hydroxide + TX, triprene + TX, triticonazole + TX, trunc-call + TX, Typhlodromus occidentalis + TX, uredep + TX, validamycin + TX, valifenalato + TX, vamidothiona + TX, vaniliprole + TX, veratridine + TX, veratrine + TX, verbutin + TX, Verticillium lecanii + TX, vinclozolin + TX, warfarin + TX, XMC + TX, xylenols + TX, zeatin + TX, zetamethrin + TX, zhongshengmicin + TX, zinc naphthenate + TX, zinc phosphate + TX, zinc thiazole + TX, zinebe + TX, ziram + TX, zolaprofos + TX;. Petition 870260106348, dated 15 / 10 / 2026, p. 183 / 266 178 / 245 Acinetobacter Iwoffii + TX, Acremonium alternatum + TX, Acremonium cephalosporium + TX, Acremonium diospyri + TX, Acremonium obclavatum + TX, Adoxophyes orana granulovirus (AdoxGV) (Capex®) + TX, onion K84 from Agrobacterium radiobacter (Galltrol-A®) + TX, Alternaria alternate + TX, Alternaria cassia + TX, Alternaria destruens (Smolder®) + TX, Ampelomyces quisqualis (AQ10®) + TX, Aspergillus flavus AF36 (AF36®) + TX, Aspergillus flavus NRRL 21882 (Aflaguard®) + TX, Aspergillus spp. + TX, Aureobasidium pullulans + TX, Azospirillum (MicroAZ®, TAZO B®) + TX, Azotobacter + TX, Azotobacter chroocuccum (Azotomeal®) + TX, Azotobacter cysts (Bionatural Blooming Blossoms®) + TX, Bacillus amyloliquefaciens + TX, Bacillus cereus + TX, Bacillus chitinosporus strain AQ746 + TX, Bacillus chitinosporus strain CM-1 + TX, Bacillus circulans + TX, Bacillus firmus (BioSafe®, BioNem-WP®) in particular strain CNMC 1-1582 (e.g.VOTIVO® from BASF SE) + TX, Bacillus licheniformis strain 3086 (EcoGuard®, Green Releaf®) + TX, Bacillus licheniformis strain HB-2 (Biostart™, formerly Rhizoboost®) + TX, Bacillus macerans + TX, Bacillus marismortui + TX, Bacillus megaterium + TX, Bacillus mycoides strain AQ726 + TX, Bacillus papillae (Milky Spore Powder®) + TX, Bacillus pumilus spp. + TX, Bacillus pumilus strain AQ717 + TX, Bacillus pumilus strain GB34 (Yield Shield®) + TX, Bacillus pumilus strain QST 2808 (Sonata®, Ballad Plus®) + TX, Bacillus sphaericus (VectoLex®) + TX, Bacillus spp. + TX, Bacillus spp. strain AQ175 + TX, Bacillus spp. strain AQ177 + TX, Bacillus spp. strain AQ178 + TX, strain AQ153 of Bacillus subtilis + TX, strain AQ743 of Bacillus subtilis + TX, strain QST 713 of Bacillus subtilis. Petition 870260106348, dated 15 / 10 / 2026, p. 184 / 266 179 / 245 (CEASE®, Serenade®, Rhapsody®) + TX, strain QST 714 of Bacillus subtilis (JAZZ®) + TX, strain QST3002 of Bacillus subtilis + TX, strain QST3004 of Bacillus subtilis + TX, strain FZB24 of Bacillus subtilis var. amyloliquefaciens (Taegro®, Rhizopro®) + TX, Bacillus thuringiensis aizawai GC 91 (Agree®) + TX, Bacillus thuringiensis Cry 2Ae + TX, Bacillus thuringiensis Cry1Ab + TX, Bacillus thuringiensis israelensis (BMP123®, Aquabac®, VectoBac®) + TX, Bacillus thuringiensis kurstaki (Javelin®, Deliver®, CryMax®, Bonide®, Scutella WP®, Turilav WP ®, Astuto®, Dipel WP®, Biobit®, Foray®) + TX, Bacillus thuringiensis kurstaki BMP 123 (Baritone®) + TX, Bacillus thuringiensis kurstaki HD-1 (Bioprotec-CAF / 3P®) + TX, strain AQ52 of Bacillus thuringiensis + TX, strain BD#32 of Bacillus thuringiensis + TX, Bacillus thuringiensis tenebrionis (Novodor®, BtBooster) + TX, Bacillus thuringiensis var. aizawai (XenTari®, DiPel®) + TX, bacteria spp.(GROWMEND®, GROWSWEET®, Shootup®) + TX, bacteriófago de Clavipacter michiganensis (AgriPhage®, Bakflor®) + TX, Beauveria bassiana (Beaugenic®, Brocaril WP®) + TX, Beauveria bassiana GHA (Mycotrol ES®, Mycotrol O®, BotaniGuard®) + TX, Beauveria brongniartii (Engerlingspilz®, Schweizer Beauveria®, Melocont®) + TX, Beauveria spp. + TX, Botrytis cineria + TX, Bradyrhizobium japonicum (TerraMax®) + TX, Brevibacillus brevis + TX, Burkholderia cepacia (Deny®, Intercept®, Blue Circle®) + TX, Burkholderia gladii + TX, Burkholderia gladioli + TX, Burkholderia spp. + TX, Canadian thistle mushroom (CBH Canadian Bioherbicide®) + TX, Candida butyri + TX, Candida famata + TX, Candida fructus + TX, Candida glabrata + TX, Candida guilliermondii + TX, Candida melibiosica + TX, cepa O de. Petition 870260106348, 15 / 10 / 2026, pág. 185 / 266 180 / 245 Candida oleophila + TX, Candida parapsilosis + TX, Candida pelliculosa + TX, Candida pulcherrima + TX, Candida reukaufii + TX, Candida saitoana (Bio-Coat®, Biocure®) + TX, Candida sake + TX, Candida spp. + TX, Candida tenius + TX, Cedecea davisae + TX, Cellulomonas flavigena + TX, Chaetomium cochliodes (Nova-Cide®) + TX, Chaetomium globosum (NovaCide®) + TX, Chromobacterium subtsugae (Grandevo®) strain PRAA4-1T + TX, Cladosporium chlorocephalum + TX, Cladosporium cladosporioides + TX, Cladosporium oxysporum + TX, Cladosporium spp. + TX, Cladosporium tenuissimum + TX, Clonostachys rosea (EndoFine®) + TX, Colletotrichum acutatum + TX, Coniothyrium minitans (Cotans WG®) + TX, Coniothyrium spp.+ TX, Cryptococcus albidus (YIELDPLUS®) + TX, Cryptococcus humicola + TX, Cryptococcus infirmo-miniatus + TX, Cryptococcus laurentii + TX, Cryptphlebia leucotreta granulovirus (Cryptex®) + TX, Cupriavidus campinensis + TX, Cydia pomonella granulovirus (CYD-X®, Madex®, Madex® Plus, Madex Max, Carpovirusine® + TX, Cylindrobasidium laeve (Stumpout®) + TX, Cylindrocladium + TX, Debaryomyces hansenii + TX, Drechslera hawaiinensis + TX, Enterobacter cloacae + TX, Enterobacteriaceae + TX, Entomophtora virulenta (Vektor®) + TX, Epicoccum nigrum + TX, Epicoccum purpurascens + TX, Epicoccum spp. + TX, Filobasidium floriforme + TX, Fusarium acuminatum + TX, Fusarium chlamydosporum + TX, Fusarium oxysporum (Fusaclean®, Biofox C®) + TX, Fusarium proliferatum + TX, Fusarium spp. + TX, Galactomyces geotrichum + TX, Gliocladium catenulatum (Primastop®, Prestop®) + TX, Gliocladium roseum + TX, Gliocladium spp. (SoilGard®) + TX, Gliocladium virens (Soilgard®) + TX, Granulovirus (Granupom®) + TX,. Petition 870260106348, dated 10 / 15 / 2026, pp. 186 / 266 181 / 245 Halobacillus halophilus + TX, Halobacillus littoralis + TX, Halobacillus trueperi + TX, Halomonas spp. + TX, Halomonas subglaciescola + TX, Halovibrio variabilis + TX, Hanseniaspora uvarum + TX, Helicoverpa armigera nucleopolyhedrovirus (Helicovex®) + TX, Helicoverpa zea nuclear polyhedrosis virus (Gemstar®) + TX, Isaria fumosorosea (previously known as PFR-97® strain of Paecilomyces futuroroseus, PreFeRal®) + TX, Isoflavone formononetin (Myconate®) + TX, Kloeckera apiculata + TX, Kloeckera spp. + TX, Lagenidium giganteum (Laginex®) + TX, Lecanicillium lecanii (formerly known as Verticillium lecanii (Mycotal®) conidia strain KV01 (e.g.Vertalec® from Koppert / Arysta) + TX, Lecanicillium longisporum (Vertiblast®) + TX, Lecanicillium muscarium (Vertikil®) + TX, Lymantria Dispar nucleopolyhedrosis virus (Disparvirus®) + TX, Marinococcus halophilus + TX, Meira geulakonigii + TX, Metarhizium anisopliae (Destruxin WP®) + TX, Metarhizium anisopliae (Met52®) + TX, Metschnikowia fruticola (Shemer®) + TX, Metschnikowia pulcherrima + TX, Microdochium dimerum (Antibot®) + TX, Micromonospora coerulea + TX, Microsphaeropsis ochracea + TX, Muscodor albus 620 (Muscudor®) + TX, Muscodor roseus in particular strain A35 (Accession No. NRRL 30548) + TX, Mycorrhizae spp. (AMykor®, Root Maximizer®) + TX, onion AARC-0255 from Myrothecium verrucaria (DiTera®, BROS PLUS®) + TX, onion D97 from Ophiostoma piliferum (Sylvanex®) + TX, Paecilomyces farinosus + TX, onion 251 from Paecilomyces lilacinus (MeloCon WG®) + TX, Paecilomyces linacinus (Biostat WP®) + TX, Paenibacillus polymyxa + TX, Pantoea agglomerans (BlightBan C9-1®) + TX, Pantoea spp.+ TX, Pasteuria nishizawae in particular strain. Petition 870260106348, dated 10 / 15 / 2026, pp. 187 / 266 182 / 245 Pn1 (CLARIVA from Syngenta / ChemChina); + TX, Pasteuria spp. (Econem®) + TX, Penicillium aurantiogriseum + TX, Penicillium billai (Jumpstart®, TagTeam®) + TX, Penicillium brevicompactum + TX, Penicillium frequentans + TX, Penicillium griseofulvum + TX, Penicillium purpurogenum + TX, Penicillium spp. + TX, Penicillium viridicatum + TX, Phlebiopsis gigantean (Rotstop®) + TX, phosphate solubilizing bacteria (Phosphomeal®) + TX, Phytophthora cryptogea + TX, Phytophthora palmivora (Devine®) + TX, Pichia anomala + TX, Pichia guilliermondii + TX, Pichia membranaefaciens + TX, Pichia onychis + TX, Pichia stipites + TX, Pseudomonas aeruginosa + TX, Pseudomonas aureofasciens (Spot-Less Biofungicide®) + TX, Pseudomonas cepacia + TX, Pseudomonas chlororaphis (AtEze®) + TX, Pseudomonas corrugate + TX, Pseudomonas fluorescens (Zequanox®) + TX, Pseudomonas fluorescens strain A506 (BlightBan A506®) + TX, Pseudomonas putida + TX, Pseudomonas reactans + TX, Pseudomonas spp.+ TX, Pseudomonas syringae (Bio-Save®) + TX, Pseudomonas viridiflava + TX, Pseudozyma flocculosa strain PF-A22 UL (Sporodex L®) + TX, Puccinia canaliculata + TX, Puccinia thlaspeos (Wood Warrior®) + TX, Pythium paroecandrum + TX, Pythium oligandrum (Polygandron®, Polyversum®) + TX, Pythium periplocum + TX, Rhanella aquatilis + TX, Rhanella spp. + TX, Rhizobia (Dormal®, Vault®) + TX, Rhizoctonia + TX, Rhodococcus globerulus strain AQ719 + TX, Rhodosporidium diobovatum + TX, Rhodosporidium toruloides + TX, Rhodotorula glutinis + TX, Rhodotorula graminis + TX, Rhodotorula mucilagnosa + TX, Rhodotorula rubra + TX, Rhodotorula spp. + TX, Saccharomyces cerevisiae + TX, Salinococcus roseus + TX, Sclerotinia minor. Petition 870260106348, dated 15 / 10 / 2026, p. 188 / 266 183 / 245 (SARRITOR®) + TX, Sclerotinia minor + TX, Scytalidium spp. + TX, Scytalidium uredinicola + TX, Serratia marcescens + TX, Serratia plymuthica + TX, Serratia spp. + TX, Sordaria fimicola + TX, Spodoptera exigua nuclear polyhedrosis virus (Spod-X®, Spexit®) + TX, nucleopoliedrovírus de Spodoptera littoralis (Littovir®) + TX, Sporobolomyces roseus + TX, Stenotrophomonas maltophilia + TX, Streptomyces albaduncus + TX, Streptomyces exfoliates + TX, Streptomyces galbus + TX, Streptomyces griseoplanus + TX, Streptomyces griseoviridis (Mycostop®) + TX, Streptomyces hygroscopicus + TX, Streptomyces lydicus (Actinovate®) + TX, Streptomyces lydicus WYEC-108 (ActinoGrow®) + TX, Streptomyces violaceus + TX, Tilletiopsis minor + TX, Tilletiopsis spp.+ TX, Trichoderma asperellum (T34 Biocontrol®) + TX, Trichoderma atroviride (Plantmate®) + TX, Trichoderma gamsii (Tenet®) + TX, Trichoderma hamatum TH 382 + TX, Trichoderma harzianum rifai (Mycostar®) + TX, Trichoderma harzianum T-22 (TrianumP®, PlantShield HC®, RootShield®, Trianum-G® + TX, Trichoderma harzianum T-39 (Trichodex®) + TX, Trichoderma inhamatum + TX, Trichoderma koningii + TX, Trichoderma lignorum + TX, Trichoderma longibrachiatum + TX, Trichoderma polysporum (Binab T®) + TX, Trichoderma spp. LC 52 (Sentinel®) + TX, Trichoderma taxi + TX, Trichoderma virens (formerly Gliocladium virens GL-21) (SoilGuard®) + TX, Trichoderma virens + TX, Trichoderma viride + TX, Trichoderma viride strain ICC 080 (Remedier®) + TX, Trichosporon pullulans + TX, Trichosporon spp. + TX, Trichothecium roseum + TX, Trichothecium spp. + TX, Typhula phacorrhiza strain 94670 + TX, Typhula phacorrhiza strain 94671 + TX, Ulocladium atrum + TX, Ulocladium oudemansii (Botry-Zen®) +. Petition 870260106348, dated 10 / 15 / 2026, pp. 189 / 266 184 / 245 TX, Ustilago maydis + TX, various bacteria and supplemental micronutrients (Natural II®) + TX, various fungi (Millennium Microbes®) + TX, Verticillium chlamydosporium + TX, Vip3Aa20 (VIPtera®) + TX, Virgibacillus marismortui + TX, Xanthomonas campestris pv. Poae (Camperico®) + TX, Xenorhabdus bovienii + TX, Xenorhabdus nematophilus + TX; AGNIQUE® MMF + TX, azadirachtin (Plasma Neem Oil®, AzaGuard®, MeemAzal®, Molt-X®, e.g., AZATIN XL from Certis, USA) + TX, Botanical IGR (Neemazad®, Neemix®) + TX, BugOil® + TX, canola oil (Lilly Miller Vegol®) + TX, Chenopodium ambrosioides near ambrosioides (Requiem®) + TX, Chrysanthemum extract (Crisant®) + TX, Labiatae essential oils (Botania®) + TX, bitterberry oil extract (Trilogy®) + TX, clove, rosemary, peppermint and thyme oil extracts (Garden insect killer®) + TX, garlic + TX, Glycine betaine (Greenstim®) + TX, kaolin (Screen®) + TX, lemongrass oil (GreenMatch®) + TX, Melaleuca alternifolia extract (also called tea tree oil) (Timorex Gold®) + TX, garlic, clove, peppermint and spearmint oil blend (Soil Shot®) + TX, clove, rosemary and peppermint extract blend (EF 400®) + TX, rosemary, sesame, peppermint, thyme and cinnamon extract blend (EF 300®) + TX, bitter melon oil + TX, Nepeta cataria (catnip oil) + TX, Nepeta catarina + TX, nicotine + TX, oregano oil (MossBuster®) + TX, Pedaliaceae oil (Nematon®) + TX, pine oil (Retenol®) + TX, pyrethrum + TX, Quillaja saponaria (NemaQ®) + TX, Reynoutria sachalinensis (Regalia®, Sakalia®) + TX, rotenone (Eco Roten®) + TX, Rutaceae plant extract (Soleo®) + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 190 / 266 185 / 245 soybean oil (Ortho ecosense®) + TX, brown algae storage glucam (Laminarin®) + TX, thyme oil + TX; (E,Z)-7,9-dodecadien-1-yl acetate + TX, (E,Z,Z)-3,8,11-tetradecatrienyl acetate + TX, (Z,Z,E)-7,11,13-hexadecatrienal + TX, 2-Methyl-1-butanol + TX, Biolure® + TX, Blackheaded Fireworm Pheromone (3M Sprayable Blackheaded Fireworm Pheromone®) + TX, Calcium Acetate + TX, Check-Mate® + TX, Apple Moth Pheromone (Paramount dispenser-(CM) / Isomate C-Plus®) + TX, Entostat powder (palm extract) (Exosex CM®) + TX, Grape Moth Pheromone (3M MEC-GBM Sprayable Pheromone®) + TX, Senecioate Lavandulilla + TX, Leafroller pheromone (3M MEC — LR Sprayable Pheromone®) + TX, Muscamona (Snip7 Fly Bait® + TX), Oriental fruit moth pheromone (3M Oriental Fruit Moth Sprayable Pheromone®) + TX, Peach borer pheromone (Isomate-P®) + TX, Scenturion® + TX, Starbar Premium Fly Bait®) + TX, Tomato leafminer pheromone (3M Sprayable Pheromone®) + TX; Acerophagus papaya + TX, Adalia bipunctata (Adalia-System®) + TX, Adalia bipunctata (Adaline®) + TX, Adalia bipunctata (Aphidalia®) + TX, Ageniaspis citricola + TX, Ageniaspis fuscicollis + TX, Amblyseius andersoni (Anderline®, Andersoni-System®) + TX, Amblyseius californicus (Amblyline®, Spical®) + TX, Amblyseius cucumeris (Thripex®, Bugline cucumeris®) + TX, Amblyseius fallacis (Fallacis®) + TX, Amblyseius swirskii (Bugline swirskii®, Swirskii-Mite®) + TX, Amblyseius womersleyi (WomerMite®) + TX, Amitus hesperidum + TX, Anagrus atomus + TX, Anagyrus fusciventris + TX, Anagyrus kamali + TX, Anagyrus loecki + TX, Anagyrus pseudococci (Citripar®) + TX, Anicetus beneficis + TX, Petition 870260106348, dated 15 / 10 / 2026, p. 191 / 266 186 / 245 Anisopteromalus calandrae + TX, Anthocoris nemoralis (Anthocoris-System®) + TX, Aphelinus abdominalis (Apheline®, Aphiline®) + TX, Aphelinus asychis + TX, Aphidius colemani (Aphipar®) + TX, Aphidius ervi (Aphelinus-System®) + TX, Aphidius ervi (Ervipar®) + TX, Aphidius gifuensis + TX, Aphidius matricariae (Aphipar-M®) + TX, Aphidoletes aphidimyza (Aphidend®, Aphidoline®) + TX, Aphytis lingnanensis + TX, Aphytis melinus + TX, Aprostocetus hagenowii + TX, Atheta coriaria (Staphyline®) + TX, Bombus spp. + TX, Bombus terrestris (Beeline®, Tripol®) + TX, Bombus terrestris (Natupol Beehive®) + TX, Cephalonomia stephanoderis + TX, Chilocorus nigritus + TX, Chrysoperla carnea (Chrysoline®, Chrysopa®) + TX, Chrysoperla rufilabris + TX, Cirrospilus ingenuus + TX, Cirrospilus quadristriatus + TX, Citrostichus phyllocnistoides + TX, Closterocerus chamaeleon + TX, Closterocerus spp.+ TX, Coccidoxenoides perminutus (Planopar®) + TX, Coccophagus cowperi + TX, Coccophagus lycimnia + TX, Cotesia flavipes + TX, Cotesia plutellae + TX, Cryptolaemus montrouzieri (Cryptobug®, Cryptoline®) + TX, Cybocephalus nipponicus + TX, Dacnusa sibirica (Minusa®, DacDigline®, Minex®) + TX, Delphastus catalinae (Delphastus®) + TX, Delphastus pusillus + TX, Diachasmimorpha krausii + TX, Diachasmimorpha longicaudata + TX, Diaparsis jucunda + TX, Diaphorencyrtus aligarhensis + TX, Diglyphus isaea (Diminex®, Miglyphus®, Digline®) + TX, Diversinervus spp. + TX, Encarsia citrina + TX, Encarsia formosa (Encarsia max®, Encarline®, En-Strip®) + TX, Encarsia guadeloupae + TX, Encarsia haitiensis + TX, Episyrphus balteatus (Syrphidend®) + TX, Eretmoceris siphonini + TX, Eretmocerus californicus + TX, Eretmocerus. Petition 870260106348, dated 15 / 10 / 2026, p. 192 / 266 187 / 245 eremicus (Enermix®, Ercal®, Eretline e®, Bemimix®) + TX, Eretmocerus hayati + TX, Eretmocerus mundus (Bemipar®, Eretline m®) + TX, Eretmocerus siphonini + TX, Exochomus quadripustulatus + TX, Feltiella acarisuga (Feltiline®) + TX, Feltiella acarisuga (Spidend®) + TX, Fopius arisanus + TX, Fopius ceratitivorus + TX, Formononetin (Wirless Beehome®) + TX, Franklinothrips vespiformis (Vespop®) + TX, Galendromus occidentalis + TX, Goniozus legneri + TX, Habrobracon hebetor + TX, Harmonia axyridis (HarmoBeetle®) + TX, Heterorhabditis bacteriophora (NemaShield HB®, Nemaseek®, Terranem-Nam®, Terranem®, Larvanem®, B-Green®, NemAttack ®, Nematop®) + TX, Heterorhabditis megidis (Nemasys H®, BioNem H®, Exhibitline hm®, Larvanem-M®) + TX, Heterorhabditis spp.(Lawn Patrol®) + TX, Hippodamia convergens + TX, Hypoaspis aculeifer (Aculeifer-System®, Entomite-A®) + TX, Hypoaspis miles (Hypoline m®, EntomiteM®) + TX, Lbalia leucospoides + TX, Lecanoideus floccissimus + TX, Lemophagus errabundus + TX, Leptomastidea abnormis + TX, Leptomastix dactylopii (Leptopar®) + TX, Leptomastix epona + TX, Lindorus lophanthae + TX, Lipolexis oregmae + TX, Lucilia caesar (Natufly®) + TX, Lysiphlebus testaceipes + TX, Macrolophus caliginosus (Mirical-N®, Macroline c®, Mirical®) + TX, Mesoseiulus longipes + TX, Metaphycus flavus + TX, Metaphycus lounsburyi + TX, Micromus angulatus (Milacewing®) + TX, Microterys flavus + TX, Muscidifurax raptorellus e Spalangia cameroni (Biopar®) + TX, Neodryinus typhlocybae + TX, Neoseiulus californicus + TX, Neoseiulus cucumeris (THRYPEX®) + TX, Neoseiulus fallacis + TX, Nesideocoris tenuis (NesidioBug®, Nesibug®) + TX, Ophyra aenescens (Biofly®) + TX, Orius insidiosus (Thripor-I®,. Petition 870260106348, dated 10 / 15 / 2026, pp. 193 / 266 188 / 245 Oriline i®) + TX, Orius laevigatus (Thripor-L®, Oriline l®) + TX, Orius majusculus (Oriline m®) + TX, Orius strigicollis (Thripor-S®) + TX, Pauesia juniperorum + TX, Pediobius foveolatus + TX, Phasmarhabditis hermaphrodita (Nemaslug®) + TX, Phymastichus coffea + TX, Phytoseiulus macropilus + TX, Phytoseiulus persimilis (Spidex®, Phytoline p®) + TX, Podisus maculiventris (Podisus®) + TX, Pseudacteon curvatus + TX, Pseudacteon obtusus + TX, Pseudacteon tricuspis + TX, Pseudaphycus maculipennis + TX, Pseudleptomastix mexicana + TX, Psyllaephagus pilosus + TX, Psyttalia concolor (complex) + TX, Quadrastichus spp.+ TX, Rhyzobius lophanthae + TX, Rodolia cardinalis + TX, Rumina decollate + TX, Semielacher petiolatus + TX, Sitobion avenae (Ervibank®) + TX, Steinernema carpocapsae (Nematac C®, Millenium®, BioNem C®, NemAttack®, Nemastar®, Capsanem®) + TX, Steinernema feltiae (NemaShield®, Nemasys F®, BioNem F®, Steinernema-System®, NemAttack®, Nemaplus®, Exhibitline sf®, Scia-rid®, Entonem®) + TX, Steinernema kraussei (Nemasys L®, BioNem L®, Exhibitline srb®) + TX, Steinernema riobrave (BioVector®, BioVektor®) + TX, Steinernema scapterisci (Nematac S®) + TX, Steinernema spp. + TX, Steinernematid spp.(Guardian Nematodes®) + TX, Stethorus punctillum (Stethorus®) + TX, Tamarixia radiate + TX, Tetrastichus setifer + TX, Thripobius semiluteus + TX, Torymus sinensis + TX, Trichogramma brassicae (Tricholine b®) + TX, Trichogramma brassicae (Tricho-Strip®) + TX, Trichogramma evanescens + TX, Trichogramma minutum + TX, Trichogramma ostriniae + TX, Trichogramma platneri + TX, Trichogramma pretiosum + TX, Xanthopimpla stemmator + TX;. Petition 870260106348, dated 15 / 10 / 2026, p. 194 / 266 189 / 245 abscisic acid + TX, Aminomite® + TX, BioGain® + TX, bioSea® + TX, CAS Number: 2643947-26-4 + TX, Chondrostereum purpureum (Chontrol Paste®) + TX, Colletotrichum gloeosporioides (Collego®) + TX, Copper Octanoate (Cueva®) + TX, Delta Traps (Trapline d®) + TX, Erwinia amylovora (Harpina) (ProAct®, Ni-HIBIT Gold CST®) + TX, fatty acids derived from a natural byproduct of extra virgin olive oil (FLIPPER®) + TX, Ferriphosphate (Ferramol®) + TX, Funnel Traps (Trapline y®) + TX, Gallex® + TX, Grower's Secret® + TX, Homobrassonolide + TX, Iron Phosphate (Lilly Miller Worry Free Ferramol Slug & Snail Bait®) + TX, MCP Hail Trap (Trapline f®) + TX, Microctonus hyperodae + TX, Mycoleptodiscus terrestris (Des-X®) + TX, Nosema locustae (Semaspore Organic Grasshopper Control®) + TX, Pheromone Trap (Thripline ams®) + TX, Potassium Bicarbonate (MilStop®) + TX, Potassium Iodide + Potassium Thiocyanate (Enzicur®) + TX,Potassium salts of fatty acids (Sanova®) + TX, Potassium silicate solution (Sil-Matrix®) + TX, Spider venom + TX, Sticky traps (Trapline YF®, Rebell Amarillo®) + TX, SuffOil-X® + TX, Traps (Takitrapline y + b®) + TX; Bacillus mojavensis strain R3B (NCAIM Accession No. (P) B001389) (WO 2013 / 034938) from Certis USA LLC + TX, Bacillus pumilus, in particular strain BU F-33, having Accession No. NRRL 50185 (CARTISSA® from BASF, EPA Reg. No. 71840-19) + TX, Bacillus subtilis CX-9060 from Certis USA LLC, Bacillus sp., in particular strain D747 (available as DOUBLE NICKEL® from Kumiai Chemical Industry Co., Ltd.), having Accession No. FERM BP-8234, US Patent No. 7,094,592 + TX, Bacillus subtilis strain BU1814 (VELONDIS®PLUS, VELONDIS®FLEX and Petition 870260106348, dated 10 / 15 / 2026, pp. 195 / 266 190 / 245 VELONDIS® EXTRA from BASF SE) + TX, strain FZB24 of Bacillus subtilis var. amyloliquefaciens having DSM Accession No. 10271 (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA Registration No. 70127-5)) + TX, Bacillus subtilis, in particular strain QST713 / AQ713 (having NRRL Accession No. B21661 and described in US Patent No. 6,060,051, available as SERENADE®OPTI or SERENADE®ASO from Bayer CropScience LP, USA) + TX, Paenibacillus polymyxa, in particular strain AC1 (e.g., TOPSEED® from Green Biotech Company Ltd.) + TX, strain of Paenibacillus sp. having NRRL Accession No. B-50972 or NRRL Accession No. B-67129, WO 2016 / 154297 + TX, Pantoea agglomerans, in particular strain E325 (NRRL Accession No. B21856) (available as BLOOMTIME BIOLOGICAL™ FD BIOPESTICIDE from Northwest Agri Products) + TX, Pseudomonas proradix (e.g., PRORADIX® from Sourcon Padena) + TX; Aureobasidium pullulans, in particular blastospores of strain DSM14940, blastospores of strain DSM14941 or mixtures of blastospores of strains DSM14940 and DSM14941 (e.g., BOTECTOR® and BLOSSOM PROTECT® from bio-ferm, CH) + TX; Pseudozyma aphidis (as disclosed in WO2011 / 151819 by Yissum Research Development Company of the Hebrew University of Jerusalem) + TX, Saccharomyces cerevisiae, in particular strains No CNCM 13936, No CNCM 1-3937, No CNCM 1-3938 or No CNCM 1-3939 (WO 2010 / 086790) by Lesaffre et Compagnie, FR + TX; Agrobacterium radiobacter strain K84 (e.g., GALLTROL-A® from AgBioChem, CA) + TX, Bacillus amyloliquefaciens isolate B246 (e.g., AVOGREEN™ from the University of Pretoria) + TX, Bacillus amyloliquefaciens strain F727 (also known as strain MBI110) (NRRL Accession No. B-50768, WO 2014 / 028521) (STARGUS® from Marrone Bio Innovations) + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 196 / 266 191 / 245 strain FZB42 of Bacillus amyloliquefaciens, DSM Accession No. 23117 (available as RHIZOVITAL® from ABiTEP, DE) + TX, Bacillus amyloliquefaciens, in particular strain D747 (available as Double Nickel™ from Kumiai Chemical Industry Co., Ltd., having FERM Accession No. BP-8234, US Patent No. 7,094,592) + TX, Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (QUARTZO® (WG) and PRESENCE® (WP) from FMC Corporation) + TX, Bacillus licheniformis, in particular strain SB3086, having ATCC Accession No. 55406, WO 2003 / 000051 (available as ECOGUARD® Biofungicide and GREEN RELEAF™ Novozymes) + TX, Bacillus methylotrophicus strain BAC-9912 (from the Chinese Academy of Sciences' Institute of Applied Ecology) + TX, Bacillus mycoides isolate, having Accession No. B-30890 (available as BMJ TGAI® or WG and LifeGard™ from Certis USA LLC) + TX, Bacillus pumilus, in particular strain GB34 (available as Yield Shield® from Bayer AG, DE) + TX, Bacillus pumilus, in particular strain QST2808 (available as SONATA® from Bayer CropScience LP, USA, having Accession No. NRRL B-30087 and described in US Patent No.o6,245,551) + TX, Bacillus subtilis CX-9060 from Certis USA LLC + TX, Bacillus subtilis IAB / BS03 (AVIV™ from STK Bio-Ag Technologies, PORTENTO® from Idai Nature) + TX, Bacillus subtilis KTSB strain (FOLIACTIVE® from Donaghys) + TX, Bacillus subtilis BU1814 strain (available as VELONDIS®PLUS, VELONDIS®FLEX and VELONDIS®EXTRA from BASF SE) + TX, Bacillus subtilis GB03 strain (available as Kodiak® from Bayer AG, DE) + TX, Bacillus subtilis MBI 600 strain (available as SUBTILEX from BASF SE), having Accession Number NRRL B-50595, US Patent No. 5,061,495 + TX, Bacillus subtilis strain Y1336 (available as BIOBAC® WP from Bion-Tech, Taiwan,. Petition 870260106348, dated 10 / 15 / 2026, pp. 197 / 266 192 / 245 registered as a biological fungicide in Taiwan under Registration Nos. 4764, 5454, 5096 and 5277) + TX, strain FZB24 of Bacillus subtilis var. amyloliquefaciens having DSM Accession No. 10271 (available from Novozymes as TAEGRO® or TAEGRO® ECO (EPA Registration No. 70127-5)) + TX, Bacillus subtilis Y1336 (available as BIOBAC® WP from Bion-Tech, Taiwan, registered as a biological fungicide in Taiwan under Registration Nos. 4764, 5454, 5096 and 5277) + TX, Paenibacillus epiphyticus (WO 2016 / 020371) from BASF SE + TX, Paenibacillus polymyxa ssp. plantarum (WO 2016 / 020371) from BASF SE + TX, Paenibacillus sp. strain having NRRL No. B-50972 or NRRL No. B-67129, WO 2016 / 154297 + TX, Pseudomonas chlororaphis strain AFS009, having NRRL No. B-50897, WO 2017 / 019448 (e.g., HOWLER™ and ZIO® from AgBiome Innovations, US) + TX, Pseudomonas chlororaphis, in particular strain MA342 (e.g., CEDOMON®, CERALL® and CEDRESS® from Bioagri and Koppert) + TX, Pseudomonas fluorescens strain A506 (e.g., BLIGHTBAN® A506 by NuFarm) + TX, Pseudomonas proradix (e.g., PRORADIX® by Sourcon Padena) + TX, Streptomyces griseoviridis strain K61 (also known as Streptomyces galbus strain K61) (No DSM Accession 7206) (MYCOSTOP® by Verdera, PREFENCE® by BioWorks, cf. Crop Protection 2006, 25, 468-475) + TX, Streptomyces lydicus strain WYEC108 (also known as Streptomyces lydicus strain WYCD108US) (ACTINO-IRON® and ACTINOVATE® by Novozymes) + TX; strain T11 of Trichoderma atroviride (IMI352941 / CECT20498) + TX, strain AQ10 of Ampelomyces quisqualis, having CNCM Accession No. 1-807 (e.g., AQ 10® from IntrachemBio Italia) + TX, Ampelomyces quisqualis, in particular strain AQ 10 (e.g., AQ 10® from IntrachemBio Italia) + TX, strain NRRL 21882 of Petition 870260106348, dated 10 / 15 / 2026, pp. 198 / 266 193 / 245 Aspergillus flavus (products known as AFLA-GUARD® from Syngenta / ChemChina) + TX, Aureobasidium pullulans, in particular blastospores of the DSM 14941 strain + TX, Aureobasidium pullulans, in particular blastospores of the DSM14940 strain + TX, Aureobasidium pullulans, in particular mixtures of blastospores of the DSM14940 and DSM 14941 strains (e.g., Botector® by bio-ferm, CH) + TX, Chaetomium cupreum (CABI Accession No. 353812) (e.g., BIOKUPRUM™ from AgriLife) + TX, Chaetomium globosum (available as RIVADIOM® from Rivale) + TX, Cladosporium cladosporioides, strain H39 + TX, having Accession No. CBS122244, US 2010 / 0291039 (by Stichting Dienst Landbouwkundig Onderzoek) + TX, Coniothyrium minitans, in particular strain CON / M / 91-8 (Accession No. DSM9660, e.g., Contans® from Bayer CropScience Biologics GmbH) + TX, Cryptococcus flavescens, strain 3C (NRRL Y-50378) + TX, Dactylaria candida, Dilophosphora alopecuri (available as TWIST FUNGUS®), Fusarium oxysporum, strain Fo47 (available as FUSACLEAN® by Natural Plant Protection) + TX, strain J1446 of Gliocladium catenulatum (Synonym: Clonostachys rosea f. catenulatum) (e.g., Prestop® by Lallemand) + TX, strain IK726 of Gliocladium roseum (also known as Clonostachys rosea f. rosea) (Jensen DF, et al. Development of a biocontrol agent for plant disease control with special emphasis on the near commercial fungal antagonist Clonostachys rosea cepa ΊK726', Australasian Plant Pathol. 2007, 36 (2): 95-101) + TX, Gliocladium roseum (also known as Clonostachys rosea f rosea), in particular Adjuvants Plus strain 321U, strain ACM941 as disclosed in Xue AG (Efficacy of Clonostachys rosea strain ACM941 and fungicide seed treatments for controlling the root tot Petition 870260106348, dated 10 / 15 / 2026, pp. 199 / 266 194 / 245 field pea complex, Can Jour Plant Sci 2003, 83 (3) : 519524) + TX, Metschnikowia fructicola, in particular strain NRRL Y-30752 + TX, Microsphaeropsis ochracea, Penicillium steckii (DSM 27859, WO 2015 / 067800) from BASF SE + TX, mixtures of strain ICC 012 of Trichoderma asperellum (also known as ICC012 of Trichoderma harzianum), having CABI CC IMI Accession No. 392716 and strain ICC 080 of Trichoderma gamsii (formerly T. viride), having IMI Accession No. 392151 (e.g., BIO-TAM™ from Isagro USA, Inc. or BIODERMA® from Agrobiosol de Mexico, SA de CV) + TX, Penicillium vermiculatum + TX, Phlebiopsis gigantea strain VRA 1992 (ROTSTOP® C from Danstar Ferment) + TX, Pseudozyma flocculosa, strain PF-A22 UL (available as SPORODEX® L from Plant Products Co., CA) + TX, strain cell walls LAS117 from Saccharomyces cerevisiae (CEREVISANE® from Lesaffre, ROMEO® from BASF SE) + TX, strains CNCM No. 1-3936, CNCM No. 1-3937, CNCM No. 1-3938, CNCM No.° 1-3939 of Saccharomyces cerevisiae (WO 2010 / 086790) from Lesaffre et Compagnie, FR + TX, Saccharomyces cerevisiae, in particular strain LASO2 (from Agro-Levures et Dérivés) + TX, Simplicillium lanosoniveum + TX, strain T34 (e.g. T34 Biocontrol from Biocontrol Technologies SL, ES) or strain ICC 012 from Isagro + TX, strain WRL-076 (NRRL Y-30842), US Patent No. 7,579,183 + TX, Talaromyces flavus, strain V117b + TX, Trichoderma asperelloides JM41R (Accession No. NRRL B-50759) (TRICHO PLUS® from BASF SE) + TX, Trichoderma asperellum, in particular strain SKT-1, having Accession No. FERM P-16510 (e.g., ECO-HOPE® from Kumiai Chemical Industry) + TX, Trichoderma asperellum, in particular strain kd (e.g., T-Gro from Andermatt Biocontrol) + TX, strain 77B of Trichoderma atroviride (T77 from Andermatt Biocontrol) +. Petition 870260106348, dated 10 / 15 / 2026, pp. 200 / 266 195 / 245 TX, strain ATCC 20476 of Trichoderma atroviride (IMI 206040) + TX, strain LC52 of Trichoderma atroviride (e.g., Tenet from Agrimm Technologies Limited) + TX, strain LU132 of Trichoderma atroviride (e.g., Sentinel from Agrimm Technologies Limited) + TX, strain NMI No. V08 / 002388 of Trichoderma atroviride + TX, strain NMI No. V08 / 002389 of Trichoderma atroviride + TX, strain NMI No. V08 / 002390 of Trichoderma atroviride + TX, strain No. V08 / 002387 of Trichoderma atroviride + TX, strain SKT-1 of Trichoderma atroviride (FERM P-16510), JP Patent Publication (Kokai) 11-253151 A + TX, Trichoderma atroviride strain SKT-2 (FERM P-16511), JP Patent Publication (Kokai) 11-253151 A + TX, Trichoderma atroviride strain SKT-3 (FERM P-17021), JP Patent Publication (Kokai) 11-253151 A + TX, Trichoderma atroviride, in particular strain SC1 (Access No. CBS 122089, WO 2009 / 116106 and US Patent No. 8,431,120 (Bi-PA)) + TX, Trichoderma atroviride, strain CNCM 1-1237 (e.g.Esquive® WP from Agrauxine, FR) + TX, Trichoderma fertile (e.g., TrichoPlus product from BASF) + TX, Trichoderma gamsii (formerly T. viride) + TX, strain ICC 080 of Trichoderma gamsii (formerly T. viride) (IMI CC 392151 CABI) (available as BIODERMA® from AGROBIOSOL DE MEXICO, SA DE CV) + TX, strain ICC080 Trichoderma gamsii (IMI CC 392151 CABI, e.g., BioDerma from AGROBIOSOL DE MEXICO, SA DE CV), + TX, Trichoderma harmatum + TX, Trichoderma harmatum, having Accession No. ATCC 28012 + TX, Trichoderma harzianum + TX, Trichoderma harzianum rifai T39 (e.g. Trichodex® from Makhteshim, US) + TX, SimbT5 strain Trichoderma harzianum (from Simbiose Agro) + TX, Trichoderma harzianum strain DB 103 (available as T-GRO® 7456 from Dagutat Biolab) + TX, ITEM 908 strain of Trichoderma harzianum (e.g. Trianum. Petition 870260106348, dated 10 / 15 / 2026, pp. 201 / 266 196 / 245 P from Koppert) + TX, Trichoderma harzianum strain T-22 (e.g., Trianum-P from Andermatt Biocontrol or Koppert) + TX, Trichoderma harzianum strain TH35 (e.g., Root-Pro from Mycontrol) + TX, Trichoderma polysporum strain IMI 206039 (e.g., Binab TF WP from BINAB Bio-Innovation AB, Sweden) + TX, Trichoderma stromaticum with Accession No. Ts3550 (e.g., Tricovab from CEPLAC, Brazil) + TX, Trichoderma virens (also known as Gliocladium virens), in particular strain GL-21 (e.g., SoilGard from Certis, US) + TX, Trichoderma virens strain G-41, formerly known as Gliocladium virens (Accession No. ATCC 20906) (e.g. ROOTSHIELD® PLUS WP and TURFSHIELD® PLUS WP from BioWorks, US) + TX, Trichoderma viride in particular strain B35 (Pietr et al., 1993, Zesz. Nauk. AR w Szczecinie 161: 125-137) + TX, TV1 strain of Trichoderma viride (e.g. Trianum-P by Koppert) + TX, strain U3 of Ulocladium oudemansii, having Accession No. NM 99 / 06216 (e.g., BOTRY-ZEN® from Botry-Zen Ltd, New Zealand and BOTRYSTOP® from BioWorks, Inc.) + TX; strain WCS850 of Verticillium albo-atrum (formerly V. dahliae) having Accession No. WCS850, deposited with the Central Bureau for Fungi Cultures (e.g., DUTCH TRIG® by Tree Care Innovations) + TX, Verticillium chlamydosporium + TX;. a mixture of Azotobacter vinelandii and Clostridium pasteurianum (available as INVIGORATE® from Agrinos) + TX, a mixture of Bacillus licheniformis FMCH001 and Bacillus subtilis FMCH002 (available as QUARTZO® (WG), PRESENCE® (WP) from FMC Corporation) + TX, Azorhizobium caulinodans, in particular the strain ZB-SK-5 + TX, Azospirillum brasilense (e.g., VIGOR® from KALO, Inc.) + TX, Azospirillum lipoferum (e.g., VERTEX-IF™ from TerraMax, Inc.) + TX, Azotobacter Petition 870260106348, dated 10 / 15 / 2026, pp. 202 / 266 197 / 245 chroococcum, in particular the strain H23 + TX, Azotobacter vinelandii, in particular the strain ATCC 12837 + TX, Bacillus amyloliquefaciens BS27 (N.° de Accesso NRRL B-5015) + TX, Bacillus amyloliquefaciens, in particular the strain FZB42 (p. ex., RHIZOVITAL® from ABiTEP, DE) + TX, Bacillus amyloliquefaciens, especially a cepa IN937a + TX, Bacillus amyloliquefaciens pm414 (LOLI-PEPTA® from Biofilm Crop Protection) + TX, Bacillus amyloliquefaciens SB3281 (ATCC # PTA-7542, WO 2017 / 205258) + TX, Bacillus amyloliquefaciens TJ1000 (available as QUIKROOTS® na Novozymes) + TX, member of the Bacillus cereus family EE128 (NRRL No. B-50917) + TX, member of the Bacillus cereus family EE349 (NRRL No. B-50928) + TX, Bacillus cereus, in particular the BP01 family (ATCC 55675, p. ex., MEPICHLOR® from Arysta Lifescience, EUA) + TX, Bacillus mycoides BT155 (NRRL No. B-50921) + TX, Bacillus mycoides BT46-3 (NRRL No. B-50922) + TX, Bacillus mycoides EE118 (NRRL No. B-50918) + TX, Bacillus mycoides EE141 (N.° NRRL B-50916) + TX, Bacillus pumilus, in particular strain GB34 (e.g., YIELD SHIELD® from Bayer Crop Science, DE), + TX, Bacillus pumilus, in particular strain QST2808 (Accession No. NRRL B-30087) + TX, Bacillus siamensis, in particular strain KCTC 13613T + TX, Bacillus subtilis, in particular strain AQ30002 (Accession No. NRRL B-50421 and described in US Patent Application No. 13 / 330,576) + TX, Bacillus subtilis, in particular strain AQ30004 (No. NRRL B-50455 and described in US Patent Application No. 13 / 330,576) + TX, Bacillus subtilis, in particular the MBI 600 strain (e.g. SUBTILEX® from BASF SE) + TX, Bacillus subtilis rm303 (RHIZOMAX® from Biofilm Crop Protection) + TX, Bacillus subtilis strain BU1814 (available as TEQUALIS® from BASF SE) + TX, Bacillus. Petition 870260106348, dated 10 / 15 / 2026, pp. 203 / 266 198 / 245 tequilensis, in particular to strain NII-0943 + TX, Bacillus thuringiensis BT013A (N.° NRRL B-50924) also known as Bacillus thuringiensis 4Q7 + TX, Bradyrhizobium japonicum (e.g., OPTIMIZE® of Novozymes) + TX, Delftia acidovorans, in particular strain RAY209 (e.g., BIOBOOST® by Brett Young Seeds) + TX, Lactobacillus sp. (e.g., LACTOPLANT® by LactoPAFI) + TX, Mesorhizobium cicer (e.g., NODULATOR by BASF SE) + TX, Paenibacillus polymyxa, particularly strain AC-1 (e.g., TOPSEED® by Green Biotech Company Ltd.) + TX, Pseudomonas aeruginosa, particularly strain PN1 + TX, Pseudomonas proradix (e.g., PRORADIX® of Sourcon Padena) + TX, Rhizobium leguminosarium biovar viciae (e.g., NODULATOR of BASF SE) + TX, Rhizobium leguminosarum, in particular strain Z25 of bv. viceae (CECT Access No. 4585) + TX, Serratia marcescens, in particular strain SRM (N.MTCC Accession No. 8708), + TX, Sinorhizobium meliloti, strain NRG-185-1 (NITRAGIN® GOLD from Bayer CropScience) + TX, Thiobacillus sp. (e.g. CROPAID® from Cropaid Ltd UK) + TX; Myrothecium verrucaria strain AARC-0255 (e.g., DiTera™ from Valent Biosciences) + TX, Penicillium bilaii strain ATCC 22348 (e.g., JumpStart® from Acceleron BioAg) + TX, Penicillium bilaii strain ATCC ATCC20851 + TX, Purpureocillium lilacinum strain 251 (previously known as Paecilomyces lilacinus) (AGAL 89 / 030550, e.g., BioAct from Bayer CropScience Biologics GmbH) + TX, Pythium oligandrum strain DV74 + TX, Pythium oligandrum strain Ml (ATCC 38472, e.g., Polyversum from Bioprepraty, CZ) + TX, Rhizopogon amylopogon (Myco-Sol from Agri-Enterprise, LLC, formerly Helena Chemical Company) + TX, Rhizopogon fulvigleba (e.g., Myco-Sol from Agri-Enterprise, LLC, formerly Helena. Petition 870260106348, dated 10 / 15 / 2026, pp. 204 / 266 199 / 245 Chemical Company) + TX, Talaromyces flavus strain V117b + TX, Trichoderma asperellum strain (Eco-T from Plant Health Products, ZA) + TX, Trichoderma asperellum strain kd (e.g., T-Gro from Andermatt Biocontrol) + TX, Trichoderma atroviride, in particular strain no. V08 / 002387 + TX, Trichoderma atroviride strain CNCM 1-1237 (e.g., Esquive® WP from Agrauxine, FR) + TX, Trichoderma atroviride strain LC52 (also known as Trichoderma atroviride strain LU132, e.g., Sentinel from Agrimm Technologies Limited) + TX, Trichoderma atroviride strain no. V08 / 002388 + TX, strain no. NMI No. V08 / 002389 of Trichoderma atroviride + TX, strain in NMI No. V08 / 002390 of Trichoderma atroviride + TX, strain SC1 of Trichoderma atroviride (described in WO2009 / 116106) + TX, strain 1295-22 of Trichoderma harzianum + TX, strain ITEM 908 of Trichoderma harzianum + TX, strain T-22 of Trichoderma harzianum (e.g., Trianum-P from Andermatt Biocontrol or Koppert) + TX, strain TSTh20 of Trichoderma harzianum + TX, strain GI-3 of Trichoderma virens + TX, strain GL-21 of Trichoderma virens (e.g., SoilGard® from Certis, USA) + TX, strain B35 of Trichoderma viride (Pietr et al., 1993, Zesz. Nauk. AR w Szczecinie 161: 125-137) + TX, Verticillium alboatrum (formerly V. dahliae) strain WCS850 (CBS 276.92, e.g., Dutch Trig from Tree Care Innovations) + TX;. Agrobacterium radiobacter strain K84 (Galltrol from AgBiochem Inc.) + TX, Bacillus amyloliquefaciens, in particular strain PTS-4838 (e.g., AVEO from Valent Biosciences, USA), + TX, Bacillus mycoides isolate J. (e.g., BmJ from Certis USA LLC), + TX, Bacillus sphaericus, in particular serotype H5a5b of strain 2362 (strain ABTS-1743) (e.g., VECTOLEX® from Valent BioSciences, USA), + TX, Bacillus BMP 144 strain Petition 870260106348, dated 15 / 10 / 2026, p. 205 / 266 200 / 245 thuringiensis israelensis (p. ex., AQUABAC® da Becker Microbial Products IL) + TX, cepa GC-91 de Bacillus thuringiensis subsp. aizawai + TX, Bacillus thuringiensis subsp. aizawai, em particular sorotipo H-7 (p. ex., FLORBAC® WG da Valent BioSciences, E.U.A.) + TX, Bacillus thuringiensis subsp. aizawai, em particular cepa ABTS-1857 (SD-1372, p. ex., XENTARI® da Valent BioSciences) + TX, cepa AM65-52 of Bacillus thuringiensis subsp. israelensis (sorotype H-14) (ATCC Accession No. 1276) (e.g., VECTOBAC® from Valent BioSciences, USA) + TX, strain ABTS 351 of Bacillus thuringiensis subsp. kurstaki + TX, strain BMP 123 of Bacillus thuringiensis subsp. course (from Becker Microbial Products, IL, BARITONE from Bayer CropScience) + TX, strain EG 2348 of Bacillus thuringiensis subsp. kurstaki (LEPINOX da Certis, USA) + TX, strain EG 7841 of Bacillus thuringiensis subsp. course (CRYMAX da Certis, USA) + TX, strain HD-1 of Bacillus thuringiensis subsp. kurstaki (e.g., DIPEL® ES from Valent BioSciences, USA) + TX, strain PB 54 of Bacillus thuringiensis subsp. kurstaki + TX, strain SA 11 of Bacillus thuringiensis subsp. course (JAVELIN da Certis, USA) + TX, strain SA 12 of Bacillus thuringiensis subsp. kurstaki (THURICIDE de Certis, USA) + TX, strain NB 176 of Bacillus thuringiensis subsp. Tenebrionis (SD-5428, e.g., NOVODOR® FC and BioFa DE) + TX, Bacillus thuringiensis var.Colmeri (e.g., TIANBAOBTC from Changzhou Jianghai Chemical Factory) + TX, Buibui strain of Bacillus thuringiensis var. japonensis + TX, strain EVB-113-19 of Bacillus thuringiensis var. kurstaki (e.g., BIOPROTEC® from AEF Global) + TX, Brevibacillus laterosporus + TX, Burkholderia spp., in particular strain A396 of Burkholderia rinojensis (also known as strain. Petition 870260106348, of 15 / 10 / 2026, p. 206 / 266 201 / 245 MBI 305 from Burkholderia rinojensis) (Accession No. NRRL B50319, WO 2011 / 106491 and WO 2013 / 032693, e.g., MBI206 TGAI and ZELTO® from Marrone Bio Innovations), + TX, Chromobacterium subtsugae, in particular the PRAA4-1T strain (e.g., MBI-203, e.g., GRANDEVO® from Marrone Bio Innovations) + TX, Lecanicillium muscarium Ve6 (MYCOTAL from Koppert) + TX, Paenibacillus popilliae (formerly Bacillus popilliae, e.g., MILKY SPORE POWDER™ or MILKY SPORE GRANULAR™ from St. Gabriel Laboratories) + TX, Serratia entomophila (e.g., INVADE® from Wrightson Seeds) + TX, Serratia marcescens, in particular the SRM strain (Accession No. MTCC 8708) + TX, Trichoderma asperellum (TRICHODERMAX from Novozymes) + TX, ZAP onion from Wolbachia pipientis (eg, ZAP MALES® from MosquitoMate) + TX; Beauveria bassiana strain ATCC 74040 (e.g., NATURALIS® from Intrachem Bio Italia) + TX, Beauveria bassiana strain ATP02 (DSM Accession No. 24665), Apopka 97 (PREFERAL from SePRO) + TX, Beauveria bassiana strain GHA (Accession No. ATCC74250, e.g., BOTANIGUARD®ES and MYCONTROL-O® from Laverlam International Corporation) + TX, Metarhizium anisopliae 3213-1 (deposited under accession number NRRL 67074, disclosed in WO 2017 / 066094, Pioneer Hi-Bred International) + TX, Metarhizium robertsii 15013-1 (deposited under accession number NRRL 67073) + TX, Metarhizium robertsii 23013-3 (deposited under accession number NRRL 67075) + TX, strain 251 of Paecilomyces lilacinus (MELOCON from Certis, USA) + TX; Cydia pomonella granulosis virus (GV) (cotton bollworm) + TX, Helicoverpa armigera nucleopolyhedrosis virus (NPV) (cotton bollworm) + TX, Adoxophyes orana granulosis virus (GV) (summer fruit fall armyworm) + Petition 870260106348, dated 10 / 15 / 2026, pp. 207 / 266 202 / 245 TX, mNPV of Spodoptera small (ligarta-do-cartucho-dabeterraba) + TX, mNPV of Spodoptera frugiperda (ligarta-do-cartucho-do-milho) + TX; Burkholderia spp., in particular Burkholderia cepacia (formerly known as Pseudomonas cepacia) + TX, Gigaspora spp. + TX, Glomus spp. + TX, Laccaria spp. + TX, Lactobacillus buchneri + TX, Paraglomus spp. + TX, Pisolithus tinctorus + TX, Pseudomonas spp. + TX, Rhizobium spp., in particular Rhizobium trifolii + TX, Rhizopogon spp. + TX, Scleroderma spp. + TX, Streptomyces spp. + TX, Suillus spp. + TX, Agrobacterium spp. + TX, Azorhizobium caulinodans + TX, Azospirillum spp. + TX, Azotobacter spp. + TX, Bradyrhizobium spp. + TX, Gigaspora monosporum + TX; Allium sativum (NEMGUARD from Eco-Spray, BRALIC from ADAMA) + TX, Armour-Zen + TX, Artemisia absinthium + TX, Biokeeper WP + TX, Brassicaceae extract, in particular rapeseed powder or mustard powder + TX, Cassia nigricans + TX, Celastrus angulatus + TX, Chenopodium anthelminticum + TX, quinoa seed saponin extract from Chenopodium quinoa (e.g., Heads Up® (Quinoa Saponins) from Heads Up Plant Protectants, CA) + TX, Chitin + TX, Dryopteris filix-mas + TX, Equisetum arvense + TX, Fortune Aza + TX, Fungastop + TX, Melaleuca alternifolia extract (TIMOREX GOLD from STK) + TX, naturally occurring Blad polypeptide extracted from lupin seeds (FRACTURE® by FMC) + TX, naturally occurring Blad polypeptide extracted from lupin seeds (PROBLAD® by Certis EU) + TX, Pyrethrins + TX, Quassia amara + TX, Quercus + TX, Quillaja extract (QL AGRI 35 by BASF) + TX, REGALIA MAXX by Marrone Bio) + TX, Requiem™ insecticide + TX, Reynoutria extract Petition 870260106348, 15 / 10 / 2026, pág. 208 / 266 203 / 245 sachalinensis (REGALLIA + TX, riânia / rianodina + TX, Symphytum officinale + TX, Tanacetum vulgare + TX, Timol + TX, Timol mixed with Geraniol (CEDROZ from Eden Research) + TX, Timol mixed with Geraniol and Eugenol (MEVALONE from Eden Research) + TX, Triact 70 + TX, TriCon + TX, Tropaeulum majus + TX, Urtica dioica + TX, Veratrina + TX, Viscum album + TX; mercuric oxide + TX, octilinona + TX, thiophanate-methyla + TX; MGK 264 + TX, 2-(2-butoxyethoxy)ethyl piperonylate + TX, 2-isovalerilindan-1,3-dione + TX, 4-(quinoxalin-2-ylamino)benzenesulfonamide + TX, 5-(1,3-benzodioxol-5-yl)3-hexylcyclohex-2-enone + TX, acibenzolar + TX, acibenzolar-S-methyl + TX, alpha-bromadiolone + TX, alpha-chlorohydrin + TX, aluminum phosphide + TX, anthraquinone + TX, antu + TX, arsenic oxide + TX, barium carbonate + TX, benoxacor + TX, bistiosemi + TX, brodifacoum + TX, bromadiolone + TX, bromethalin + TX, calcium cyanide + TX, chloralose + TX, chlorophacinone + TX, cholecalciferol + TX, cloquintocete (including cloquintocete-mexil) + TX, copper naphthenate + TX, copper oxychloride + TX, coumachlor + TX, coumafuryl + TX, coumatetralyl + TX, crimidine + TX, cyprosulfamide + TX, diazinone + TX, dichlormide + TX, dicyclopentadiene + TX, difenacoum + TX, diphethialone + TX, diphacinone + TX, ergocalciferol + TX, farnesol + TX, farnesol with nerolidol + TX, fenchlorazole (including phenchlorazolethyl) + TX, phenclorim + TX,flocoumafen + TX, fluoroacetamide + TX, flupropadine + TX, flupropadine hydrochloride + TX, fluxfenim + TX, furilazole + TX, gamma-HCH + TX, guazatine + TX, guazatine acetates + TX, HCH + TX, Petition 870260106348, dated 10 / 15 / 2026, pp. 209 / 266 204 / 245 hydrogen cyanide + TX, imanine + TX, iodomethane + TX, isoxadifen (including isoxadifen-ethyl) + TX, lindane + TX, magnesium phosphide + TX, MB-599 + TX, mefenpyr (including mefenpyr-diethyl) + TX, metcamifene + TX, methiocarb + TX, methyl bromide + TX, nerolidol + TX, norbormide + TX, petroleum oils + TX, phosacetin + TX, phosphine + TX, phosphorus + TX, pindone + TX, piperonyl butoxide + TX, piprotal + TX, potassium arsenite + TX, probenazole + TX, propyl isomer + TX, pyridin-4-amine + TX, pirinurone + TX, Reynoutria extract sachalinensis + TX, ribavirin + TX, S421 + TX, esciliroside + TX, sesamex + TX, sesasmolina + TX, sodium arsenite + TX, sodium cyanide + TX, sodium fluoroacetate + TX, strychnine + TX, sulfoxide + TX, thallium sulfate + TX, thiram + TX, trimetacarb + TX, warfarin + TX, zinc naphthenate + TX, zinc phosphide + TX, ziram + TX.

[0285] In addition, the compositions of the invention can also be applied with one or more systemically acquired resistance inducers (SAR inducers). SAR inducers are known and described, for example, in U.S. Patent No. 6,919,298 and include, for example, salicylates and the commercial SAR inducer acibenzolar-S-methyl.

[0286] The compounds of formula (I), as defined in the present invention, are normally used in the form of compositions and can be applied to the crop area or plant to be treated, simultaneously or successively with other compounds. These other compounds may be, for example, fertilizers or micronutrient donors or other preparations that influence plant growth. The Petition 870260106348, dated 10 / 15 / 2026, pp. 210 / 266 205 / 245 can also be selective or non-selective herbicides, as well as insecticides, fungicides, bactericides, nematicides, molluscicides, or mixtures of several of these preparations, if desired, along with other carriers, surfactants, or application enhancers commonly used in the formulation technique.

[0287] The compounds of formula (I), as defined in the present invention, can be used in the form of compositions (fungicides) for control or protection against phytopathogenic microorganisms, comprising as an active ingredient at least one compound of formula (I), as defined in the present invention, or at least one preferred individual compound as defined above, in free form or in the form of an agrochemically usable salt, and at least one of the adjuvants mentioned above.

[0288] Consequently, the invention provides a composition, preferably a fungicidal composition, comprising at least one compound of formula (I), as defined in the present invention, an agriculturally acceptable carrier and optionally an adjuvant. An agriculturally acceptable carrier is, for example, one suitable for agricultural use. Carriers for agricultural purposes are well known in the art. Preferably, said composition may comprise at least one or more active compounds in pesticidal terms, for example, an additional fungicidal active ingredient in addition to the compound of formula (I), as defined in the present invention.

[0289] Another aspect of the invention relates to a method of controlling or preventing an infestation of plants, e.g., useful plants, such as cultivated plants, material Petition 870260106348, dated 10 / 15 / 2026, pp. 211 / 266 206 / 245 of propagation thereof, e.g., seeds, harvested crops, e.g., harvested food crops, or non-living materials, by phytopathogenic or deteriorating microorganisms, or organisms potentially harmful to humans, especially fungal organisms, comprising the application of a compound of formula (I), as defined in the present invention, or of a preferred individual compound, as defined above, as an active ingredient in plants, plant parts or loci thereof, in their propagation material or in any part of the non-living materials.

[0290] Control or prevention means reducing infestation by insects or phytopathogenic microorganisms or those that cause deterioration or organisms potentially harmful to humans, especially fungal organisms, to such a level that an improvement is demonstrated.

[0291] A preferred method of controlling or preventing an infestation of crop plants by phytopathogenic microorganisms, especially fungal organisms, comprising the application of a compound of formula (I), as defined in the present invention, or an agrochemical composition containing at least one of said compounds, is foliar application. The frequency and rate of application will depend on the risk of infestation by the corresponding pathogen or insect. However, the compounds of formula (I), as defined in the present invention, can also penetrate the plant through the roots via the soil (systemic action), by soaking the plant locus with a liquid formulation or by applying the compounds in solid form to the soil, e.g., in granular form (soil application). In rice crops in Petition 870260106348, dated 10 / 15 / 2026, pp. 212 / 266 207 / 245 water, these granules can be applied to flooded rice paddies. The compounds of formula (I), as defined in the present invention, can also be applied to seeds (coating), by impregnating the seeds or tubers with a liquid formulation of the fungicide or by coating them with a solid formulation.

[0292] A formulation, e.g., a composition containing the compound of formula (I), as defined in the present invention, and, if desired, a solid or liquid adjuvant or monomers to encapsulate the compound of formula (I), as defined in the present invention, can be prepared in a known manner, typically by thoroughly mixing and / or grinding the compound with extenders, for example, solvents, solid carriers and optionally surfactants.

[0293] The methods of applying the compositions, that is, the methods of controlling pathogens of the type mentioned above, such as spraying, atomizing, dusting, brushing, covering, spreading or pouring – which must be selected to suit the intended purposes of the existing circumstances – and the use of the compositions for controlling pathogens of the type mentioned above are other subjects of the invention. Typical concentration rates range from 0.1 to 1000 ppm, preferably from 0.1 to 500 ppm, of active ingredient. The application rate per hectare is preferably 1 to 2000 g of active ingredient per hectare, more preferably from 10 to 1000 g / ha, most preferably from 10 to 600 g / ha. When used as a soaking agent Petition 870260106348, dated 10 / 15 / 2026, pp. 213 / 266 For seeds weighing 208 / 245, the appropriate dosages are 10 mg to 1 g of active ingredient per kg of seeds.

[0294] When the combinations of the present invention are used for seed treatment, rates of 0.001 to 50 g of a compound of formula (I) per kg of seeds, preferably 0.01 to 10 g per kg of seeds, are generally sufficient.

[0295] Suitably, a composition comprising a compound of formula (I), as defined in the present invention, is applied preventively, i.e., before the development of disease, or curatively, i.e., after the development of disease.

[0296] The compositions of the invention can be employed in any conventional form, for example, in the form of a double package, a dry seed treatment powder (DS), a seed treatment emulsion (ES), a flowable seed treatment concentrate (FS), a seed treatment solution (LS), a water-dispersible seed treatment powder (WS), a seed treatment capsule suspension (CF), a seed treatment gel (GF), an emulsifiable concentrate (EC), a suspension concentrate (SC), a suspoemulsion (SE), a capsule suspension (CS), a water-dispersible granule (WG), an emulsifiable granule (EG), a water-in-oil emulsion (EO), an oil-in-water emulsion (EW), a microemulsion (ME), an oil dispersion (OD), an oil-miscible fluid (OF), an oil-miscible liquid (OL), a soluble concentrate (SL), an ultra-low volume suspension (SU), an ultra-low volume (UL) liquid,a technical concentrate (TK), a dispersible concentrate (DC), a wettable powder, Petition 870260106348, dated 10 / 15 / 2026, pp. 214 / 266 209 / 245 (WP) or any technically feasible formulation in combination with agriculturally acceptable adjuvants.

[0297] These compositions can be produced conventionally, e.g., by mixing the active ingredients with appropriate formulation inerts (diluents, solvents, fillers and optionally other formulation ingredients such as surfactants, biocides, antifreeze, adhesives, thickeners and compounds that provide adjuvant effects). Similarly, conventional slow-release formulations can be used when long-lasting efficacy is desired. In particular, formulations to be applied in spray forms, such as water-dispersible concentrates (e.g., EC, SC, DC, OD, SE, EW, EO and the like), wettable powders and granules, may contain surfactants such as wetting agents and dispersants and other compounds that provide adjuvant effects, e.g., the condensation product of formaldehyde with naphthalenesulfonate, an alkylarylsulfonate, a lignin sulfonate, a fatty alkylsulfate and ethoxylated alkylphenol and an ethoxylated fatty alcohol.

[0298] A seed coating formulation is applied to seeds in a manner known per se employing the combination of the invention and a diluent in a formulation suitable for seed coating, e.g., as an aqueous suspension or dry powder with good adherence to the seeds. These seed coating formulations are known in the art. The seed coating formulations may contain the individual active ingredients or the combination of active ingredients in encapsulated form, e.g., as slow-release capsules or microcapsules. Petition 870260106348, dated 10 / 15 / 2026, pp. 215 / 266 210 / 245

[0299] In general, formulations include 0.01 to 90% by weight of active agent, 0 to 20% of agriculturally acceptable surfactant, and 10 to 99.99% of solid or liquid formulation inerts and adjuvant(s), the active agent consisting at least of the compound of formula (I), as defined in the present invention, together with components (B) and (C), and optionally other active agents, particularly microbicides or preservatives or the like. Concentrated forms of the compositions generally contain between about 2 and 80%, preferably between about 5 and 70%, by weight of active agent. Application forms of the formulation may, for example, contain 0.01 to 20% by weight, preferably 0.01 to 5% by weight, of active agent. Although commercial products are preferably formulated as concentrates, the end user will normally employ diluted formulations.

[0300] Although it is preferable to formulate commercial products as concentrates, the end user will typically use diluted formulations. EXAMPLES

[0301] The following Examples serve to illustrate the invention. Certain compounds of the invention can be distinguished from known compounds by virtue of greater effectiveness at low application rates, which can be verified by a person skilled in the art using the experimental procedures outlined in the Examples. Formulation Examples Table 3 Wettable powders a) b) c) active ingredient [compound of the formula 25% 50% 75% (I)] Petition 870260106348, dated 10 / 15 / 2026, pp. 216 / 266 211 / 245 sodium lignosulfonate sodium lauryl sulfate sodium diisobutylnaphthalenesulfonate - 6% 10% sodium phenolic ether polyethylene glycol (7 to 8 mol of ethylene oxide) highly dispersed silicic acid Kaolin - 2% 5% 10% 10% % 27%

[0302] The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, providing wettable powders that can be diluted with water to provide suspensions of the desired concentration. Table 4 Powders for dry seed treatment a) b) c) active ingredient [compound of the formula 25% 50% 75% (I)] light mineral oil 5% 5% 5% highly dispersed silicic acid 5% 5% - Kaolin 65% 40% - Talc - 20%

[0303] The active ingredient is thoroughly mixed with the adjuvants and the mixture is thoroughly ground in a suitable mill, providing powders that can be used directly for seed treatment. Table 5 Emulsifiable concentrate active ingredient [compound of formula (I)] 10% octylphenolic ether of polyethylene glycol 3% (4 to 5 mol of ethylene oxide) Petition 870260106348, dated 10 / 15 / 2026, pp. 217 / 266 212 / 245 calcium dodecylbenzenesulfonate 3% castor oil polyglycol ether (35 mol of 4% ethylene oxide) Cyclohexanone 30% xylene mixture 50%

[0304] Emulsions of any required dilution, which can be used for plant protection, can be obtained from this concentrate by dilution with water. Table 6 Dusts a) b) c) Active ingredient [compound of formula (I)] 5% 6% 4% Talc 95% - - Kaolin - 94% - Mineral filler - - 96%

[0305] Ready-to-use powders are obtained by mixing the active ingredient with the carrier and grinding the mixture in a suitable mill. These powders can also be used for dry seed coatings. Table 7 Extruder granules Active ingredient [compound of formula (I)] 15% sodium lignosulfonate 2% carboxymethylcellulose 1% Kaolin 82%

[0306] The active ingredient is mixed and ground with the excipients, and the mixture is moistened with water. The mixture is extruded and then dried in an air stream. Petition 870260106348, dated 10 / 15 / 2026, pp. 218 / 266 213 / 245 Table 8 Coated granules Active ingredient [compound of formula (I)] 8% polyethylene glycol (200 mol by weight) 3% Kaolin 89%

[0307] The finely ground active ingredient is uniformly applied, in a mixer, to kaolin moistened with polyethylene glycol. Dust-free coated granules are obtained in this way. Table 9 Concentrated suspension active ingredient [compound of formula (I)] 40% propylene glycol 10% nonylphenol polyethylene glycol ether (15 mol 6% ethylene oxide) Sodium lignosulfonate 10% carboxymethylcellulose 1% silicone oil (in the form of a 75% 1% emulsion in water) Water 32%

[0308] The finely ground active ingredient is thoroughly mixed with the adjuvants, providing a concentrated suspension from which suspensions of any desired dilution can be obtained by dilution with water. Using these dilutions, it is possible to treat and protect live plants, as well as plant propagation material, against infestation by microorganisms, by spraying, pouring or immersion. Table 10 Concentrate suitable for flowable seed treatment. Petition 870260106348, dated 10 / 15 / 2026, pp. 219 / 266 214 / 245 active ingredient [compound of formula (I)] 40% propylene glycol 5% butanol copolymer PO / EO 2% tristenephenol with 10-20 moles of EO 2% 1,2-benzisothiazolin-3-one (in the form of a 0.5% solution in 20% water) calcium salt of monoazo pigment 5% silicone oil (in the form of a 75% emulsion in 0.2% water) Water 45.3%

[0309] The finely ground active ingredient is thoroughly mixed with the adjuvants, providing a concentrated suspension from which suspensions of any desired dilution can be obtained by dilution with water. Using these dilutions, it is possible to treat and protect live plants, as well as plant propagation material, against infestation by microorganisms, by spraying, pouring or immersion. Slow-Release Capsule Suspension

[0310] 28 parts of a combination of the compound of formula (I) are mixed with 2 parts of an aromatic solvent and 7 parts of a mixture of toluene diisocyanate / polymethylene-polyphenylisocyanate (8:1). This mixture is emulsified in a mixture of 1.2 parts polyvinyl alcohol, 0.05 parts an antifoaming agent and 51.6 parts water until the desired particle size is achieved. To this emulsion, a mixture of 2.8 parts 1,6-diaminohexane in 5.3 parts water is added. The mixture is stirred until the polymerization reaction is complete. Petition 870260106348, dated 10 / 15 / 2026, pp. 220 / 266 215 / 245

[0311] The resulting capsule suspension is stabilized by adding 0.25 parts of a thickener and 3 parts of a dispersing agent. The capsule suspension formulation contains 28% of the active ingredients. The average diameter of the capsules is 8 to 15 micrometers.

[0312] The resulting formulation is applied to seeds as an aqueous suspension in an apparatus suitable for that purpose. Analytical Methods

[0313] Throughout this description, temperatures are given in degrees Celsius (°C) and mf. means melting point. LC / MS stands for Liquid Chromatography Mass Spectrometry and the description of the apparatus and method is as follows: Method A:

[0314] Spectra were recorded on a Waters Mass Spectrometer (Acquity SDa Mass Spectrometer) equipped with an electrospray source (Polarity: Positive and Negative Polarity Exchange), Capillary: 0.8 kV, Cone Gamma: 25 V, Extractor: V (No extractor voltage for QDa detector) Source Temperature: 120 °C, Desolvation Temperature: 600 °C, Cone Gas Flow: 50 L / h, Desolvation Gas Flow: 1000 L / h, Mass Range: 110 to 850 Da) and a Waters Acquity UPLC: Quaternary solvent manager, heated column compartment, diode array detector. Column: Acquity UPLC HSS T3 C18, 1.8 μm, 30 x 2.1 mm, Temp: 40 °C, DAD wavelength range (nm): 200 to 400, Solvent Gradient: A = water + 5% Acetonitrile + 0.1% HCOOH, B = Acetonitrile + 0.05% HCOOH: gradient: 0 min 10% B; 0.0 to 0.2 min Petition 870260106348, dated 10 / 15 / 2026, pp. 221 / 266 216 / 245 at 50% B; 0.2 to 0.6 min 50 to 100% B; 0.6 to 1.3 min 100% B; 1.3 to 1.4 min 100 to 10% B; 1.4 to 1.6 min 10% B; Flow (mL / min) 0.6. Method B:

[0315] Spectra were recorded on a Waters Corporation Mass Spectrometer (Single Quadrupole Mass Spectrometer SQD, SQDII or QDa) equipped with an electrospray source (Polarity: positive and negative ions), Capillary: 0.8 to 3.00 kV, Cone: 5 to 30 V, Source Temperature: 120 to 150 °C, Desolvation Temperature: 350 to 600 °C, Cone Gas Flow: 50 to 150 L / h, Desolvation Gas Flow: 650 to 1000 L / h, Mass Range: 110 to 950 Da and a Waters Corporation Acquity UPLC: binary pump, heated column compartment, diode array detector and ELSD.Column: UPLC HSS T3, 1.8 μm, 30 x 2.1 mm from Waters, Temp: 60 °C, Wavelength range DAD (nm): 210 to 400, Running time: 1.5 min; Solvents: A = water + 5% MeOH + 0.05% HCOOH, B = Acetonitrile + 0.05% HCOOH; Flow rate (mL / min) 0.85, Gradient: 10% isocratic B for 0.2 min, then 10 to 100% B in 1.0 min, 100% isocratic B for 0.2 min, 100 to 10% B in 0.05 min, 10% isocratic B for 0.05 min. Method C:

[0316] Spectra were recorded on an Agilent Mass Spectrometer (simple quad mass spectrometer) equipped with a multimode electron sprayer and APCI (polarity: positive and negative ions), Capillary: 4.00 kV, Corona Current 4.0 μA, Charging Voltage, 2.00 kV, Nitrogen Gas Flow: 12.0 L / min, Sprayer Pressure: 40 psi, Mass Range: 100 to 1000 m / z), dry gas temperature 250 Petition 870260106348, dated 10 / 15 / 2026, pp. 222 / 266 217 / 245 °C, vaporizer temperature 200 °C and a Waters UPLC: quaternary pump, heated column compartment, variable wavelength detector. Column: X-Bridge BEH C18, 2.5 µm (2.1 * 50 mm), Column Temp: Ambient, Wavelength (nm): 215 nm, Gradient: A = 0.05% TFA in water, B = 0.05% TFA in Acetonitrile. Gradient: time / % of B: 0 / 5, 1 / 5, 5 / 70, 7 / 95, 8.5 / 95, 8, 6 / 5, 10 / 5; Flow rate: 0.6 mL / min.

[0317] Table 11 below gathers compounds of formula (I): - LC-MS data, such as retention time (RT), [M+H]+, - the type of method and / or - melting point (mp). Table 11: Compound name Molecule structure TR (min ) [M+H] (measured) Method pf (°C ) 1 N- [5- [6-[ (4- fluoro-3methyl-phenyl) - methyl- carbamoyl]-8- methyl- imidazo [1,2— b]pyridazin-3yl]-2- pyridyl] methyl carbamate —v / y XX / XI Z-^\ / ° 1.07 449 TO 196 198 Petition 870260106348, dated 10 / 15 / 2026, pp. 223 / 266 218 / 245 Compound name Molecular structure TR (min ) [Μ+Η] (medid ο) Method pf (°C ) 2 N- [5- [6-(6fluoro-3,4-dihidro-2Hquinolina-1carbonyl)-8metilimidazo[1,2 — b]piridazin-3yl]-2piridil]carbarn ato de methyla ° / / ! A—-z 1 d / Γ ΖΟ ο χ----' 1, 12 461 A 224 226 3 N- [5- [6-[ (4fluorophenyl) methylcarbamoyl]-8methylimidazo[1,2— b]pyridazin-311]-2pyridyl]carbarn ato de methyl ο / \^° ... Petition 870260106348, 15 / 10 / 2026, pág. 224 / 266 219 / 245 Compound name Molecule structure TR (min ) [M+H] (measured) Method mp (°C ) methyl-imidazo[1,2 — b]pyridazin-3- 11]-2pyridyl]methylcarbarnate 5 N- [5-[6-(6fluoro-3,4-dihydro-2Hquinoline-1carbonyl)imidazo [ o / Al / / \ox 0.99 421 A 208 210 Petition 870260106348, dated 10 / 15 / 2026, pp. 225 / 266 220 / 245 Compound name Molecule structure TR (min ) [M+H] (measured) Method mp (°C ) 7 N- [5- [6-[ (4- fluoro-3methyl-phenyl) - methyl- carbamoyl]imid azo [1,2- b]pyridazin-3- 11]-2pyridyl]methylcarbarnate \ ° \^ / tij Trv / z*^^ o—X / ° 1, 02 435 A 187 189 8 N-[5- [6- [ (4-fluoro-3methoxy-phenyl) methyl-carbamoyl]imid azo [1,2- b]pyridazin-3- yl]-2pyridyl]methylcarbarnate ° / X-° z ' z 1 AX\ ox 1.05 451 A 202 205 9 3- (4-acetamidothenyl)-N-(4-chlorophenyl)-Nmethyl-imidazo[1,2- b · \ / / ASxjÍX Ao 6, 51 420 C 230 240 Petition 870260106348, dated 10 / 15 / 2026, pp. 226 / 266 221 / 245 Name of the compound | Molecular structure | TR (min) | [M+H] (measured) | Method | pf (°C) | a]pyrimidine-6-carboxamide | 1 | 0 | 3-(4-acetamidophenyl)-N-(4-chlorophenyl)-N-methyl-imidazo[1,2b]pyridazine-6-carboxamide | ° | / N'X / ^rj | z / ZX\ / zN\ / '''''X XT M | 120 | 125 Example 1: Preparation of N-[5-[6-[(4-fluoro-3-methylphenyl)methylcarbamoyl]-8-methylimidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]methyl carbamate (Compound 1) (Compound 1) Step A: Preparation of 6-chloro-8-methylimidazo[1,2b]pyridazine (Compound Xl) (Compound XL)

[0318] To a solution of 6-chloro-4-methyl-pyridazin-3-amine (5.00 g, 34.1 mmol, 1.00 equiv.) in isopropanol (100 mL), Petition 870260106348, dated 10 / 15 / 2026, pp. 227 / 266 222 / 245 was added bromo-acetaldehyde-diethyl-acetal (14.7 mL, 92.2 mmol, 2.70 equiv.). The reaction mixture was stirred under reflux for 3 hours. The reaction mixture was diluted with water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure to provide 6-chloro-8-methyl-imidazo[1,2-b]pyridazine. LC-MS (method A): Tr 0.35 min, m / z = 168 / 170 (M+H)+ 1H-NMR (400 MHz, CDC1a, ppm) δ = 7.81 - 7.84 (m, 1H), 7.63 - 7.67 (m, 1H), 6.81 - 6.84 (m, 1H), 2.57 - 2.61 (m, 3H) Step B: preparation of N-(4-fluoro-3-methylphenyl)-N,8-dimethylimidazo[1-b-iridazine-6-carboxamide]

[0319] A mixture of 6-chloro-8-methyl-imidazo[1,2b]pyridazine (Compound X-1, 0.700 g, 4.17 mmol, 1.00 equiv.), 4-fluoro-N,3-dimethyl-aniline (0.58 g, 4.2 mmol, 1.0 equiv.), triethylamine (0.88 mL, 16 mmol, 1.1 equiv.), bis(benzonitrile)palladium chloride (0.246 g, 0.420 mmol, 0.100 equiv.) and 4,5-bis(diphenylphosphine)-9,9-dimethylxanthene (0.168 g, 0.420 mmol, 0.100 equiv.) in toluene (10.4 mL) in a high-pressure vessel was purged with nitrogen. The flask was pressurized with nitrogen and then with CO₂ gas. The reaction mixture was stirred at 110 °C for 12 hours. It was filtered through celite and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane / ethyl acetate). Petition 870260106348, dated 10 / 15 / 2026, pp. 228 / 266 223 / 245 to provide N-(4-fluoro-3-methylphenyl)-N,8-dimethylimidazo[1,2-b]pyridazine-6-carboxamide. LC-MS (method A) 2.61 (s, 3 H), 2.15 - 2.20 (m, 3 H). Step C: Preparation of 3-bromo-N-(4-fluoro-3-methylphenyl)N,8-dimethylimidazo[1,2-b]pyridazine-6-carboxamide

[0320] A solution of N-(4-fluoro-3-methylphenyl)-N,8-dimethylimidazo[1,2-b]pyridazine-6-carboxamide (0.400 g, 1.34 mmol, 1.00 equiv.) and N-bromosuccinimide (0.268 g, 1.47 mmol, 1.10 equiv.) in acetonitrile (5.36 mL) was stirred at room temperature for 16 hours. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane / ethyl acetate) to provide 3-bromo-N-(4-fluoro-3-methylphenyl)-N,8-dimethylimidazo[1,2-b]pyridazine-6-carboxamide. LC-MS (método A): Tr 1,13 min, m / z = 377 / 379 (M+H)+ 1H-NMR (400 MHz, CDCla, ppm) δ = 7,55 - 7, 65 (m, 1 H),7,13 - 7,27 (m, 1 H), 7,04 (br d, J = 4,75 Hz, 1 H), 6,81 -6,85 (m, 1 H), 6,78 (br d, J = 8,88 Hz, 1 H), 3,42 (s, 3 H),2,57 (s, 3 H), 2,14 (s, 3 H) Petição 870260106348, de 15 / 10 / 2026, pág. 229 / 266 224 / 245 Step D: Preparation of N-[5-[6-[(4-fluoro-3-methylphenyl)methylcarbamoyl]-8-methylimidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]methyl carbamate (Compound 1)

[0321] To a mixture of 3-bromo-N-(4-fluoro-3-methylphenyl)N,8-dimethylimidazo[1,2-b]pyridazine-6-carboxamide (0.200 g, 0.42 mmol, 1.00 equiv.), N-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-pyridyl]methyl carbamate (0.16 g, 0.55 mmol, 1.30 equiv.) and sodium carbonate (0.13 g, 1.27 mmol, To a solution of 3.00 equiv. in acetonitrile (3.39 mL), chlorine(2-dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2-(2'-amino-1,1'-biphenyl)]palladium(II) (0.034 g, 0.042 mmol, 0.10 equiv.) was added. The reaction mixture was degassed with argon and then stirred in a microwave at 80 °C for 2 hours. After cooling to room temperature, the reaction mixture was filtered through a Celite pad and washed with methanol. The filtrate was concentrated under reduced pressure.The crude residue was purified over a silica gel cartridge (cyclohexane / ethyl acetate) to provide N-[5-[6-[(4-fluoro-3-methylphenyl)-methylcarbamoyl]-8-methylimidazo[1,2b]pyridazin-3-yl]-2-pyridyl]methyl carbamate. LC-MS (method A): Tr 1.07 min, m / z = 449 (M+H)+ 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 10.41 (s, 1 H), 8.63 (s, 1 H), 8.20 (s, 1 H), 7.94 - 7.96 (m, 2 H), 7.41 - 7.43 (m, 2 H), 6.92 - 6.97 (m, 2 H), 3.72 (s, 3 H), 3.44 (s, 3 H), 2.61 (s, 3 H), 2.12 (m, 3 H). Example 2: Preparation of N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]methyl carbamate (Compound 2) Petition 870260106348, dated 10 / 15 / 2026, pp. 230 / 266 225 / 245 1-yl)-(8-methylimidazo[1,2-b]pyridazin-6-yl)methanone 6-chloro-8-methyl-imidazo[1,2b]pyridazine (Compound X-1) (0.500 g, 2.98 mmol, 1.00 equiv.), 6-fluoro-1,2,3,4-tetrahydroquinoline (0.47 g, 3.1 mmol, 1.1 equiv.), triethylamine (0.624 mL, 4.47 mmol, 1.50 equiv.), bis(benzonitrile)palladium chloride (0.120 g, 0.298 mmol, 0.100 equiv.), and 4,5-bis(diphenylphosphine)-9,9-dimethylxanthene (0.176 g, 0.300 mmol, 0.100 equiv.) in toluene (7.45 mL) in a high-pressure vessel was purged with nitrogen. The flask was pressurized with nitrogen and then with CO₂ gas. The reaction mixture was stirred at 110 °C for 6 hours. The reaction mixture was filtered through celite and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane / ethyl acetate) to provide (6-fluoro-3,4-dihydro-2H-quinolin-1-yl)-(8-methylimidazo[1,2-b]pyridazin-6yl)methanone.

[0323] LC-MS (method A): Tr 1.06 min, m / z = 311 (M+H)+ Petition 870260106348, dated 10 / 15 / 2026, pp. 231 / 266 226 / 245 Step B: preparation of (3-bromo-8-methyl-imidazo[1,2b]pyridazin-6-yl)-(6-fluoro-3,4-dihydro-2H-quinolin-1-

[0324] A solution of (6-fluoro-3,4-dihydro-2H-quinolin-1-yl)-(8-methylimidazo[1,2-b]pyridazin-6-yl)methanone (0.450 g, 1.23 mmol) and N-bromosuccinimide (0.246 g, 1.36 mmol, 1.10 equiv.) in acetonitrile (4.93 mL) was stirred at room temperature for 1 hour. The reaction mixture was poured into water and extracted with ethyl acetate. The combined organic layers were washed with brine, dried over sodium sulfate, filtered, and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane / ethyl acetate) to provide (3-bromo-8-methylimidazo[1,2-b]pyridazin-6-yl)-(6-fluoro-3,4-dihydro-2H-quinolin-1-yl)methanone. LC-MS (method A): Rt 1.18 min, m / z = 389 (M+H)+ Step C: Preparation of N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]methyl carbamate (Compound 2)

[0325] To a mixture of (3-bromo-8-methyl-imidazo[1,2b]pyridazin-6-yl)-(6-fluoro-3,4-dihydro-2H-quinolin-1yl)methanone (0.118 g, 0.300 mmol, 1.00 equiv.), Methyl N-[5(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2pyridyl]carbamate (0.116 g, 0.390 mmol, 1.30 equiv.) and sodium carbonate (0.096 g, 0.91 mmol, 3.00 equiv.) in acetonitrile (2.42 mL) were added chlorine(2 Petition 870260106348, dated 10 / 15 / 2026, pp. 232 / 266 227 / 245 dicyclohexylphosphino-2',4',6'-triisopropyl-1,1'-biphenyl)[2(2'-amino-1,1'-biphenyl)]palladium(II) (0.024 g, 0.03 mmol, 0.10 equiv.). The reaction mixture was degassed with argon and then stirred in a microwave at 80 °C for 2.5 hours. After cooling to room temperature, the reaction mixture was filtered through a Celite pad and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane / ethyl acetate) to give N-[5-[6-(6-fluoro-3,4-dihydro-2H-quinoline-1-carbonyl)-8-methylimidazo[1,2-b]pyridazin-3-yl]-2-pyridyl]methyl carbamate as a yellow solid. LC-MS (method A): Tr 1.12 min, m / z = 461 (M+H)+ 1H-NMR (400 MHz, DMSO-d6, ppm) δ = 10.38 (s, 1 H), 8.60 8.70 (m, 1 H), 8.26 (s, 1 H), 7.85 (br d, J = 8.44 Hz, 2 H), 7.4 - 7.4 - 16 H, (7.16 H 7.17 (m, 2 H), 6.74 - 6.87 (m, 1 H), 3.86 (br t, J = 6.24 Hz, 2 H), 3.71 (s, 3 H), 2.87 (t, J = 6.54 Hz, 2 H), Example 3: preparation of N-[5-[6-[(4-fluoro-3-methoxy-phenyl)methyl-carbamoyl]-8-methyl-imidazo[1,2-b]pyridazin-3-yl]-2pyridyl]methyl carbamate (Compound 4) dimethyl-imide zo[1^-b]pyride zine-6-carboxamide Petition 870260106348, of 15 / 10 / 2026, p. 233 / 266 228 / 245

[0326] A mixture of 6-chloro-8-methyl-imidazo[1,2b]pyridazine (Compound X-1) (0.500 g, 2.98 mmol, 1.00 equiv.), 4-fluoro-3-methoxy-N-methyl-aniline (0.486 g, 3.13 mmol, 1.05 equiv.), triethylamine (0.627 mL, 4.47 mmol, 1.50 equiv.), bis(benzonitrile)palladium chloride (0.120 g, 0.30 mmol, 0.10 equiv.) and 4,5-bis(diphenylphosphine)-9,9-dimethylxanthene (0.176 g, 0.30 mmol, 0.10 equiv.) in toluene (7.45 mL) in a high-pressure vessel was purged with nitrogen. The flask was pressurized with nitrogen and then with CO₂ gas. The reaction mixture was stirred at 110 °C for 6 hours. The reaction mixture was filtered through celite and concentrated under reduced pressure. The crude residue was purified over a silica gel cartridge (cyclohexane / ethyl acetate) to provide N-(4-fluoro-3-methoxyphenyl)-N,8-dimethylimidazo[1,2-b]pyridazine-6-carboxamide. LC-MS (method A): Tr 0.96 min, m / z = 315 (M+H)+ 1H-NMR (400 MHz, CDCla, ppm) δ = 7.68 (br s, 2 H), 7.01 (br s, 1 H), 6.85 - 6.94 (m, 1 H), 6.75 - 6.84 (m, 1 H), 6.64 (br s, 1 H), 3.78 (br s, 3 H), 3.50 (s, 3 H), 2.60 (br s, 3 H). Step B: preparation of 3-bromo-N-(4-fluoro-3-methoxyphenyl)N,8-dimethylimidazo[1,2-b]pyridazine-6-carboxamide Petition 870260106348, dated 10 / 15 / 2026, pp. 234 / 266 229 / 245

[0327] A solution of N-(4-fluoro-3-methoxyphenyl)-N,8-dimethylimidazo[1,2-b]pyridazine-6-carboxamide (0.662 g, 2.11 mmol, 1.00 equiv.) and N-bromosuccinimide (0.412 g, 2.32 mmol, 1.10 equiv.) in acetonitrile (8.42 mL) was stirred at room temperature for 1 hour. The re...

Claims

1. Compound of formula (I) characterized in that Z is O or S and preferably Z is O; each A1 is N or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6 alkyl, C3-6 cycloalkyl, C16 alkoxy-C1-6 alkyl, C3-6 cycloalkyl-C1-4 alkyl, C16 alkylsulfanyl, C1-6 alkylsulfinyl, C1-6 alkylsulfonyl, C1-6 alkoxy, amino and -NHC(O)C1-6 alkyl; A2 are independently CR2 or N, provided that no more than three A2 are N, preferably no more than two A2 are N, preferably no more than one A2 is N, and most preferably all four A2 are CR. R2 are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C2-6-alkenyl, C2-6-alkynyl, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-6alkyl, C16-alkylsulfanyl, C1-6-alkylsulfinyl, C1-6-alkylsulfonyl, C1-6-alkoxycarbonyl.C1-6-alkylaminocarbonyl,diC1 Petition 870260106348, of 10 / 15 / 2026, page 252 / 266 2 / 12 e-alkylaminocarbonyl and C1-alkylcarbonyl, wherein each of the C1-alkyl, C1-alkoxy, C1-alkoxy-C1-alkyl, C1-alkoxy-C1-alkoxy, C2-alkenyl, C2-alkynyl, C3-cycloalkyl, C3-cycloalkyl-C1-alkyl, C1-alkylsulfanyl, C1-alkylsulfinyl, C1-alkylsulfonyl, C1-alkoxycarbonyl, C1-alkylaminocarbonyl,diC1-alkylaminocarbonyl and C1-alkylcarbonyl groups is optionally substituted by one to three substituents independently selected from halogen, hydroxy and CN; A3 is CR3 or N; R3 is selected from hydrogen, halogen, Cn, C1-alkyl, C1-alkoxy, C1-alkoxy-C1-alkyl, C1-alkoxy-C1-alkoxy, C2-alkenyl, C2-alkynyl, C3-cycloalkyl, C3-cycloalkyl-C1-alkyl, C1-alkylsulfanyl, C1-alkylsulfinyl, C1-alkylsulfonyl, amino, C1-alkylamino, diC1-alkylamino and C3-cycloalkylamino, wherein each of the C1-alkyl, C1-alkoxy, C1-alkoxy-C1-alkyl groupsC1-C1-alkoxy, C2-alkenyl, C2-alkynyl, C3-cycloalkyl, C3-cycloalkyl-C1-alkyl, C1-alkylsulfanyl, C1-alkylsulfinyl, C1-alkylsulfonyl, amino, C1-alkylamino, diC1-alkylamino and C3-cycloalkylamino is optionally replaced by one to three substituents independently selected from halogen and CN; A4 is CH or N; R4 is selected from Ci-alkyl, Ci-alkoxy-Ci-alkyl, C3ecycloalkyl, C3-ecycloalkyl-Ci-4alkyl, C2-ealkenyl, C2ealkynyl, Ci-ealkoxy, Ci-ealkylsulfanyl-Ci-ealkyl, Ciealkylsulfinyl-Ci-ealkyl, Ci-alkylsulfonyl-Ci-alkyl, Ci-alkoxycarbonyl-Ci-alkyl, Ci-alkylaminocarbonyl-Ci Petition 870260106348, of 10 / 15 / 2026, p. 253 / 266 3 / 12 ealkyl, diCi-ealkylaminocarbonyl-Ci-ealkyl and CN, wherein each of the groups C1-ealkyl, C1-ealkoxy-C1-ealkyl, C3ecycloalkyl, C3-ecycloalkyl-Ci-4alkyl, C2-ealkenyl, C2ealkynyl, Ci-ealkoxy, Ci-ealkylsulfanyl-Ci-ealkyl, Cigalkylsulfinyl-Ci-galkyl,C1-ealkylsulfonyl-C1-ealkyl, C1-ealkoxycarbonyl-C1-ealkyl, C1-ealkylaminocarbonyl-C1-ealkyl and diC1-ealkylaminocarbonyl-C1-ealkyl are optionally substituted by one to three substituents independently selected from halogen and CN; wherein A3 and R4, considered together, optionally form a ring, preferably a heterocycle with 5 to 8 members and more preferably a heterocycle with 8 members; and R5 is selected from C1-alkyl, C1-alkoxy, C3-cycloalkyl, C3-cycloalkyl-C1-alkyl, C1-alkoxyC1-alkyl, C1-alkylamino, diC1-alkylamino, C1-alkoxyamino and C1-alkylC1-alkoxyamino, wherein each of the C1-alkyl, C1-alkoxy, C3-cycloalkyl, C3-cycloalkyl-C1-alkyl, C1-alkoxyC1-alkyl, C1-alkylamino, diC1-alkylamino, C1-alkoxyamino and C1-alkylC1-alkoxyamino groups is optionally substituted by one to three substituents independently selected from halogen and CN; or a salt or N-oxide thereof.

2. Compound according to claim i, characterized in that R1 are independently selected from hydrogen, C1-alkyl, C3-cycloalkyl, C1-alkoxy-C1-alkyl, C3-cycloalkyl-C1-4-alkyl and C1-alkoxy and, more preferably, R1 are independently selected from hydrogen and C1-alkyl. Petition 870260106348, dated 10 / 15 / 2026, pp. 254 / 266 4 / 12 3. Compound, according to any one of claims 1 or 2, characterized in that R1 are independently selected from hydrogen and C16 alkyl.

4. A compound according to any one of claims 1, 2 or 3, characterized in that R2 are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6-alkyl and C1-6-alkoxy-C1-6-alkoxy, C1-6-alkoxycarbonyl, C16-alkylaminocarbonyl, diC1-6-alkylaminocarbonyl and C16-alkylcarbonyl, wherein each of the C1-6-alkyl, C1-6-alkoxy-C1-6-alkyl, C1-6-alkoxy-C1-6-alkoxy, C1-6-alkoxycarbonyl, C1-6-alkylaminocarbonyl, diC16-alkylaminocarbonyl and C1-6-alkylcarbonyl groups is optionally substituted by one to three substituents independently selected from halogen, hydroxyl and CN.

5. Compound according to any one of claims 1, 2, 3 or 4, characterized in that R3 is selected from hydroxy, halogen, CN, C1-6 alkyl, C1-6 alkoxy, C16 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkoxy, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-6 alkyl, amino, C1-6 alkylamino, diC1-6 alkylamino and C3-6 cycloalkylamino, wherein each of the C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxy-C1-6 alkyl, C1-6 alkoxy-C1-6 alkoxy, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-6 alkyl, amino, C1-6 alkylamino, diC1-6 alkylamino and C3-6 cycloalkylamino groups is optionally substituted by one to three Substituents independently selected from halogen, hydroxyl, and CN. Petition 870260106348, dated 10 / 15 / 2026, pp. 255 / 266 5 / 12 6. Compound according to any one of claims 1, 2, 3, 4 or 5, characterized in that four A2s are CR2 and A3 is N.

7. Compound, according to any one of claims 1, 2, 3, 4 or 5, characterized in that χΧχ ^2<ÍT3 I 11 2 1 2 A2 A2 AC / AA is and, preferably, the three A2 are CR2 and A3 is CR3.

8. A compound according to any one of claims 1, 2, 3, 4 or 5, characterized in that A< 2X AC 2^NA is A and, preferably, the three A2 are CR2 and A3 is CR3.

9. Compound, according to any one of claims 1, 2, 3, 4 or 5, characterized in that four A2s are CR2 and A3 is CR3.

10. Compound according to claim 9, characterized in that A is 11. Compound, according to any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, characterized in that R4 is selected from C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl, C2-6 alkenyl, C2-6 alkynyl and C1-6 alkoxy, wherein each of the C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl, C2-6 alkenyl, C2-6 alkynyl and C1-6 alkoxy groups is optionally replaced by one to three Petition 870260106348, 15 / 10 / 2026, p. 256 / 266 6 / 12 substituents selected independently from halogen and CN.

12. Compound according to any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 11, characterized in that R5 is selected from C1-g-alkyl, C1-6-alkoxy, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-6-alkyl and C1-6-alkoxyC16-alkyl, wherein each of said groups is optionally substituted by one to three substituents independently selected from halogen and CN.

13. Composition, characterized in that it comprises an effective amount, in fungicidal terms, of a compound according to any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12.

14. Composition according to claim 13, characterized in that it further comprises at least one compound selected from an additional active ingredient, an appropriately formulated inert, a carrier, an adjuvant, and any mixtures thereof.

15. A method for combating, preventing, or controlling phytopathogenic diseases, characterized in that it comprises applying to a phytopathogen, at the locus of a phytopathogen, on a plant susceptible to attack by a phytopathogen, or on propagation material thereof, an effective quantity in fungicidal terms of a compound according to any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, or a composition characterized in that it comprises a compound according to any one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, or 12, or a composition according to any one of claims 13 or 14. Petition 870260106348, dated 15 / 10 / 2026, p. 257 / 266 7 / 12 16. A compound of the formula (XXX) 1 1 NI z>—r1 A θ' 0H Λλ ( A4 o N__ / / H \ \ 5 R (XXX) characterized in that each A1 is N or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6 alkyl, C3-6 cycloalkyl, C16 alkoxy-C1-6 alkyl, C3-6 cycloalkyl-C1-4 alkyl, C16 alkylsulfonyl, C1-6 alkoxy, amino and -NHC(O)C1-6 alkyl; and preferably R1 are independently selected from hydrogen and C1-6 alkyl; A4 is CH or N;and R5 is selected from C1-alkyl, C1-6-alkoxy, C3-6-cycloalkyl, C3-6-cycloalkyl-C1-6alkyl, C1-6-alkoxyC1-6alkyl, C1-6-alkylamino, diC1-6alkylamino, C1-6-alkoxyamino and C1-6alkylC1-6alkoxyamino, wherein each of the C16alkyl, C1-6alkoxy, C3-6-cycloalkyl, C3-6-cycloalkyl-C16alkyl, C1-6-alkoxyC1-6alkyl, C1-6-alkylamino, diC16alkylamino, C1-6-alkoxyamino and C1-6alkylC1-6alkoxyamino groups is optionally substituted by one to three substituents independently selected from halogen and CN; or a salt or N-oxide thereof.

17. A compound of formula (XI) Petition 870260106348, 10 / 15 / 2026, page 258 / 266 8 / 12 characterized in that each A1 is N or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1; R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6 alkyl, C3-6 cycloalkyl, C16 alkoxy-C1-6 alkyl, C3-6 cycloalkyl-C1-4 alkyl, C16 alkylsulfonyl, C1-6 alkoxy, amino and -NHC(O)C1-6 alkyl; and preferably R1 are independently selected from hydrogen and C1-6 alkyl; A2 are independently CR2 or N, provided that no more than three A2 are N, preferably all four A2 are CR2;R2 are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C3-6-cycloalkyl, C16-alkylsulfonyl, C1-6-alkoxycarbonyl, C16-alkylaminocarbonyl, diC1-6-alkylaminocarbonyl and C16-alkylcarbonyl, wherein each of the C1-6-alkyl, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C3-6-cycloalkyl, C1-6-alkylsulfonyl, C1-6-alkoxycarbonyl, C16-alkylaminocarbonyl, diC1-6-alkylaminocarbonyl and C16-alkylcarbonyl groups is optionally replaced by one to three substituents selected from halogen, hydroxyl and CN; and preferably, R2 are independently selected from hydrogen, halogen, CN, C1-6-alkyl, C1-6-alkoxy and C1-6-alkoxy-C1-6-alkyl; A3 is CR3 or N;Petition 870260106348, dated 10 / 15 / 2026, page 259 / 266 9 / 12 R3 is selected from hydrogen, halogen, CN, C1-alkoxy, C1-alkoxy-C ...3-alkoxy-C1-alkoxy-C1-alkoxy-C1-alkoxy-C1-alkoxy-C3-alkoxy-C1-alkoxy-C1-alkoxy-C1-alkoxy-C1-alkoxy-C3-alkoxy-C1-alkoxy-C1-alkoxy-C1-alkoxy-C3-alkoxy-C3-alkoxy-C1-alkoxy-C1-alkoxy-C1-alkoxy-C1-alkoxy-C1-alkoxy-C3-alkoxy-C3-alkoxy-C1-alkoxyR4 is selected from C1-g-alkyl, C1-galkoxy-C1-g-alkyl, C3g-cycloalkyl, C3-g-cycloalkyl-C1-4-alkyl, C2-galkenyl, C2-galquinyl, C1-galkoxy, C1-g-alkylsulfonyl-C1-g-alkyl, C1-galkoxycarbonyl-C1-g-alkyl, C1-g-alkylaminocarbonyl-C1g-alkyl, diC1-g-alkylaminocarbonyl-C1-g-alkyl and CN, wherein each of the groups C1-g-alkyl, C1-galkoxy-C1-g-alkyl, C3g-cycloalkyl, C3-g-cycloalkyl-C1-4-alkyl, C2-galkenyl, C2-galquinyl, C1-galkoxy, C1-g-alkylsulfonyl-C1-g-alkyl, C1-galkoxycarbonyl-C1-g-alkyl, C1-γ-alkylaminocarbonyl-C1γ-alkyl and diC1-γ-alkylaminocarbonyl-C1γ-alkyl are optionally substituted by one to three substituents selected from halogen and CN;and preferably R4 is selected from C1-g-alkyl, C1-galkoxy-C1-g-alkyl, C3g-cycloalkyl, C3-g-cycloalkyl-C1-4-alkyl and C1-galkoxy, wherein each of the C1-g-alkyl, C1-galkoxy-C1-g-alkyl, C3g-cycloalkyl, C3-g-cycloalkyl-C1-4-alkyl and C1-galkoxy groups is optionally substituted by one to three substituents selected independently from halogen and CN; and wherein A3 and R4, considered together, optionally form a ring, preferably a heterocycle with g members; Petition 870260106348, 15 / 10 / 2026, p. 260 / 266 10 / 12 or a salt or N-oxide thereof; or a compound of formula (II) (II) wherein each A1 is N or one A1 is N and one A1 is CR1; and preferably one A1 is N and one A1 is CR1. R1 are independently selected from hydrogen, hydroxy, halogen, CN, C1-6 alkyl, C3-6 cycloalkyl, C16 alkoxy-C1-6 alkyl, C3-6 cycloalkyl-C1-4 alkyl, C16 alkylsulfonyl, C1-6 alkoxy, amino and -NHC(O)C1-6 alkyl;and preferably, R1 are independently selected from hydrogen and C1-6 alkyl; A2 are independently CR2 or N, provided that no more than three A2 are N, preferably all four A2 are CR2; R2 are independently selected from hydrogen, hydroxyl, halogen, CN, C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C3-6-cycloalkyl, C16-alkylsulfonyl, C1-6-alkoxycarbonyl, C16-alkylaminocarbonyl, diC1-6-alkylaminocarbonyl and C16-alkylcarbonyl, wherein each of the C1-6-alkyl, C1-6-alkoxy-C1-6alkyl, C1-6-alkoxy-C1-6alkoxy, C3-6-cycloalkyl, C1-6-alkylsulfonyl, C1-6-alkoxycarbonyl, C16-alkylaminocarbonyl, diC1-6-alkylaminocarbonyl and C16-alkylcarbonyl groups is optionally replaced by one to three substituents selected from halogen, hydroxyl and CN;Petition 870260106348, dated 10 / 15 / 2026, pp. 261 / 266 11 / 12 and, preferably, R2 are independently selected from hydrogen, halogen, CN, C1-6 alkyl, C1-6 alkoxy and C1-6 alkoxy-C1-6 alkyl; A3 is CR3 or N; R3 is selected from hydrogen, halogen, CN, C16-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6-alkyl, C3-6-cycloalkyl, C1-6-alkylsulfonyl, amino, C1-6-alkylamino, diC1-6-alkylamino and C3-6-cycloalkylamino, wherein each of the C1-6-alkyl, C1-6-alkoxy, C1-6-alkoxy-C1-6-alkyl, C36-cycloalkyl, C1-6-alkylsulfonyl, amino, C1-6-alkylamino, diC1-6-alkylamino and C3-6-cycloalkylamino groups is optionally replaced by one to three substituents selected from halogen, hydroxy and CN; and preferably R3 is hydrogen;R4 is selected from C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C1-6 alkylsulfonyl-C1-6 alkyl, C1-6 alkoxycarbonyl-C1-6 alkyl, C1-6 alkylaminocarbonyl-C1-6 alkyl, diC1-6 alkylaminocarbonyl-C1-6 alkyl and CN, wherein each of the groups C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl, C2-6 alkenyl, C2-6 alkynyl, C1-6 alkoxy, C1-6 alkylsulfonyl-C1-6 alkyl, C1-6 alkoxycarbonyl-C1-6 alkyl, C1-6-alkylaminocarbonyl-C16alkyl and diC1-6-alkylaminocarbonyl-C1-6alkyl are optionally substituted by one to three substituents selected from halogen and CN;and preferably R4 is selected from C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, C36 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl and C1-6 alkoxy, wherein each of the C1-6 alkyl, C1-6 alkoxy-C1-6 alkyl, C36 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl and C1-6 alkoxy groups is optionally substituted by one to three substituents independently selected from halogen and CN; wherein A3 and R4, considered together, optionally form a ring, preferably a 6-membered heterocycle; and X is Cl, Br or I; or a salt or N-oxide thereof.